Clinical Trials

Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS

Conditions:   Venous Thromboses;   Stent Stenosis
Intervention:   Drug: Aspirin 100mg
Sponsors:   University of Zurich;   University Hospital Heidelberg;   Medical University of Vienna;   RWTH Aachen University;   Klinikum Arnsberg
Recruiting

Wed, 16 Oct 2019 12:00:00 EDT

Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin

Condition:   Aspirin
Intervention:   Drug: Aspirin 81 mg
Sponsor:   Hamilton Health Sciences Corporation
Completed

Wed, 07 Feb 2018 12:00:00 EST

TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease

Condition:   Cardiovascular Diseases
Interventions:   Other: placebo after awakening + aspirin before bedtime;   Other: aspirin after awakening + placebo before bedtime
Sponsors:   Leiden University Medical Center;   ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting

Mon, 21 Oct 2019 12:00:00 EDT

The Effectiveness of Aspirin on Preventing Pre-eclampsia

Condition:   Pre-Eclampsia
Intervention:   Drug: Aspirin
Sponsor:   The Third Affiliated Hospital of Guangzhou Medical University
Not yet recruiting

Mon, 07 Dec 2020 12:00:00 EST

Mobilization of Endothelial Progenitor Cells and Aspirin

Condition:   Hypertrophic Obstructive Cardiomyopathy
Intervention:   Drug: Aspirin
Sponsor:   Ottawa Heart Institute Research Corporation
Recruiting

Fri, 05 Feb 2016 12:00:00 EST

Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT).

Conditions:   Intracranial Aneurysm;   Inflammation
Intervention:   Drug: Aspirin
Sponsor:   University Hospital Southampton NHS Foundation Trust
Unknown status

Fri, 07 Sep 2018 12:00:00 EDT

Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery

Condition:   Coronary Artery Disease
Interventions:   Drug: aspirin continuation;   Drug: aspirin discontinuation
Sponsor:   Seoul National University Hospital
Completed

Wed, 06 Aug 2014 12:00:00 EDT

Aspirin for Uncontrolled Asthma

Condition:   Uncontrolled Asthma
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting

Tue, 20 Sep 2016 12:00:00 EDT

Prospective Study Investigating Aspirin and Intraoperative Blood Loss and Complications Following Inguinal Hernia Repair

Conditions:   Hernia, Inguinal;   Postoperative Complications;   Postoperative Hemorrhage
Intervention:   Drug: Aspirin
Sponsor:   Jesse Brown VA Medical Center
Unknown status

Wed, 12 Mar 2014 12:00:00 EDT

A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers

Condition:   Peptic Ulcer
Intervention:   Drug: aspirin
Sponsor:   Kaohsiung Veterans General Hospital.
Completed

Thu, 12 May 2011 12:00:00 EDT

Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip

Conditions:   Osteonecrosis of Femoral Head;   Osteonecrosis; Aseptic, Idiopathic
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   McGill University Health Centre/Research Institute of the McGill University Health Centre
Recruiting

Tue, 23 Jan 2018 12:00:00 EST

Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm Delivery

Condition:   Adenomyosis of Uterus
Intervention:   Drug: Aspirin/placebo
Sponsor:   Shanghai First Maternity and Infant Hospital
Not yet recruiting

Wed, 02 Sep 2020 12:00:00 EDT

Peri-operative Aspirin Continuation Versus Discontinuation

Conditions:   Hematuria;   Urinary Bladder Neoplasms
Intervention:   Drug: Aspirin
Sponsor:   Rabin Medical Center
Terminated

Thu, 29 Jan 2015 12:00:00 EST

Perioperative Bleeding and Aspirin Use in Spine Surgery

Conditions:   Hemorrhage;   Thrombosis
Intervention:   Drug: Acetylsalicylic acid
Sponsor:   University Hospitals Cleveland Medical Center
Unknown status

Tue, 21 Jun 2016 12:00:00 EDT

The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis

Condition:   Hemodialysis
Intervention:   Drug: acetylsalicylic acid
Sponsor:   Shanghai Jiao Tong University School of Medicine
Completed

Thu, 09 Oct 2014 12:00:00 EDT

Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease

Condition:   Kawasaki Disease
Intervention:   Drug: Aspirin
Sponsor:   Chang Gung Memorial Hospital
Unknown status

Tue, 10 Feb 2015 12:00:00 EST

Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin

Condition:   Platelet Aggregation Inhibitors
Intervention:   Drug: Aspirin
Sponsor:   Inova Health Care Services
Completed

Wed, 01 Apr 2020 12:00:00 EDT

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Condition:   Coronary Artery Disease
Intervention:   Drug: Dual antiplatelet therapy with a P2Y12 inhibitor plus aspirin
Sponsors:   Samsung Medical Center;   Inje University;   Seoul St. Mary's Hospital;   Mediplex Sejong Hospital;   Chonnam National University Hospital;   Sejong General Hospital;   Wonkwang University Hospital;   Gachon University Gil Medical Center;   Keimyung University Dongsan Medical Center;   Chungbuk National University Hospital;   Yeungnam University Hospital;   Chungnam National University Hospital;   Wonju Severance Christian Hospital;   Konkuk University Chungju Hospital;   Chung-Ang University Hosptial, Chung-Ang University College of Medicine;   Dankook University;   Incheon St.Mary's Hospital;   Gyeongsang National University Hospital;   Soonchunhyang University Hospital;   Ewha Womans University
Not yet recruiting

Wed, 10 Jul 2019 12:00:00 EDT

Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension

Condition:   Pre-Eclampsia
Intervention:   Drug: Aspirin 81mg
Sponsors:   Eastern Virginia Medical School;   AMAG Pharmaceuticals, Inc.
Recruiting

Tue, 01 Jun 2021 12:00:00 EDT

Aspirin on CTCs of Advanced Breast and Colorectal Cancer

Conditions:   Epithelial-Mesenchymal Transition;   Circulating Tumor Cells
Intervention:   Drug: Aspirin
Sponsor:   Zhejiang Provincial People's Hospital
Unknown status

Wed, 11 Nov 2015 12:00:00 EST

ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Condition:   CKD (Chronic Kidney Disease) Stage 5D
Intervention:   Drug: Aspirin 100 mg Oral Tablet
Sponsors:   Guangdong Provincial People's Hospital;   George Clinical Pty Ltd
Recruiting

Fri, 08 May 2020 12:00:00 EDT

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Conditions:   Venous Thromboembolism;   Ovarian Cancer
Intervention:   Drug: Aspirin
Sponsor:   Duke University
Recruiting

Mon, 20 Apr 2020 12:00:00 EDT

COMT on Aspirin Platelets Effects (CAPE)

Condition:   Cardiovascular Diseases
Interventions:   Drug: Aspirin 81 mg;   Drug: Placebo
Sponsors:   Brigham and Women's Hospital;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting

Wed, 14 Feb 2018 12:00:00 EST

Protective Effect of Aspirin on COVID-19 Patients

Conditions:   Novel Coronavirus Pneumonia;   Aspirin;   Treatment
Intervention:   Drug: Aspirin 100mg
Sponsor:   Xijing Hospital
Enrolling by invitation

Tue, 28 Apr 2020 12:00:00 EDT

Body Weight, Aspirin Dose and Pro-resolving Mediators

Condition:   Body Weight
Interventions:   Drug: Aspirin 81mg;   Drug: Aspirin 325mg
Sponsor:   NYU Langone Health
Recruiting

Wed, 06 Jan 2021 12:00:00 EST

Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds

Condition:   Ischemic Stroke
Interventions:   Drug: low-dose aspirin;   Drug: conventional-does aspirin
Sponsors:   Xijing Hospital;   Shaanxi Provincial People's Hospital;   The First Affiliated Hospital of Jiaotong University;   Tang-Du Hospital;   The First Affiliated Hospital of Xi'an Medical University;   Xi'an Central Hospital;   Xiangyang Central Hospital;   Baoji Central Hospital
Not yet recruiting

Fri, 07 Aug 2020 12:00:00 EDT

Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting

Conditions:   Coronary Artery Disease;   Aspirin
Interventions:   Drug: Aspirin;   Drug: vitamin C
Sponsor:   Medinet Heart Centre
Unknown status

Thu, 09 Feb 2017 12:00:00 EST

Effect of Aspirin on Gut Microbiome

Condition:   Healthy
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   University of Minnesota
Completed

Wed, 04 May 2016 12:00:00 EDT

EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - Taiwan

Condition:   Colorectal Neoplasms
Interventions:   Drug: Aspirin (Acetylsalicylic Acid, BAYE4465);   Other: No drug
Sponsor:   Bayer
Completed

Mon, 09 Jul 2018 12:00:00 EDT

Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease

Condition:   Cardiovascular Disease
Interventions:   Drug: Aspirin;   Drug: Durlaza™
Sponsor:   New Haven Pharmaceuticals, Inc.
Completed

Wed, 25 Feb 2015 12:00:00 EST

Platelet Hyperreactivity to Aspirin and Stroke

Conditions:   Stroke;   Cerebral Infarction;   Cardiovascular Diseases;   Vascular Diseases;   Atherosclerosis;   Ischemia;   Thrombosis;   Acute Coronary Syndrome
Intervention:   Drug: Aspirin (platelet sensitive versus platelet hyperreactivity)
Sponsors:   University of Sao Paulo;   Fundação de Amparo à Pesquisa do Estado de São Paulo;   Accumetrics, Inc.;   Helena Laboratories Point of Care;   Chrono-Log Corporation
Completed

Mon, 06 Oct 2008 12:00:00 EDT

Aspirin Resistance in Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Drug: enteric-coated aspirin;   Drug: Chewable aspirin
Sponsors:   Vanderbilt University;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Wed, 17 Sep 2008 12:00:00 EDT

Low-dose Aspirin Therapy for Esophageal Cancer

Condition:   Esophageal Cancer
Intervention:   Drug: Acetylsalicylic acid
Sponsor:   Zhejiang University
Withdrawn

Mon, 29 Dec 2014 12:00:00 EST

Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)

Conditions:   Pre-Eclampsia;   Stage 1 Hypertension;   Elevated Blood Pressure
Interventions:   Drug: Aspirin 81 mg;   Drug: Placebo
Sponsor:   Yale University
Recruiting

Tue, 26 May 2020 12:00:00 EDT

Transplacental Aspirin Therapy for Early Onset Fetal Growth Restriction

Conditions:   Fetal Growth Restriction;   Fetal Growth Retardation;   Intrauterine Growth Restriction;   Intrauterine Growth Retardation
Intervention:   Drug: Aspirin
Sponsor:   Johns Hopkins University
Withdrawn

Mon, 21 Sep 2020 12:00:00 EDT

Genotypic and Phenotypic Correlates of Resistance to Aspirin

Condition:   Platelet Dysfunction Due to Aspirin
Intervention:   Drug: aspirin
Sponsor:   George Washington University
Completed

Fri, 27 May 2011 12:00:00 EDT

Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia

Conditions:   Medication Adherence;   Preeclampsia
Intervention:   Drug: Low-dose aspirin
Sponsor:   Women and Infants Hospital of Rhode Island
Recruiting

Mon, 15 Mar 2021 12:00:00 EDT

Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)

Conditions:   G6PD Deficiency;   Stroke
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   First Affiliated Hospital, Sun Yat-Sen University
Recruiting

Thu, 12 Sep 2019 12:00:00 EDT

Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers

Condition:   Lynch Syndrome I (Site-specific Colonic Cancer)
Intervention:   Drug: Aspirin
Sponsors:   Tel-Aviv Sourasky Medical Center;   Rambam Health Care Campus;   Rabin Medical Center;   Soroka University Medical Center;   Sheba Academic Medical Center Hospital
Not yet recruiting

Wed, 15 Jul 2015 12:00:00 EDT

Antenatal Platelet Response On Aspirin and Correlation With HDP (Hypertensive Disorders of Pregnancy)

Condition:   Preeclampsia
Intervention:   Drug: Aspirin 81 mg
Sponsor:   Thomas Jefferson University
Recruiting

Thu, 05 Mar 2020 12:00:00 EST

Postoperative Aspirin and Ankle Fracture Healing

Condition:   Ankle Fractures
Intervention:   Drug: Aspirin
Sponsor:   University of Alabama at Birmingham
Recruiting

Wed, 05 Dec 2018 12:00:00 EST

Postpartum Low-Dose Aspirin and Preeclampsia

Condition:   Preeclampsia Postpartum
Interventions:   Drug: Aspirin;   Drug: Placebo oral capsule
Sponsor:   Columbia University
Recruiting

Wed, 12 Sep 2018 12:00:00 EDT

Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort

Condition:   Preeclampsia
Intervention:   Drug: Aspirin
Sponsor:   Peking Union Medical College Hospital
Not yet recruiting

Tue, 17 Nov 2020 12:00:00 EST

Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

Conditions:   Fallopian Tube Cancer;   Fallopian Tube Infection
Intervention:   Drug: Aspirin 81 mg
Sponsor:   University of Oklahoma
Recruiting

Tue, 11 Dec 2018 12:00:00 EST

Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum

Conditions:   Cardiovascular Disease;   Colorectal Cancer
Intervention:   Drug: Acetylsalicylic acid (Aspirin, BAYE4465)
Sponsor:   Bayer
Completed

Fri, 27 Jul 2018 12:00:00 EDT

Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI

Conditions:   Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions:   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Completed

Tue, 29 Dec 2015 12:00:00 EST

Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

Conditions:   Venous Thromboembolism;   Postpartum Period;   Aspirin
Interventions:   Drug: Aspirin 81 mg;   Drug: Placebo
Sponsors:   University of Calgary;   Canadian Institutes of Health Research (CIHR);   Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
Recruiting

Wed, 06 Nov 2019 12:00:00 EST

Low Dose Aspirin in the Prevention of Preeclampsia in China

Condition:   Preeclampsia
Interventions:   Drug: Aspirin;   Other: Blank
Sponsor:   Peking University First Hospital
Completed

Mon, 13 Jun 2016 12:00:00 EDT

Fish Oil and Aspirin With Type 2 Diabetes

Condition:   Cardiovascular Disease
Intervention:   Dietary Supplement: Fish Oil and Aspirin
Sponsors:   University of Rochester;   Cornell University;   Albany College of Pharmacy and Health Sciences
Completed

Fri, 13 Aug 2010 12:00:00 EDT

Role of ASpirin in Placental and Maternal Endothelial Cell Regulation IN Pre-eclampsia

Condition:   Pre-Eclampsia
Interventions:   Drug: Acetylsalicylic Acid 81 mg;   Drug: Acetylsalicylic Acid 162 mg;   Other: Control
Sponsor:   John O'Brien, MD
Recruiting

Thu, 28 Mar 2019 12:00:00 EDT

Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting

Conditions:   Cardiovascular Risk Factor;   C.Medical Procedure; Vascular, Functional or Late;   Electrolyte and Fluid Balance Conditions
Intervention:   Drug: 81 mg enteric coated aspirin
Sponsors:   University of Illinois at Urbana-Champaign;   Federal Emergency Management Agency
Completed

Thu, 13 Jan 2011 12:00:00 EST

Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients

Conditions:   Aspirin;   Gastric Cancer
Interventions:   Drug: Aspirin 100mg;   Drug: Placebo oral tablet
Sponsors:   National Cancer Center, Korea;   Incheon St.Mary's Hospital/The Catholic University;   Kosin University Gospel Hospital;   Pusan National University Hospital;   SMG-SNU Boramae Medical Center;   Chonnam National University Hospital;   Chung-Ang University Hosptial, Chung-Ang University College of Medicine;   Chilgok Kyungpook National University;   Hallym University Medical Center;   Seoul National University Hospital;   Asan Medical Center
Recruiting

Thu, 02 Jan 2020 12:00:00 EST

Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes

Condition:   Diabetes
Interventions:   Drug: Aspirin;   Other: Placebo
Sponsor:   University of Roma La Sapienza
Unknown status

Fri, 09 Sep 2016 12:00:00 EDT

Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients

Condition:   HIV-infected Patients
Intervention:   Drug: Aspirin
Sponsor:   Azienda Ospedaliera di Perugia
Completed

Fri, 20 Oct 2017 12:00:00 EDT

ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase

Conditions:   Purpura, Thrombocytopenic;   Idiopath Thrombocytopenic Purp;   Aspirin
Intervention:   Drug: Aspirin
Sponsor:   University Hospital, Toulouse
Not yet recruiting

Thu, 03 Jun 2021 12:00:00 EDT

ASpirin for Patients With SEPsis and SeptIc Shock

Condition:   Sepsis
Intervention:   Drug: Aspirin
Sponsor:   Federal University of São Paulo
Recruiting

Tue, 05 Feb 2013 12:00:00 EST

Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease

Condition:   Healthy Participants With Moderate and High Cardiovascular Risk
Intervention:   Other: Withdrawal of aspirin
Sponsor:   Yonsei University
Not yet recruiting

Wed, 28 Nov 2018 12:00:00 EST

Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention

Condition:   Preeclampsia
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   Rabin Medical Center;   University College, London
Completed

Wed, 26 Nov 2014 12:00:00 EST

Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy

Conditions:   Acute Coronary Syndrome;   Platelet Function and Reactivity Tests;   Novel P2Y12 Inhibitors
Intervention:   Drug: Aspirin
Sponsor:   Sheba Medical Center
Completed

Thu, 30 Jan 2014 12:00:00 EST

Low Doses of Aspirin in the Prevention of Preeclampsia

Condition:   Preeclampsia
Intervention:   Drug: acetylsalicylic acid
Sponsor:   Weill Medical College of Cornell University
Recruiting

Wed, 28 Aug 2019 12:00:00 EDT

The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease(AURORA)

Conditions:   Coronary Artery Disease;   Hyperuricemia
Interventions:   Drug: Aspirin 100 mg;   Drug: Clopidogrel 75mg
Sponsor:   Shanghai Zhongshan Hospital
Recruiting

Tue, 02 Oct 2018 12:00:00 EDT

An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.

Condition:   Stroke, Ischemic
Interventions:   Drug: Enteric Coated Aspirin Tablet;   Drug: Plain Aspirin
Sponsor:   Hamad Medical Corporation
Completed

Thu, 02 Apr 2020 12:00:00 EDT

Aspirin Dosing in Diabetic Patients

Conditions:   Type 2 Diabetes Mellitus;   Coronary Artery Disease
Intervention:   Drug: Aspirin
Sponsor:   University of Florida
Completed

Wed, 15 Sep 2010 12:00:00 EDT

WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)

Condition:   Acute Coronary Syndrome
Intervention:   Drug: Aspirin
Sponsor:   Sheffield Teaching Hospitals NHS Foundation Trust
Completed

Mon, 18 Apr 2016 12:00:00 EDT

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term

Condition:   Atherosclerotic Cardiovascular Disease
Intervention:   Drug: aspirin
Sponsors:   Duke University;   Patient-Centered Outcomes Research Institute;   Mytrus;   Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN);   Greater Plains Collaborative Clinical Data Research Network;   Mid-South Clinical Data Research Network;   Research Action for Health Network (REACHnet);   Patient-Centered Scalable National Network for Effectiveness Research;   PaTH Clinical Data Research Network;   New York City Clinical Data Research Network;   Health eHeart Patient Powered Network;   OneFlorida Clinical Data Research Network;   HealthCore-Anthem Research Network;   Humana-HUMnet;   The Patient-Centered Network of Learning Health Systems
Completed

Thu, 03 Mar 2016 12:00:00 EST

Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease

Conditions:   Nonalcoholic Fatty Liver;   Nonalcoholic Steatohepatitis
Interventions:   Drug: Aspirin 81 mg;   Drug: Placebo oral tablet
Sponsor:   Massachusetts General Hospital
Recruiting

Wed, 24 Jul 2019 12:00:00 EDT

The Effect of Aspirin on Patency of Metal Stent in Malignant Distal Bile Duct Obstruction

Condition:   Biliary Stasis, Extrahepatic
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   Woo Hyun Paik
Terminated

Tue, 12 Sep 2017 12:00:00 EDT

Aspirin and Preeclampsia

Condition:   Preeclampsia Postpartum
Interventions:   Drug: Aspirin 81 mg;   Drug: Placebo
Sponsor:   University of Chicago
Recruiting

Tue, 21 Jul 2020 12:00:00 EDT

PPARGC1β and CNTN4 Genotype Aspirin Study

Condition:   Cardiovascular Diseases
Intervention:   Drug: Aspirin
Sponsor:   Royal College of Surgeons, Ireland
Unknown status

Tue, 22 Nov 2016 12:00:00 EST

Study of Aspirin in Patients With Vestibular Schwannoma

Conditions:   Vestibular Schwannoma;   Acoustic Neuroma;   Neurofibromatosis 2
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   Massachusetts Eye and Ear Infirmary;   United States Department of Defense;   Massachusetts General Hospital
Recruiting

Wed, 15 Mar 2017 12:00:00 EDT

Effects of Aspirin on Uterine Endometrial Repair Severe Intrauterine Adhesion

Condition:   Intrauterine Adhesion
Interventions:   Drug: Aspirin;   Device: intrauterine balloon
Sponsor:   First Affiliated Hospital, Sun Yat-Sen University
Completed

Wed, 20 Apr 2016 12:00:00 EDT

Aspirin for Prevention of Preeclampsia

Condition:   Preeclampsia
Interventions:   Drug: aspirin 162 mg;   Drug: aspirin 81 mg;   Drug: placebo
Sponsor:   Aswan University Hospital
Unknown status

Wed, 31 Oct 2018 12:00:00 EDT

Adjuvant Aspirin Treatment for Colon Cancer Patients

Condition:   Colon Cancer
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   Swiss Group for Clinical Cancer Research;   European Organisation for Research and Treatment of Cancer - EORTC;   Central European Society for Anticancer Drug Research
Active, not recruiting

Wed, 10 Jun 2015 12:00:00 EDT

Resistance to Aspirin and/or Clopidogrel Among Patients With PAD.

Condition:   Intermittent Claudication
Intervention:   Drug: Aspirin
Sponsors:   Aalborg University Hospital;   Danish Heart Foundation
Completed

Wed, 07 Dec 2005 12:00:00 EST

Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting

Conditions:   Coronary Artery Bypass Surgery;   Stable Angina
Intervention:   Drug: Acetylsalicylic acid
Sponsors:   Karolinska University Hospital;   Karolinska Institutet
Completed

Fri, 26 Jun 2015 12:00:00 EDT

Early Administration of Aspirin in Patients With Acute Ischemic Stroke Treated With Systemic Thrombolysis

Conditions:   Stroke;   Brain Ischemia
Intervention:   Drug: acetylsalicylic acid
Sponsor:   City Clinical Hospital No. 67, Moscow, Russia
Unknown status

Mon, 03 Oct 2016 12:00:00 EDT

A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

Conditions:   Colon Cancer;   Adjuvant Therapy
Interventions:   Drug: Acetylsalicylic acid;   Drug: Placebo Acetylsalicylic acid
Sponsors:   Leiden University;   Stichting voor Patienten met Kanker aan het Spijsverteringskanaal (SPKS);   Dutch Colorectal Cancer Group;   Stichting Geriatrische Oncologie Nederland (GeriOnNe);   Fonds NutsOhra;   Innovatiefonds Zorgverzekeraars
Recruiting

Tue, 25 Nov 2014 12:00:00 EST

Aspirin Resistance in OSA Patients

Condition:   Obstructive Sleep Apnea
Intervention:   Other: Aspirin Resistance testing
Sponsors:   Danbury Hospital;   Accriva Diagnostics
Completed

Mon, 29 Apr 2019 12:00:00 EDT

Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)

Condition:   Premature Birth
Interventions:   Drug: Low dose aspirin;   Drug: Placebo
Sponsors:   NICHD Global Network for Women's and Children's Health;   Thomas Jefferson University;   Jawaharlal Nehru Medical College
Completed

Tue, 07 Apr 2015 12:00:00 EDT

Aspirin for Venous Ulcers: Randomised Trial (AVURT)

Condition:   Venous Leg Ulcer
Interventions:   Drug: Aspirin;   Drug: Placebo (for Aspirin)
Sponsors:   St George's, University of London;   University of York;   University of Manchester;   Bradford Teaching Hospitals NHS Foundation Trust;   Harrogate & District NHS Foundation Trust;   Hull University Teaching Hospitals NHS Trust;   University of Nottingham;   Cardiff University;   University of Newcastle Upon-Tyne
Terminated

Wed, 07 Jan 2015 12:00:00 EST

Chronic Subdural Hematoma and Aspirin

Condition:   Chronic Subdural Hematoma
Interventions:   Drug: Acetylsalicylic acid;   Drug: Placebo Oral Tablet
Sponsor:   University Hospital, Basel, Switzerland
Recruiting

Wed, 19 Apr 2017 12:00:00 EDT

Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma

Condition:   Aspirin as Adjuvant Therapy in Patients With Surgically Treated High Risk Renal Cell Carcinoma
Intervention:   Drug: Low dose of aspirin
Sponsor:   RenJi Hospital
Recruiting

Thu, 08 Nov 2018 12:00:00 EST

Ticagrelol Versus Aspirin in Ischemic Stroke

Conditions:   Acute Stroke;   Ischemic Stroke
Interventions:   Drug: Ticagrelor (Brilique) 90;   Drug: Aspirin 75mg
Sponsors:   Kafrelsheikh University;   Ain Shams University
Completed

Thu, 21 Mar 2019 12:00:00 EDT

Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Stroke;   Bleeding
Interventions:   Drug: Aspirin Tablet;   Drug: Placebo
Sponsor:   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting

Wed, 30 Jan 2019 12:00:00 EST

Aspirin for Prevention of Preeclampsia in Healthy, Nulliparous Obese and Overweight Pregnant Women

Condition:   Preeclampsia
Interventions:   Drug: Aspirin 162 mg;   Drug: Aspirin 81 mg;   Drug: placebo
Sponsor:   Aswan University Hospital
Recruiting

Wed, 31 Oct 2018 12:00:00 EDT

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority

Condition:   Rheumatic Heart Disease
Interventions:   Drug: Rivaroxaban (15 mg);   Drug: Aspirin
Sponsors:   Population Health Research Institute;   University of Cape Town
Not yet recruiting

Thu, 14 Jul 2016 12:00:00 EDT

Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma?

Conditions:   Head Trauma;   Traumatic Brain Injury;   Chronic Subdural Hematoma
Interventions:   Drug: discontinuation of aspirin therapy;   Drug: continuation of aspirin therapy
Sponsor:   Hadassah Medical Organization
Unknown status

Fri, 11 Nov 2011 12:00:00 EST

ASPIRIN: Neurodevelopmental Follow-up Trial

Condition:   Neurodevelopmental Abnormality
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   NICHD Global Network for Women's and Children's Health;   Thomas Jefferson University;   RTI International;   Thrasher Research Fund
Not yet recruiting

Mon, 17 May 2021 12:00:00 EDT

Effect of Aspirin on Mammogram Density in Healthy Postmenopausal Women With a Moderate or High Level of Breast Density

Condition:   Mammographic Breast Density
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI)
Completed

Mon, 07 May 2007 12:00:00 EDT

Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention

Conditions:   Acute Coronary Syndrome;   Interventional Cardiology
Interventions:   Drug: Aspirin;   Drug: Ticagrelor
Sponsor:   Fu Wai Hospital, Beijing, China
Not yet recruiting

Mon, 27 Jan 2020 12:00:00 EST

Trial of Aspirin and Arginine Restriction in Colorectal Cancer

Condition:   Colorectal Cancer
Intervention:   Drug: Aspirin
Sponsor:   University of California, Irvine
Active, not recruiting

Fri, 21 Dec 2007 12:00:00 EST

Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients

Conditions:   Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 3
Intervention:   Drug: Aspirin
Sponsor:   Fundación de Ayuda a la Investigación sobre la Hipertensión, Riesgo Cardiovascular y Enfermedades Renales
Unknown status

Thu, 18 Oct 2012 12:00:00 EDT

Antenatal Platelet Response on Aspirin and Correlation With Hypertensive Disorders of Pregnancy: a Pharmacokinetic Study Through Pregnancy

Condition:   Preeclampsia
Intervention:   Drug: Aspirin 81Mg Ec Tab
Sponsors:   Thomas Jefferson University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   March of Dimes
Recruiting

Wed, 25 Nov 2020 12:00:00 EST

Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects

Condition:   Healthy
Intervention:   Drug: aspirin
Sponsor:   Brigham and Women's Hospital
Completed

Tue, 12 May 2009 12:00:00 EDT

An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants

Condition:   Healthy Volunteers
Interventions:   Drug: Aspirin;   Drug: BMS-986177;   Drug: Placebo
Sponsor:   Bristol-Myers Squibb
Completed

Tue, 14 Nov 2017 12:00:00 EST

Mechanism Based Resistance to Aspirin

Conditions:   Aspirin Resistance;   Pharmacological Aspirin Non-responsiveness
Intervention:   Drug: Aspirin
Sponsors:   University of Pennsylvania;   National Institutes of Health (NIH);   Bayer
Completed

Thu, 30 Jul 2009 12:00:00 EDT

The Effects of Aspirin in Gestation and Reproduction

Conditions:   Birth;   Spontaneous Abortion
Interventions:   Drug: acetylsalicylic-acid (aspirin);   Dietary Supplement: Folic acid
Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed

Mon, 30 Apr 2007 12:00:00 EDT

Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer

Conditions:   Rectal Cancer, Adenocarcinoma;   Locally Advanced Malignant Neoplasm;   Chemoradiation
Interventions:   Drug: Aspirin;   Drug: Placebo Oral Tablet
Sponsor:   Instituto Nacional de Cancer, Brazil
Terminated

Tue, 30 May 2017 12:00:00 EDT

Aspirin Effects on Emotional Reactions

Condition:   Healthy Adults
Interventions:   Drug: Aspirin 500 MG;   Drug: Placebo
Sponsor:   Ohio State University
Enrolling by invitation

Thu, 31 Oct 2019 12:00:00 EDT

Aspirin to Target Arterial Events in Chronic Kidney Disease

Conditions:   Chronic Kidney Diseases;   Cardiovascular Diseases;   Bleeding
Intervention:   Drug: Aspirin
Sponsors:   University of Southampton;   University of Nottingham;   University of Warwick;   Nottingham University Hospitals NHS Trust;   East Kent Hospitals University NHS Foundation Trust;   University of Durham;   Epsom and St Helier University Hospitals NHS Trust
Recruiting

Tue, 08 Jan 2019 12:00:00 EST

Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial

Conditions:   Aortic Valve Disease;   Myocardial Infarction;   Stroke
Interventions:   Drug: Aspirin (80 mg/d) + clopidogrel (75 mg/d);   Drug: Aspirin
Sponsors:   Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec;   Edwards Lifesciences
Completed

Wed, 21 Mar 2012 12:00:00 EDT

Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: PL2200 Aspirin Capsules;   Drug: Enteric-coated aspirin caplets
Sponsor:   PLx Pharma
Completed

Wed, 11 Dec 2013 12:00:00 EST

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial

Condition:   Coronary Artery Disease
Interventions:   Drug: Clopidogrel and Aspirin;   Drug: Fixed dose combination of clopidogrel/aspirin
Sponsors:   Chong Kun Dang Pharmaceutical;   Inje University
Completed

Wed, 21 Dec 2011 12:00:00 EST

Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages

Condition:   Recurrent Pregnancy Loss
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   Ain Shams University
Unknown status

Mon, 09 Jul 2012 12:00:00 EDT

Aspirin in Asymmetrically Intrauterine Growth

Condition:   Intrauterine Growth Restriction Asymmetrical
Intervention:   Drug: Aspirin
Sponsor:   Assiut University
Completed

Tue, 31 Jan 2017 12:00:00 EST

Aspirin Attenuates Inflammation in Human Cerebral Aneurysms

Condition:   The Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral Aneurysm
Intervention:   Drug: aspirin
Sponsor:   University of Iowa
Completed

Thu, 18 Oct 2012 12:00:00 EDT

Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Cilostazol;   Drug: Acetylsalicylic acid
Sponsors:   Kangbuk Samsung Hospital;   Asan Medical Center
Unknown status

Fri, 14 Oct 2016 12:00:00 EDT

Low Dose Aspirin for Venous Leg Ulcers

Condition:   Venous Leg Ulcer
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   University of Auckland, New Zealand;   Health Research Council, New Zealand
Completed

Mon, 09 Jun 2014 12:00:00 EDT

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II

Conditions:   Stroke;   Transient Ischemic Attack
Interventions:   Drug: Ticagrelor and Aspirin;   Drug: Clopidogrel and Aspirin
Sponsors:   Beijing Tiantan Hospital;   Ministry of Science and Technology of the People´s Republic of China
Active, not recruiting

Fri, 06 Sep 2019 12:00:00 EDT

ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

Condition:   Colorectal Cancer
Interventions:   Drug: Aspirin;   Other: Placebo
Sponsors:   Massachusetts General Hospital;   National Cancer Institute/NIH/DHHS (NCI);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Institutes of Health (NIH)
Not yet recruiting

Mon, 27 Sep 2021 12:00:00 EDT

Multiple Daily Doses of Aspirin to Overcome Hyporesponsiveness Post Cardiac Bypass Surgery (ASACABG)- Part B

Condition:   Postoperative Dysfunction Following Cardiac Surgery
Intervention:   Drug: Aspirin
Sponsor:   Hamilton Health Sciences Corporation
Completed

Thu, 18 Jul 2013 12:00:00 EDT

Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients

Condition:   End-Stage Renal Disease
Interventions:   Drug: aspirin;   Drug: Placebo
Sponsors:   Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation;   Taipei Veterans General Hospital, Taiwan
Withdrawn

Fri, 10 Sep 2010 12:00:00 EDT

Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study

Condition:   Heart Failure
Interventions:   Drug: Aspirin;   Other: withdrawal of aspirin
Sponsor:   The Alfred
Completed

Thu, 16 Feb 2012 12:00:00 EST

Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

Condition:   Venous Thromboembolism
Intervention:   Drug: Aspirin
Sponsors:   University of Miami;   Sagie Haziza
Recruiting

Wed, 04 Mar 2020 12:00:00 EST

Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida

Conditions:   Pre-Eclampsia;   Hypertension in Pregnancy;   Obesity
Interventions:   Drug: Aspirin 81 mg;   Drug: Aspirin 162 mg
Sponsor:   The University of Texas Health Science Center, Houston
Recruiting

Thu, 23 May 2019 12:00:00 EDT

Adjuvant Low Dose Aspirin in Colorectal Cancer

Condition:   Colorectal Cancer
Interventions:   Drug: Acetylsalicylic acid;   Drug: Placebo
Sponsors:   Anna Martling;   Uppsala University Hospital;   Skane University Hospital
Recruiting

Wed, 06 Jan 2016 12:00:00 EST

Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis

Conditions:   Fatigue;   Overheating
Interventions:   Drug: Acetylsalicylic acid at 1st visit, then Placebo at 2nd visit;   Drug: Placebo at 1st visit, then Acetylsalicylic acid at 2nd visit
Sponsors:   Columbia University;   National Multiple Sclerosis Society
Completed

Tue, 14 Feb 2017 12:00:00 EST

ASPirin Intervention for the REDuction of Colorectal Cancer Risk

Condition:   Colorectal Cancer
Interventions:   Drug: Aspirin;   Drug: Placebo for Aspirin
Sponsors:   Massachusetts General Hospital;   National Cancer Institute (NCI)
Active, not recruiting

Fri, 20 Mar 2015 12:00:00 EDT

The Effect Of Aspirin On Survival in Lung Cancer

Conditions:   Non Small Cell Lung Cancer;   Survival;   Aspirin
Interventions:   Drug: Aspirin 75 mg;   Other: no aspirin
Sponsor:   Liverpool Heart and Chest Hospital NHS Foundation Trust
Withdrawn

Fri, 29 Jan 2010 12:00:00 EST

The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases

Condition:   Asthma, Aspirin-Induced
Intervention:   Drug: aspirin
Sponsors:   Tehran University of Medical Sciences;   Rassoul Akram Hospital
Completed

Mon, 03 Jun 2013 12:00:00 EDT

A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

Condition:   Gastric Ulcer
Interventions:   Drug: PA32540;   Drug: EC Aspirin 325
Sponsor:   POZEN
Completed

Tue, 18 Aug 2009 12:00:00 EDT

GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet Therapy

Conditions:   Coronary Artery Disease;   Gastroesophageal Reflux Disease
Interventions:   Drug: Indobufen and aspirin mimetic;   Drug: Aspirin and indobufen mimetic
Sponsor:   Beijing Anzhen Hospital
Unknown status

Wed, 16 Oct 2019 12:00:00 EDT

ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial

Condition:   Acute Respiratory Distress Syndrome
Interventions:   Drug: Aspirin 75mg;   Drug: Lactose powder
Sponsors:   Belfast Health and Social Care Trust;   Queen's University, Belfast;   Northern Ireland Clinical Trials Unit
Terminated

Mon, 29 Dec 2014 12:00:00 EST

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Condition:   Lynch Syndrome
Interventions:   Drug: Atorvastatin 20mg;   Drug: Atorvastatin 20mg AND Aspirin 325 mg
Sponsor:   Fox Chase Cancer Center
Recruiting

Fri, 08 May 2020 12:00:00 EDT

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

Condition:   Gastric Ulcer
Interventions:   Drug: PA32540;   Drug: EC-Aspirin 325 mg
Sponsor:   POZEN
Completed

Tue, 18 Aug 2009 12:00:00 EDT

Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of Digoxin

Condition:   DRUG REACTIONS
Interventions:   Drug: Aspirin+Clopidogrel/Digoxin(oral);   Drug: Aspirin+Clopidogrel/Digoxin(IV)
Sponsor:   Seoul National University Hospital
Completed

Fri, 25 Jan 2013 12:00:00 EST

Influence of Aspirin on Human Gut Microbiota Composition and Metabolome

Conditions:   Aspirin;   Microbiota
Intervention:   Drug: Aspirin 80mg
Sponsor:   Chinese University of Hong Kong
Recruiting

Thu, 01 Mar 2018 12:00:00 EST

Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.

Condition:   Coronary Arteriosclerosis
Intervention:   Drug: Aspirin
Sponsor:   University of Roma La Sapienza
Completed

Thu, 16 Jun 2011 12:00:00 EDT

Pharmacokinetic and Pharmacodynamic Assessment of a Novel, Pharmaceutical Lipid-Aspirin Complex

Condition:   Bioequivalence
Intervention:   Drug: Aspirin
Sponsor:   PLx Pharma
Completed

Fri, 05 Jul 2019 12:00:00 EDT

INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE

Conditions:   Ischemic Stroke;   Indobufen;   Aspirin
Interventions:   Drug: Indobufen;   Drug: Aspirin
Sponsor:   Ministry of Science and Technology of the People´s Republic of China
Not yet recruiting

Tue, 12 Mar 2019 12:00:00 EDT

Low Dose Aspirin for the Prevention of Preeclampsia

Condition:   Preeclampsia
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   Saint Thomas Hospital, Panama
Unknown status

Mon, 01 Jul 2013 12:00:00 EDT

Aspirin for Treatment of Multiple Sclerosis-Related Fatigue

Conditions:   Multiple Sclerosis;   Fatigue
Interventions:   Drug: High Dose Aspirin (1300 mg/day);   Drug: Low Dose Aspirin (162 mg/day);   Drug: Placebo
Sponsors:   Mayo Clinic;   National Multiple Sclerosis Society
Terminated

Mon, 30 Apr 2007 12:00:00 EDT

Randomized, Crossover Bioequivalence Study of PL-ASA vs Immediate-release Aspirin in Healthy Volunteers.

Condition:   To Establish Bioequivalence of a Novel Formulation PL-ASA to Immediate Release Aspirin
Intervention:   Drug: Pharmaceutical-lipid aspirin (PL-ASA)
Sponsor:   PLx Pharma
Completed

Fri, 24 Sep 2021 12:00:00 EDT

Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention

Conditions:   Cardiovascular Disease;   Interventional Cardiology
Interventions:   Drug: Aspirin;   Drug: Placebo;   Drug: ticagrelor
Sponsors:   Icahn School of Medicine at Mount Sinai;   AstraZeneca
Completed

Tue, 21 Oct 2014 12:00:00 EDT

Aspirin Prophylaxis in Sickle Cell Disease

Condition:   Sickle Cell Disease
Intervention:   Drug: aspirin
Sponsors:   University of Rochester;   University of Miami;   Bayer;   National Institute of Neurological Disorders and Stroke (NINDS)
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Aspirin Responsiveness in Women at Risk for Cardiac Events

Condition:   Heart Disease
Intervention:   Drug: Aspirin
Sponsor:   Creighton University
Completed

Wed, 07 Jan 2009 12:00:00 EST

Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet

Condition:   Cardiovascular Diseases
Interventions:   Drug: Sublingual aspirin;   Drug: Oral aspirin
Sponsor:   Vita Green Health Products Co. Ltd
Not yet recruiting

Thu, 11 Mar 2021 12:00:00 EST

Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)

Conditions:   Non-Small Cell Lung Cancer Stage IIIB;   Non-small Cell Lung Cancer Stage IV;   EGFR T790M
Interventions:   Drug: Aspirin;   Drug: Osimertinib
Sponsor:   Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not yet recruiting

Tue, 22 May 2018 12:00:00 EDT

Outcome Analysis of Aspirin in Liver Transplantation

Condition:   Liver Transplant; Complications
Intervention:   Other: Aspirin
Sponsor:   University of Zurich
Recruiting

Tue, 31 Mar 2020 12:00:00 EDT

Aspirin (ASA) Therapy and Preeclampsia Prevention

Condition:   Preeclampsia
Interventions:   Drug: Aspirin 81 mg Enteric Coated Tab - 1 tablet;   Drug: Aspirin 81 mg Enteric Coated Tab - 2 tablets
Sponsor:   University of Tennessee
Withdrawn

Tue, 12 Nov 2019 12:00:00 EST

Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes

Condition:   Diabetes Mellitus, Type 1
Intervention:   Drug: Aspirin
Sponsor:   Karolinska Institutet
Completed

Tue, 19 Jul 2011 12:00:00 EDT

The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia

Condition:   Preeclampsia
Intervention:   Drug: 162mg aspirin dose
Sponsor:   Ohio State University
Recruiting

Thu, 08 Nov 2018 12:00:00 EST

Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC

Conditions:   Non-Small Cell Lung Cancer Stage IIIB;   Non-small Cell Lung Cancer Stage IV;   EGFR T790M
Interventions:   Drug: Osimertinib;   Drug: Aspirin
Sponsor:   Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not yet recruiting

Fri, 01 Jun 2018 12:00:00 EDT

When Should Low-dose Aspirin be Resumed After Peptic Ulcer Bleeding?

Conditions:   Aspirin;   GastroIntestinal Bleeding
Interventions:   Other: Resume Aspirin within 12 hours;   Other: Resume Aspirin 72 - 84 hours
Sponsors:   Chinese University of Hong Kong;   Beijing Friendship Hospital;   National Taiwan University Hospital
Recruiting

Mon, 24 Dec 2018 12:00:00 EST

Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels

Conditions:   Myocardial Infarction;   Stroke (Including Ischaemic Stroke and Transient Ischaemic Attack);   Unstable Angina;   Angina;   Ischaemic Heart Disease
Intervention:   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465)
Sponsor:   Bayer
Completed

Fri, 20 Sep 2019 12:00:00 EDT

Modulation of Immune Activation by Aspirin

Condition:   HIV-1 Infection
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Wed, 04 Jun 2014 12:00:00 EDT

Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome

Conditions:   Diabetes Mellitus;   Acute Coronary Syndrome;   Coronary Artery Disease;   Obesity
Interventions:   Drug: Novel strategy Aspirin;   Drug: Conventional strategy Aspirin
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Bayer
Recruiting

Thu, 13 Aug 2015 12:00:00 EDT

Chronotherapy With Low-dose Aspirin for Primary Prevention

Condition:   Type 2 Diabetes
Intervention:   Drug: aspirin
Sponsor:   University of Vigo
Recruiting

Wed, 30 Jul 2008 12:00:00 EDT

Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Condition:   Cancer Patients First-ever Acute Ischemic Stroke
Interventions:   Drug: Enoxaparin;   Drug: Aspirin
Sponsors:   Memorial Sloan Kettering Cancer Center;   New York Presbyterian Hospital;   Weill Medical College of Cornell University
Completed

Wed, 09 Jan 2013 12:00:00 EST

Aspirin in Young Psychotic Patients

Conditions:   Psychosis;   Acute Psychosis;   Schizophrenia
Interventions:   Drug: Aspirin;   Drug: Placebo;   Drug: Pantoprazole
Sponsors:   Clinic for Psychiatric Disorders, Dr Laza Lazarevic;   Stanley Medical Research Institute
Completed

Fri, 19 Feb 2016 12:00:00 EST

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination

Condition:   Coronary Artery Disease
Interventions:   Drug: Clopidogrel;   Drug: Fixed dose combination of clopidogrel/Aspirin;   Drug: Aspirin
Sponsors:   Chong Kun Dang Pharmaceutical;   Inje University
Completed

Mon, 13 Aug 2012 12:00:00 EDT

Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients

Condition:   Fontan Procedure
Intervention:   Drug: Aspirin
Sponsor:   University of Michigan
Terminated

Thu, 17 Nov 2016 12:00:00 EST

Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease

Condition:   Stable Coronary Heart Disease
Interventions:   Drug: Indobufen;   Drug: Aspirin
Sponsor:   Henan Institute of Cardiovascular Epidemiology
Not yet recruiting

Mon, 16 Mar 2020 12:00:00 EDT

Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers

Conditions:   Pre-eclampsia;   Intra-uterine Growth Restriction
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   University Hospital, Tours
Completed

Tue, 20 Nov 2012 12:00:00 EST

Acetylsalicylic Acid and Type 2 Diabetes Mellitus

Conditions:   Diabetes Mellitus, Type 2;   Antioxidant Enzyme System
Interventions:   Drug: Acetylsalicylic acid;   Drug: Calcined magnesia
Sponsor:   Centro Universitario de Ciencias de la Salud, Mexico
Completed

Tue, 14 Nov 2017 12:00:00 EST

Aspirin Resistance in Women With Migraine

Conditions:   Episodic Migraine;   Chronic Migraine
Interventions:   Drug: Aspirin (acetylsalicylic acid);   Drug: Placebo
Sponsors:   Swedish Medical Center;   University of Washington;   National Headache Foundation;   Wadsworth Foundation;   Accumetrics, Inc.
Withdrawn

Fri, 10 Dec 2010 12:00:00 EST

Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine

Condition:   Acute Migraine
Interventions:   Drug: Acetaminophen 250 mg and Aspirin 250 mg;   Drug: Placebo
Sponsor:   Novartis
Completed

Thu, 31 Oct 2013 12:00:00 EDT

The Effects of Omega-3 Fatty Acids on Aspirin Resistance

Condition:   Increased Drug Resistance
Interventions:   Drug: Aspirin;   Drug: Lovaza;   Drug: Both Aspirin and Lovaza;   Other: Placebo
Sponsors:   University of Rochester;   GlaxoSmithKline;   American College of Clinical Pharmacy;   Cornell University
Completed

Wed, 15 Oct 2008 12:00:00 EDT

Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis

Condition:   Clinical High Risk for Psychosis
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   Yale University
Terminated

Tue, 28 Jan 2014 12:00:00 EST

Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)

Condition:   Bipolar Disorder
Interventions:   Drug: acetylsalicylic acid;   Drug: Calcium
Sponsor:   Lars Vedel Kessing
Not yet recruiting

Sun, 05 Sep 2021 12:00:00 EDT

Trial of Early Screening Test for Pre-eclampsia and Growth Restriction

Conditions:   Pre-Eclampsia;   Placenta Diseases;   Eclampsia Preeclampsia;   Fetal Growth Retardation;   Foetal Growth Restriction
Intervention:   Drug: Low dose aspirin
Sponsors:   University College Dublin;   Perinatal Ireland;   National Maternity Hospital, Ireland;   Royal College of Surgeons, Ireland
Completed

Mon, 17 Sep 2018 12:00:00 EDT

Enteric Coating as a Factor in Aspirin Resistance

Condition:   Cardiovascular Disease
Intervention:   Drug: Plain aspirin
Sponsors:   Royal College of Surgeons, Ireland;   Irish Heart Foundation
Completed

Tue, 18 Sep 2007 12:00:00 EDT

Aspirin AM or PM: Effect on Circadian Rhythm of Platelet Reactivity

Conditions:   Aspirin;   Circadian Rhythm;   Platelet Activation;   Cardiovascular Diseases
Intervention:   Behavioral: change time of intake of aspirin
Sponsor:   Leiden University Medical Center
Completed

Tue, 16 Jul 2013 12:00:00 EDT

The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations

Conditions:   COVID;   Vitamin D Deficiency;   Coagulopathy;   Disseminated Intravascular Coagulation
Interventions:   Drug: Aspirin 81 mg;   Dietary Supplement: Vitamin D
Sponsor:   Louisiana State University Health Sciences Center in New Orleans
Not yet recruiting

Mon, 27 Apr 2020 12:00:00 EDT

Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma

Condition:   Hepatocellular Carcinoma
Interventions:   Other: control;   Drug: sorafenib;   Drug: aspirin
Sponsor:   Fudan University
Terminated

Fri, 22 Apr 2016 12:00:00 EDT

WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?

Condition:   Coronary Syndrome
Interventions:   Drug: Aspirin 75mg;   Drug: Aspirin 20mg;   Drug: Rivaroxaban 2.5 mg
Sponsor:   Sheffield Teaching Hospitals NHS Foundation Trust
Recruiting

Wed, 04 Aug 2021 12:00:00 EDT

The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin

Condition:   Gastrointestinal Hemorrhage
Interventions:   Drug: Aspirin (ASA);   Drug: Placebo
Sponsors:   Maria Sklodowska-Curie Institute - Oncology Center;   Centre of Postgraduate Medical Education
Unknown status

Fri, 09 Mar 2012 12:00:00 EST

Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke

Condition:   Ischemic Stroke
Interventions:   Drug: Ginkgo Diterpene Lactone Meglumine Injection;   Drug: Acetylsalicylic acid
Sponsors:   RenJi Hospital;   Jiangsu Kanion Pharmaceutical Co., Ltd
Unknown status

Mon, 17 Jul 2017 12:00:00 EDT

The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury

Condition:   Acute Lung Injury
Interventions:   Drug: Aspirin 75mg;   Drug: Lactose powder;   Drug: Aspirin 1200mg
Sponsors:   Belfast Health and Social Care Trust;   The Intensive Care Society United Kingdom;   Northern Ireland Clinical Trials Unit;   Queen's University, Belfast
Unknown status

Tue, 07 Aug 2012 12:00:00 EDT

Timed Aspirin Chronobiome Study

Condition:   Healthy
Interventions:   Drug: Aspirin 81 mg;   Drug: Celecoxib 200mg capsule
Sponsor:   University of Pennsylvania
Not yet recruiting

Wed, 18 Jul 2018 12:00:00 EDT

Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial

Condition:   Colorectal Cancer
Interventions:   Drug: Acetylsalicylic acid (ASA)/aspirin 200 mg daily;   Drug: Acetylsalicylic acid (ASA)/aspirin 100 mg daily;   Drug: Placebo
Sponsors:   The Fourth Affiliated Hospital of Anhui Medical University;   The First Affiliated Hospital of Anhui Medical University;   Anhui Provincial Hospital
Recruiting

Tue, 17 Nov 2015 12:00:00 EST

Effects of Omega-3 Plus Low-dose Aspirin as Adjunct to Periodontal Debridement for Chronic Periodontitis in Diabetics

Conditions:   Diabetes Mellitus;   Chronic Periodontitis
Interventions:   Drug: Placebo;   Drug: 3g omega-3 plus 100mg aspirin daily for 60 days;   Drug: omega-3 plus aspirin before periodontal therapy
Sponsors:   Universidade Estadual Paulista Júlio de Mesquita Filho;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Unknown status

Wed, 15 Jun 2016 12:00:00 EDT

Aspirin, Heparin and Miscarriage

Conditions:   Pregnancy;   Miscarriage
Interventions:   Drug: Aspirin;   Drug: Heparin
Sponsor:   University of Khartoum
Unknown status

Wed, 07 Aug 2013 12:00:00 EDT

Rivaroxaban or Aspirin for Biological Aortic Prosthesis

Conditions:   Aortic Stenosis;   Aortic Regurgitation;   Thrombosis
Interventions:   Drug: Rivaroxaban 10 MG;   Drug: Aspirin
Sponsors:   Christian Torp-Pedersen;   Aalborg University Hospital;   Aarhus University Hospital;   Odense University Hospital;   Rigshospitalet, Denmark
Recruiting

Tue, 29 Nov 2016 12:00:00 EST

The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy

Conditions:   Breast Cancer;   Angiogenesis
Intervention:   Drug: Aspirin
Sponsor:   University of Vermont
Completed

Mon, 04 Aug 2008 12:00:00 EDT

Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients

Condition:   Peripheral Arterial Disease
Intervention:   Drug: Aspirin
Sponsors:   Unity Health Toronto;   University of Toronto
Not yet recruiting

Mon, 17 Feb 2020 12:00:00 EST

Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine Cancer

Condition:   Gastrointestinal Cancer
Intervention:   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465)
Sponsor:   Bayer
Completed

Mon, 09 Sep 2019 12:00:00 EDT

A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis

Condition:   Tuberculous Meningitis
Interventions:   Drug: 81mg aspirin;   Drug: 1000mg aspirin;   Drug: Placebo
Sponsors:   Oxford University Clinical Research Unit, Vietnam;   Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
Completed

Thu, 11 Sep 2014 12:00:00 EDT

Aspirin in Colorectal Cancer Liver Metastases

Conditions:   Colorectal Cancer Liver Metastases;   Colorectal Cancer;   Liver Metastases
Interventions:   Drug: Acetylsalicylic acid;   Drug: Placebo Oral Tablet
Sponsors:   Oslo University Hospital;   Norwegian Cancer Society;   The Research Council of Norway;   Klinbeforsk
Recruiting

Tue, 31 Oct 2017 12:00:00 EDT

Aspirin in Reducing Events in the Elderly

Conditions:   Functional Disability;   Dementia;   Heart Disease;   Stroke;   Cancer;   Bleeding;   Depression
Interventions:   Drug: 100 mg enteric-coated aspirin;   Drug: Placebo
Sponsors:   Hennepin Healthcare Research Institute;   National Health and Medical Research Council, Australia;   Bayer;   Monash University;   Berman Center for Outcomes and Clinical Research;   National Institute on Aging (NIA);   National Cancer Institute (NCI)
Active, not recruiting

Thu, 24 Dec 2009 12:00:00 EST

Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

Condition:   Lung Cancer Non-small Cell Stage IV
Interventions:   Drug: Aspirin 100mg;   Drug: Osimertinib 80 MG
Sponsor:   Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not yet recruiting

Wed, 04 Dec 2019 12:00:00 EST

Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers

Conditions:   Tobacco Use Disorder;   Smoking
Interventions:   Drug: Aspirin 325 mg daily;   Drug: Celecoxib 200 mg BID
Sponsor:   Vanderbilt University
Completed

Fri, 22 Feb 2013 12:00:00 EST

Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects

Condition:   Gastroduodenal Ulceration
Interventions:   Drug: PL2200;   Drug: Aspirin tablets
Sponsor:   PLx Pharma
Completed

Fri, 20 Jul 2012 12:00:00 EDT

Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial

Conditions:   Coronary Disease;   Arteriosclerosis;   Diabetes Mellitus, Type 2
Interventions:   Drug: Aspirin;   Drug: No aspirin
Sponsor:   Kumamoto University
Completed

Tue, 10 May 2005 12:00:00 EDT

Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin

Conditions:   Thromboembolism;   Bleeding
Interventions:   Drug: Aspirin;   Drug: Warfarin
Sponsor:   Rigshospitalet, Denmark
Completed

Mon, 17 Oct 2011 12:00:00 EDT

Clopidogrel and Aspirin Interaction Study-2

Condition:   Drug Action Increased
Interventions:   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   Population Health Research Institute
Completed

Tue, 26 Apr 2011 12:00:00 EDT

Aspirin Desensitization Registry in Patients With Aspirin Hypersensitivity

Condition:   Aspirin Hypersensitivity
Intervention:   Drug: aspirin
Sponsor:   Italian Society of Cardiology
Completed

Thu, 28 Jul 2016 12:00:00 EDT

Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate

Conditions:   Blood Loss, Surgical;   Intraoperative Complications;   Re-operation Rates in Patients With Aspirin Treatment
Intervention:   Drug: transurethral surgery with or without aspirin
Sponsor:   University Hospital, Basel, Switzerland
Withdrawn

Fri, 13 Mar 2009 12:00:00 EDT

Aspirin in Patients With Myocardial Infarction and Thrombocytopenia

Conditions:   Thrombocytopenia;   Myocardial Infarction
Intervention:   Drug: Aspirin
Sponsor:   M.D. Anderson Cancer Center
Terminated

Mon, 16 Jul 2007 12:00:00 EDT

Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery

Condition:   Myocardial Injury
Interventions:   Drug: ticagrelor;   Drug: aspirin
Sponsors:   The Cleveland Clinic;   AstraZeneca
Terminated

Fri, 14 Nov 2014 12:00:00 EST

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

Condition:   Breast Neoplasms
Interventions:   Drug: aspirin;   Drug: Exemestane
Sponsor:   Chinese Academy of Medical Sciences
Unknown status

Fri, 09 Sep 2011 12:00:00 EDT

The Effects of Preoperative Aspirin on Graft Patency and Cardiac Events in Off-pump Coronary Artery Bypass

Conditions:   Coronary Artery Disease;   Off-pump Coronary Artery Bypass;   Aspirin
Intervention:   Drug: aspirin
Sponsor:   Chinese Academy of Medical Sciences, Fuwai Hospital
Unknown status

Fri, 31 Dec 2010 12:00:00 EST

Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.

Conditions:   Coronary Heart Disease;   Angina Pectoris;   Atherosclerosis
Interventions:   Drug: aspirin;   Drug: clopidogrel
Sponsors:   Ullevaal University Hospital;   The Norwegian Council for Cardiovascular Diseases.;   Ada and Hagbart Waages Humanitarian and Charity Foundation;   Alf and Aagot Helgesens Research Foundation.
Completed

Thu, 22 Sep 2005 12:00:00 EDT

Low-Dose Aspirin in in Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Treatments

Conditions:   Pregnancy;   Miscarriage Less Than 12 Gestational Weeks;   Extrauterine Pregnancy;   Preeclampsia;   Intrauterine Fetal Growth Restriction
Interventions:   Drug: Acetylsalicylic acid;   Drug: Placebo
Sponsors:   University of Oulu;   Bayer;   Kuopio University Hospital;   Tampere University
Completed

Fri, 23 May 2008 12:00:00 EDT

Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers

Condition:   Colorectal Cancer
Interventions:   Other: placebo;   Drug: Acetylsalicylic acid
Sponsors:   National Cancer Centre, Singapore;   University of Oxford;   Australasian Gastro-Intestinal Trials Group;   INDOX Cancer Research Network
Active, not recruiting

Fri, 30 Nov 2007 12:00:00 EST

Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation

Condition:   Coronary Artery Disease
Interventions:   Drug: Aspirin;   Drug: Aspirin,Clopidogrel
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea
Completed

Thu, 10 Jan 2008 12:00:00 EST

Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)

Condition:   Coronary Artery Disease
Interventions:   Drug: Aspirin monotherapy;   Drug: Aspirin,Clopidogrel
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea
Completed

Mon, 23 Aug 2010 12:00:00 EDT

ASPIRIN Trial Belgium

Condition:   Colon Cancer
Interventions:   Drug: acetylsalicylic acid;   Drug: Placebo
Sponsors:   University Hospital, Antwerp;   Kom Op Tegen Kanker;   Anticancerfund
Recruiting

Wed, 14 Mar 2018 12:00:00 EDT

Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events

Conditions:   Ischemic Stroke;   TIA
Interventions:   Drug: rivaroxaban;   Drug: Aspirin;   Drug: placebo
Sponsor:   Xijing Hospital
Unknown status

Fri, 16 Aug 2013 12:00:00 EDT

Mono Antiplatelet and Colchicine Therapy

Conditions:   Acute Coronary Syndrome;   Drug-Eluting Stents
Interventions:   Drug: Aspirin;   Drug: Colchicine
Sponsor:   Wonkwang University Hospital
Recruiting

Fri, 02 Jul 2021 12:00:00 EDT

Efficacy of BNG-1 to Treat Acute Ischemic Stroke

Condition:   Ischemic Stroke
Interventions:   Drug: BNG-1;   Drug: Aspirin
Sponsor:   Chang Gung Memorial Hospital
Completed

Wed, 29 Aug 2012 12:00:00 EDT

Continuing Low Dose Aspirin Before Prostate Biopsy

Condition:   Complication
Intervention:   Drug: Aspirin
Sponsor:   National Taiwan University Hospital
Unknown status

Wed, 20 Apr 2016 12:00:00 EDT

Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization

Conditions:   Carotid Stenosis;   Cardiovascular Disease;   Atherosclerosis;   Stroke
Interventions:   Drug: Aspirin;   Drug: aspirin plus dipyridamole
Sponsors:   University of Roma La Sapienza;   Civic Hospital, Italy
Completed

Tue, 15 Dec 2015 12:00:00 EST

Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy

Conditions:   Coronary Artery Disease;   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban 2.5 Mg Oral Tablet;   Drug: Aspirin 81 mg
Sponsors:   LifeBridge Health;   Janssen Scientific Affairs, LLC
Recruiting

Fri, 16 Aug 2019 12:00:00 EDT

Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies

Conditions:   Twin Pregnancy;   Preeclampsia;   Preterm Birth;   Fetal Growth Restriction
Intervention:   Drug: Aspirin 100mg
Sponsors:   Ministry of Science and Technology of the People´s Republic of China;   Peking University Third Hospital;   Chongqing Health Center for Women and Children
Unknown status

Fri, 09 Aug 2019 12:00:00 EDT

Effect of Aspirin, Hemodilution and Desmopressin on Platelet Dysfunction

Conditions:   Platelet Dysfunction;   Hemodilution;   Mild Hypothermia;   NSAID;   Desmopressin
Interventions:   Drug: Aspirin, desmopressin;   Drug: Placebo, desmopressin
Sponsor:   The University of Hong Kong
Completed

Mon, 27 Jun 2011 12:00:00 EDT

RECAB-ASA; Treatment of Recurrent Abortion With Aspirin

Condition:   Abortion, Habitual
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   Göteborg University;   Vastra Gotaland Region
Completed

Wed, 06 Jul 2016 12:00:00 EDT

In-Vivo Bleeding Volume Test for Platelet-Aspirin Interaction

Condition:   Healthy
Interventions:   Drug: Aspirin ingestion followed by doing a Bleeding Volume Test;   Procedure: Gatorade Placebo followed by Bleeding Volume Test.
Sponsor:   Klein, Jeffrey A., M.D.
Unknown status

Wed, 13 Jan 2010 12:00:00 EST

Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes

Condition:   Diabetes Type 2
Interventions:   Drug: Aspirin;   Other: placebo tablet
Sponsor:   University of Portsmouth
Completed

Tue, 12 May 2009 12:00:00 EDT

An Assessment of Aspirin Plus Prednisone Treatment for Euthyroid Women With Thyroid Autoimmunity

Condition:   Thyroid Diseases
Intervention:   Drug: Prednisone 10 MG+aspirin 100MG
Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Ningbo Women and Children's Hospital;   People's Hospital of Jinhua
Recruiting

Tue, 29 Jun 2021 12:00:00 EDT

Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets

Condition:   Pain
Intervention:   Drug: Acetylsalicylic acid (Aspirin, BAY1019036)
Sponsor:   Bayer
Completed

Fri, 17 Feb 2017 12:00:00 EST

Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration

Condition:   Atherosclerosis
Interventions:   Drug: G0041(75/100mg);   Drug: Clopidogrel & Aspirin
Sponsor:   Dong-A ST Co., Ltd.
Completed

Fri, 03 Feb 2012 12:00:00 EST

Aspirin and Enoxaparin for VTE in Trauma

Conditions:   Venous Thromboembolism;   Thromboprophylaxis;   Trauma
Interventions:   Drug: Aspirin;   Drug: Enoxaparin
Sponsor:   University of Miami
Terminated

Tue, 24 Mar 2015 12:00:00 EDT

Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation

Conditions:   Cardioembolic Stroke;   Atrial Fibrillation
Interventions:   Drug: hirudin plus aspirin;   Drug: Warfarin
Sponsors:   Xijing Hospital;   Xi'an Central Hospital;   Shaanxi people's Hospital;   The Third Hospital of PLA;   Hanzhong Central Hospital;   Xianyang 215 hospital;   Yulin Second Hospital;   Yan'an University Affiliated Hospital;   Baoji Central Hospital;   Ankang Central Hospital;   Baoji People's Hospital;   Yan'an people's Hospital;   451 Hospital;   Shangluo Central Hospital;   Central Hospital of China Railway 20th Bureau;   Xiangyang Central Hospital;   Xi'an Ninth Hospital;   Shangluo Second People's Hospital
Completed

Thu, 03 Jul 2014 12:00:00 EDT

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Conditions:   Tuberous Sclerosis Complex;   Aspirin;   Epilepsy;   Cognitive Decline;   Skin Lesions
Interventions:   Drug: Aspirin;   Drug: AED;   Drug: Placebo
Sponsors:   Peking Union Medical College Hospital;   Shijiazhuang Yiling Pharmaceutical Co. Ltd
Recruiting

Wed, 29 Nov 2017 12:00:00 EST

Association of Clopidogrel Therapy and Stent Thrombosis

Condition:   Coronary Artery Disease
Interventions:   Drug: Aspirin monotherapy;   Drug: Aspirin,Clopidogrel
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea
Completed

Tue, 12 Jun 2007 12:00:00 EDT

Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease

Conditions:   Atrial Fibrillation;   Chronic Kidney Disease
Interventions:   Drug: warfarin;   Drug: Aspirin
Sponsor:   Seoul National University Hospital
Withdrawn

Mon, 20 Aug 2012 12:00:00 EDT

Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females

Condition:   Healthy
Interventions:   Drug: Meloxicam;   Drug: Aspirin
Sponsor:   Boehringer Ingelheim
Completed

Fri, 11 Jul 2014 12:00:00 EDT

Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients

Condition:   Acute Myocardial Infarction
Interventions:   Drug: Lysine Acetilsalicilate;   Drug: Aspirin
Sponsor:   Fundacion Investigacion Interhospitalaria Cardiovascular
Unknown status

Tue, 11 Oct 2016 12:00:00 EDT

Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes

Conditions:   Peripheral Artery Disease;   Type 2 Diabetes
Interventions:   Drug: Aspirin;   Drug: Ticagrelor;   Drug: Aspirin Placebo;   Drug: Ticagrelor Placebo
Sponsor:   Icahn School of Medicine at Mount Sinai
Completed

Thu, 25 Dec 2014 12:00:00 EST

LIPS-A: Lung Injury Prevention Study With Aspirin

Condition:   Acute Respiratory Distress Syndrome
Interventions:   Drug: Aspirin;   Drug: Lactose powder
Sponsors:   Mayo Clinic;   Beth Israel Deaconess Medical Center;   Montefiore Medical Center;   Vanderbilt University Medical Center;   National Heart, Lung, and Blood Institute (NHLBI);   National Center for Research Resources (NCRR)
Completed

Fri, 06 Jan 2012 12:00:00 EST

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Condition:   Node Positive HER2 Negative Breast Cancer
Interventions:   Other: Placebo;   Drug: Aspirin
Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI);   United States Department of Defense;   Bayer;   Canadian Cancer Trials Group
Active, not recruiting

Fri, 07 Oct 2016 12:00:00 EDT

Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)

Conditions:   Preeclampsia Severe;   Cardiovascular Diseases;   Primary Prevention
Interventions:   Drug: Low-dose aspirin;   Drug: Placebo oral tablet
Sponsor:   Dr. Graeme Smith
Recruiting

Tue, 28 Jan 2020 12:00:00 EST

Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients

Conditions:   Peripheral Artery Disease;   Intermittent Claudication
Intervention:   Drug: Rivaroxaban 2.5 Mg Oral Tablet
Sponsors:   Science Valley Research Institute;   Bayer
Recruiting

Wed, 21 Apr 2021 12:00:00 EDT

STAT-STatin and Aspirin in Trauma

Conditions:   Wounds and Injuries;   Venous Thromboembolism
Interventions:   Drug: Aspirin and Rosuvastatin;   Drug: Placebo (for Aspirin and Rosuvastatin)
Sponsor:   Denver Health and Hospital Authority
Active, not recruiting

Thu, 15 Sep 2016 12:00:00 EDT

Pharmacogenomics of Antiplatelet Response

Condition:   Atherosclerosis
Intervention:   Drug: Aspirin
Sponsor:   Johns Hopkins University
Completed

Tue, 09 Sep 2014 12:00:00 EDT

The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia Patients

Conditions:   Ischemic Stroke;   Endothelial Dysfunction
Interventions:   Drug: Cilostazol 100mg;   Drug: Aspirin
Sponsor:   Ajou University School of Medicine
Completed

Mon, 17 Apr 2017 12:00:00 EDT

Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study

Condition:   Chronic Kidney Disease
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsors:   University of Texas Southwestern Medical Center;   American Heart Association
Completed

Tue, 15 Jan 2013 12:00:00 EST

Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk

Condition:   Colorectal Cancer
Interventions:   Drug: aspirin intake;   Drug: placebo intake;   Procedure: Surgical resection of colonic adenocarcinoma stage III or II high risk;   Biological: Molecular analysis of exon 9 and 20 of PI3K;   Biological: blood intake
Sponsors:   University Hospital, Rouen;   Federation Francophone de Cancerologie Digestive
Recruiting

Wed, 26 Oct 2016 12:00:00 EDT

Validation of an Assay to Measure Cyclooxygenase-1 Activity

Condition:   Healthy
Intervention:   Other: Chewable aspirin
Sponsor:   Vanderbilt University
Completed

Tue, 30 Sep 2008 12:00:00 EDT

Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes.

Condition:   Pre-Eclampsia
Interventions:   Drug: Acetylsalicylic acid;   Drug: Placebo
Sponsor:   Instituto de Investigacion Sanitaria La Fe
Terminated

Wed, 25 Jun 2014 12:00:00 EDT

Effect of Aspirin at the Acute Phase of Cerebral Ischemic Event.

Condition:   Ischemic Stroke
Interventions:   Drug: Aspirin;   Biological: blood sample
Sponsor:   Central Hospital, Nancy, France
Unknown status

Fri, 17 Jun 2011 12:00:00 EDT


Postpolypectomy Bleeding in Patients With Antiplatelet Therapy

Condition:   Bleeding Complication During Colon Polypectomy
Intervention:   Drug: Aspirin
Sponsor:   Soonchunhyang University Hospital
Unknown status

Fri, 04 Nov 2011 12:00:00 EDT

Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin

Condition:   Angina, Stable
Interventions:   Drug: salvianolate injection;   Drug: Aspirin Tablet
Sponsor:   Xiyuan Hospital of China Academy of Chinese Medical Sciences
Unknown status

Wed, 11 Oct 2017 12:00:00 EDT

Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia

Conditions:   MPN;   Essential Thrombocythemia
Interventions:   Other: Aspirin therapy interruption;   Other: Usual treatment by aspirin 100 mg/d in the active comparator arm;   Other: No interruption of aspirin in the Observational arm;   Drug: Hydroxyurea treatment (HU)
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting

Mon, 23 Nov 2015 12:00:00 EST

Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1)

Condition:   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Vitamin K antagonist or direct oral anticoagulant treatment;   Drug: Aspirin
Sponsors:   Centre Hospitalier Universitaire de Nīmes;   Medtronic
Recruiting

Wed, 13 Apr 2016 12:00:00 EDT

Aspirin Resistance in Systemic Lupus Erythematosus (SLE)

Condition:   Systemic Lupus Erythematosus
Intervention:   Drug: aspirin and meloxicam
Sponsors:   Vanderbilt University;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Fri, 08 Aug 2008 12:00:00 EDT

Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma

Condition:   Glioblastoma
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   M.D. Anderson Cancer Center
Terminated

Thu, 13 Nov 2008 12:00:00 EST

Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus

Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions:   Drug: Ticagrelor monotherapy;   Drug: Ticagrelor plus aspirin;   Drug: Clopidogrel with aspirin
Sponsors:   University of Florida;   AstraZeneca
Recruiting

Thu, 23 Jul 2020 12:00:00 EDT

Aspirin and Plavix Following Coronary Artery Bypass Grafting

Condition:   Coronary Graft Patency
Interventions:   Drug: clopidogrel;   Drug: sugar pill;   Drug: Aspirin
Sponsors:   Ahmad Slim;   Bristol-Myers Squibb
Terminated

Thu, 08 Jul 2010 12:00:00 EDT

Multiple Daily Doses Of Aspirin To Overcome Aspirin Hyporesponsiveness Post Cardiac Bypass Surgery

Condition:   Postoperative; Dysfunction Following Cardiac Surgery
Intervention:   Drug: Aspirin
Sponsor:   Hamilton Health Sciences Corporation
Completed

Wed, 13 Jun 2012 12:00:00 EDT

Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Beraprost;   Drug: Aspirin
Sponsor:   Astellas Pharma Inc
Terminated

Wed, 01 Jun 2016 12:00:00 EDT

Aspirin for Exercise in Multiple Sclerosis (ASPIRE)

Condition:   Multiple Sclerosis
Interventions:   Drug: Aspirin 650mg Oral Capsule;   Drug: Acetaminophen Tab 650mg;   Other: Placebo
Sponsors:   Columbia University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting

Thu, 31 Jan 2019 12:00:00 EST

Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection

Condition:   Angina
Interventions:   Drug: Salvianolate injection;   Drug: Aspirin
Sponsors:   China Academy of Chinese Medical Sciences;   Xiyuan Hospital of China Academy of Chinese Medical Sciences;   Guang'anmen Hospital of China Academy of Chinese Medical Sciences;   General Hospital of Beijing PLA Military Region;   Guangdong Provincial Hospital of Traditional Chinese Medicine
Unknown status

Tue, 01 Mar 2016 12:00:00 EST


Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Cilostazol;   Drug: Aspirin
Sponsors:   Hanyang University;   Ajou University School of Medicine;   Kyunghee University Medical Center;   Korea University Guro Hospital;   Inha University Hospital;   Inje University;   Hallym University Medical Center
Unknown status

Thu, 23 Apr 2009 12:00:00 EDT

A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin

Condition:   Healthy
Intervention:   Drug: HCP0911 / clopidogrel, aspirin
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Fri, 07 Oct 2011 12:00:00 EDT

VTE Prevention Following Total Hip and Knee Arthroplasty

Condition:   Venous Thromboembolism
Interventions:   Drug: Rivaroxaban 10 MG and acetylsalicylic acid 81 mg;   Drug: acetylsalicylic acid 81 mg
Sponsors:   Sudeep Shivakumar;   Canadian Institutes of Health Research (CIHR);   Nova Scotia Health Authority;   Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
Not yet recruiting

Fri, 30 Aug 2019 12:00:00 EDT

Effects of Omacor and Aspirin on Platelet Function

Condition:   Healthy
Interventions:   Drug: Aspirin;   Drug: omega-3 acid ethyl esters
Sponsor:   Sanford Research
Completed

Tue, 03 Jun 2008 12:00:00 EDT

Evaluating the Need for Pneumatic Compression Devices

Condition:   Osteoarthritis
Interventions:   Drug: Aspirin;   Device: Portable Compression Device
Sponsor:   West Virginia University
Completed

Tue, 29 Dec 2015 12:00:00 EST

Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)

Condition:   Coronary Artery Disease
Intervention:   Drug: Optimizing ASA and clopidogrel treatment
Sponsor:   Ruhr University of Bochum
Completed

Thu, 30 Sep 2010 12:00:00 EDT

Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?

Conditions:   Early Gastric Cancer;   Gastric Dysplasia
Intervention:   Drug: aspirin and/or clopidogrel
Sponsors:   Asan Medical Center;   Takeda
Unknown status

Mon, 18 Jun 2012 12:00:00 EDT

Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk

Condition:   Atrial Fibrillation
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   Chuncheon Sacred Heart Hospital
Unknown status

Wed, 09 Nov 2016 12:00:00 EST

Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols

Condition:   Carcinoma, Squamous Cell
Interventions:   Drug: Aspirin;   Dietary Supplement: Tea Polyphenols
Sponsor:   Beijing Friendship Hospital
Unknown status

Wed, 21 Dec 2011 12:00:00 EST

REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction

Condition:   Acute Myocardial Infarction
Intervention:   Drug: Aspirin 200mg qd, Clopidogrel 2x75mg qd
Sponsor:   University Hospital Ostrava
Completed

Mon, 27 Jun 2011 12:00:00 EDT

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3

Condition:   Coronary Artery Disease
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   Samsung Medical Center
Not yet recruiting

Fri, 05 Jun 2020 12:00:00 EDT

Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia

Condition:   Preeclampsia
Interventions:   Drug: Aspirin;   Drug: Placebo Oral Tablet;   Drug: Progesterone
Sponsor:   John Uckele
Terminated

Mon, 21 Jul 2008 12:00:00 EDT

Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease

Condition:   Cerebral Small Vessel Disease
Interventions:   Drug: aspirin;   Drug: cilostazol
Sponsors:   Inha University Hospital;   Otsuka Pharmaceutical Development & Commercialization, Inc.
Unknown status

Fri, 30 Aug 2013 12:00:00 EDT

Study to Develop a Prediction Model to Understand the Effect of Low-dose Aspirin on Cancer That Develops in the Colon and/or the Rectum, Diseases That Affects the Heart or Blood Vessels and Safety Outcomes in European Countries. The Study is Also Called PEACOS Model EU

Conditions:   Colorectal Cancer;   Cardiovascular Disease;   Bleeding
Intervention:   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465)
Sponsor:   Bayer
Completed

Fri, 05 Apr 2019 12:00:00 EDT

Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance

Condition:   Acute ST SEgment Elevation Myocardial Infarction
Interventions:   Drug: Aspirin (200mg) and/or Plavix (150mg) dosage according to TEG;   Drug: Aspirin 100mg and Plavix 75mg
Sponsor:   Assaf-Harofeh Medical Center
Unknown status

Fri, 13 Jun 2008 12:00:00 EDT

Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

Condition:   Breast Cancer
Interventions:   Drug: Aspirin Low Dose;   Drug: Placebo Oral Tablet
Sponsor:   Centro Hospitalar Lisboa Ocidental
Not yet recruiting

Mon, 09 Apr 2018 12:00:00 EDT

Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty

Conditions:   DVT - Deep Vein Thrombosis;   PE - Pulmonary Thromboembolism
Interventions:   Drug: Aspirin;   Device: (Post- discharge) Mechanical Compression Device
Sponsors:   Washington University School of Medicine;   Medical Compression Systems
Withdrawn

Mon, 23 Jan 2017 12:00:00 EST

Aspirin Dose and Atherosclerosis in Patients With Heart Disease

Conditions:   Cardiovascular Diseases;   Atherosclerosis;   Myocardial Infarction
Intervention:   Drug: Aspirin
Sponsors:   Florida Atlantic University;   Bayer
Completed

Thu, 05 Jan 2006 12:00:00 EST

The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Aspirin;   Drug: Ticagrelor
Sponsor:   Sheffield Teaching Hospitals NHS Foundation Trust
Recruiting

Mon, 11 Mar 2019 12:00:00 EDT

Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG

Conditions:   Coronary Artery Disease;   Stable Angina;   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor;   Drug: Aspirin;   Drug: Placebo - Ticagrelor;   Drug: Placebo - Aspirin
Sponsors:   Deutsches Herzzentrum Muenchen;   AstraZeneca
Terminated

Mon, 24 Dec 2012 12:00:00 EST

Efficacy of Aspirin and L-arginine in High Risk Preeclamptic

Condition:   High Risk Pregnancy
Interventions:   Drug: L-arginine;   Drug: Placebo (for L-arginine);   Drug: acetylsalicylic acid
Sponsors:   University of Guadalajara;   PhD Ernesto Javier Ramírez Lizardo;   PhD Sylvia Elena Totsuka Sutto;   PhD Fernando Grover Páez;   MD Diego Hernández Molina
Suspended

Wed, 20 Jul 2016 12:00:00 EDT

A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension

Condition:   Hypertension, Pulmonary
Interventions:   Drug: Simvastatin;   Drug: Aspirin;   Drug: Placebo
Sponsors:   University of Pennsylvania;   National Heart, Lung, and Blood Institute (NHLBI)
Terminated

Fri, 06 Oct 2006 12:00:00 EDT

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

Condition:   Stroke
Interventions:   Drug: Apixaban;   Drug: Aspirin
Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS);   University of Cincinnati;   Medical University of South Carolina;   Bristol-Myers Squibb;   Pfizer;   Roche Pharma AG;   Weill Medical College of Cornell University;   University of Washington
Recruiting

Tue, 20 Jun 2017 12:00:00 EDT

Role of Inflammatory Mediators in AERD

Condition:   Asthma, Aspirin-Induced
Intervention:   Drug: aspirin
Sponsor:   Brigham and Women's Hospital
Unknown status

Wed, 06 Jul 2016 12:00:00 EDT

Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome

Condition:   Lynch Syndrome
Interventions:   Drug: Acetylsalicylic acid lysinate 300 mg;   Drug: Placebo (for Aspirin 300);   Drug: Acetylsalicylic acid lysinate 100 mg;   Drug: Placebo 100 (for Aspirin 100)
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting

Mon, 27 Jun 2016 12:00:00 EDT

Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.

Conditions:   Small for Gestational Age;   Infant, Very Low Birth Weight;   Fetal Growth Retardation;   Preeclampsia;   Premature Birth
Interventions:   Drug: Acetylsalicylic Acid;   Drug: Placebo
Sponsor:   CHU de Quebec-Universite Laval
Completed

Fri, 31 Oct 2014 12:00:00 EDT

Evaluate Analgesic Efficacy of Fast Release Aspirin

Condition:   Drugs, Investigational
Interventions:   Drug: Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036);   Drug: Acetylsalicyclic acid (Aspirin, BAYE4465);   Drug: Placebo
Sponsor:   Bayer
Completed

Thu, 13 May 2010 12:00:00 EDT

Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor 60 mg;   Drug: Aspirin 100 MG Oral Tablet, Enteric Coated
Sponsor:   The University of Hong Kong
Completed

Wed, 20 Mar 2019 12:00:00 EDT

Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation With Stabilized Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Drug: OAC + Aspirin 100mg od;   Drug: OAC + placebo of Aspirin 100mg od
Sponsors:   University Hospital, Brest;   Bayer
Not yet recruiting

Fri, 03 Jan 2020 12:00:00 EST

The Effect of Serum LDL Lowering on Aspirin Resistance

Conditions:   Aspirin Resistance;   Hypercholesterolemia
Intervention:   Drug: Aspirin
Sponsor:   Ziv Hospital
Completed

Fri, 27 Apr 2007 12:00:00 EDT

Early Prevention of Preeclampsia Study

Condition:   Preeclampsia
Interventions:   Drug: Aspirin;   Drug: placebo
Sponsor:   Washington University School of Medicine
Terminated

Wed, 07 Mar 2012 12:00:00 EST

ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)

Condition:   Atherothrombosis
Interventions:   Drug: Aspirin;   Drug: Triflusal
Sponsor:   University of Ioannina
Completed

Mon, 30 Nov 2015 12:00:00 EST

Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis

Condition:   Aggressive Periodontitis
Interventions:   Dietary Supplement: Omega-3 polyunsaturated fatty acids;   Drug: Aspirin;   Other: Placebo;   Procedure: Full-mouth ultrasonic debridement
Sponsor:   Universidade Estadual Paulista Júlio de Mesquita Filho
Completed

Tue, 28 Mar 2017 12:00:00 EDT

Evaluate Analgesic Efficacy of Fast Release Aspirin

Condition:   Drugs, Investigational
Interventions:   Drug: Acetylsalicylic acid (Fast release Aspirin, BAY1019036);   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465);   Drug: Placebo
Sponsor:   Bayer
Completed

Wed, 05 May 2010 12:00:00 EDT

Warfarin Versus Aspirin Recurrent Stroke Study

Condition:   Stroke
Interventions:   Drug: Active Aspirin;   Drug: Active Warfarin;   Drug: Aspirin placebo;   Drug: Warfarin placebo
Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)
Completed

Wed, 21 Nov 2001 12:00:00 EST

Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Drug: Sarpogrelate;   Drug: Aspirin
Sponsor:   Seoul National University Bundang Hospital
Completed

Wed, 18 Nov 2015 12:00:00 EST

Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: PL2200 Aspirin Capsules;   Drug: Immediate-Release Aspirin Tablets;   Drug: Enteric-coated aspirin caplets
Sponsor:   PLx Pharma
Completed

Tue, 24 Jan 2012 12:00:00 EST

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

Conditions:   Cancer;   Breast Cancer;   Prostate Cancer;   Colorectal Cancer;   Gastro-oesophageal Cancer
Interventions:   Drug: Aspirin 100mg;   Drug: Aspirin 300mg;   Drug: Placebo 100mg;   Drug: Placebo 300mg
Sponsor:   University College, London
Recruiting

Fri, 17 Jun 2016 12:00:00 EDT

Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers

Condition:   Upper Gastrointestinal Mucosal Damage
Intervention:   Drug: acetylsalicylic acid
Sponsor:   PLx Pharma
Completed

Tue, 31 Mar 2009 12:00:00 EDT

Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome

Conditions:   Cardiovascular Diseases;   Metabolic Syndrome X;   Atherosclerosis
Intervention:   Drug: Aspirin
Sponsors:   Florida Atlantic University;   Bayer
Completed

Thu, 05 Jan 2006 12:00:00 EST

Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis

Conditions:   Residual Disease;   Aggressive Periodontitis
Interventions:   Procedure: Open flap debridement;   Other: Placebo;   Dietary Supplement: Omega-3 polyunsaturated fatty acids;   Drug: Aspirin
Sponsor:   Universidade Estadual Paulista Júlio de Mesquita Filho
Completed

Tue, 28 Mar 2017 12:00:00 EDT

Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation Recipients

Condition:   Renal Transplant
Interventions:   Drug: Aspirin 100mg;   Other: Placebo
Sponsor:   Henan Provincial People's Hospital
Recruiting

Fri, 07 Feb 2020 12:00:00 EST

Minocycline and Aspirin in the Treatment of Bipolar Depression

Condition:   Bipolar Disorder Depression
Interventions:   Drug: Minocycline;   Drug: Aspirin;   Drug: placebo
Sponsors:   Laureate Institute for Brain Research, Inc.;   Stanley Medical Research Institute;   University of Oklahoma
Completed

Wed, 07 Sep 2011 12:00:00 EDT

Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia

Conditions:   Pre-Eclampsia;   Fetal Growth Retardation;   Premature Birth;   Placental Insufficiency
Interventions:   Drug: Acetylsalicylic Acid 160 mg;   Drug: Acetylsalicylic Acid 80 mg
Sponsor:   CHU de Quebec-Universite Laval
Completed

Wed, 11 May 2011 12:00:00 EDT

Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer

Conditions:   Adenocarcinoma of the Lung;   Recurrent Non-small Cell Lung Cancer;   Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions:   Drug: acetylsalicylic acid;   Other: laboratory biomarker analysis
Sponsors:   Vanderbilt-Ingram Cancer Center;   National Cancer Institute (NCI)
Terminated

Tue, 16 Oct 2012 12:00:00 EDT

Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers

Conditions:   Lung Carcinoma;   Tobacco Use Disorder
Interventions:   Drug: Aspirin;   Other: Laboratory Biomarker Analysis;   Other: Placebo
Sponsor:   National Cancer Institute (NCI)
Completed

Mon, 28 Apr 2014 12:00:00 EDT

N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder

Condition:   Bipolar Disorder
Interventions:   Drug: Aspirin;   Dietary Supplement: N-acetyl-cysteine (NAC);   Drug: Sugar Pill
Sponsors:   The University of Texas Health Science Center, Houston;   Stanley Medical Research Institute
Completed

Fri, 22 Feb 2013 12:00:00 EST

Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy

Condition:   Cardiovascular Prevention
Intervention:   Drug: Risk of low dose aspirin discontinuation
Sponsor:   AstraZeneca
Completed

Fri, 28 Jun 2013 12:00:00 EDT

NSAIDs vs. Coxibs in the Presence of Aspirin

Conditions:   Rheumatoid Arthritis;   Cardiovascular Diseases
Interventions:   Drug: celecoxib 200mg capsule;   Drug: naproxen sodium 550mg tablet;   Drug: Aspirin 81mg tablet
Sponsor:   Inova Health Care Services
Unknown status

Tue, 09 Oct 2018 12:00:00 EDT

A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease

Condition:   Moderate Risk of CVD
Interventions:   Drug: Aspirin (Acetylsalicylic acid, BAYE4465);   Drug: Placebo
Sponsor:   Bayer
Completed

Fri, 13 Jul 2007 12:00:00 EDT

PACT (Platelet Activity After Clopidogrel Termination)

Conditions:   Blood Platelets;   Clopidogrel
Interventions:   Drug: clopidogrel + aspirin;   Drug: placebo;   Drug: Aspirin
Sponsors:   University of Massachusetts, Worcester;   Sanofi;   Bristol-Myers Squibb
Completed

Wed, 20 Feb 2008 12:00:00 EST

Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Aspirin;   Drug: aspirin
Sponsor:   Karolinska Institutet
Completed

Fri, 19 Dec 2008 12:00:00 EST

Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events

Conditions:   Stroke;   Myocardial Infarctions
Interventions:   Drug: Clopidogrel;   Drug: Aspirin 81 mg;   Drug: Aspirin >300 mg
Sponsor:   Northwestern University
Completed

Fri, 27 Apr 2012 12:00:00 EDT

Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty

Condition:   Venous Thromboembolism
Interventions:   Drug: acetylsalicylic acid;   Drug: rivaroxaban
Sponsor:   Hanyang University Seoul Hospital
Completed

Wed, 22 Oct 2014 12:00:00 EDT

Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis

Condition:   Thrombosis
Intervention:   Drug: aspirin
Sponsor:   Tunis University
Unknown status

Tue, 04 Feb 2014 12:00:00 EST

Aspirin in Reduction of Tension II Study

Conditions:   Hypertension;   Cardiovascular Diseases
Interventions:   Drug: Acetylsalicylic acid;   Drug: Acetylsalicylic acid lysinate
Sponsors:   Leiden University Medical Center;   Netherlands Heart Foundation
Completed

Thu, 23 Jun 2011 12:00:00 EDT

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)

Condition:   Coronary Heart Disease
Interventions:   Drug: Clopidogrel;   Drug: Aspirin
Sponsors:   Seoul National University Hospital;   Chong Kun Dang Pharmaceutical;   Samjin Pharmaceutical Co., Ltd.;   Daewoong Pharmaceutical Co. LTD.;   Hanmi Pharmaceutical co., ltd.
Completed

Thu, 23 Jan 2014 12:00:00 EST

Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration

Condition:   Platelet Aggregation
Interventions:   Drug: aspirin;   Drug: placebo
Sponsor:   Vanderbilt University
Terminated

Mon, 08 Sep 2008 12:00:00 EDT

An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute

Condition:   Pain
Interventions:   Drug: aspirin and ketamine;   Drug: Nurtec (Rimegepant)
Sponsor:   Antonios Likourezos
Recruiting

Tue, 27 Apr 2021 12:00:00 EDT

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Conditions:   Heart Disease;   Stroke;   Ischemic Heart Disease;   Myocardial Infarction
Interventions:   Drug: aspirin;   Drug: Warfarin
Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)
Completed

Mon, 22 Jul 2002 12:00:00 EDT

A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain

Condition:   Pain
Interventions:   Drug: Aspirin and Ketamine;   Drug: Oral Ketamine
Sponsor:   Antonios Likourezos
Recruiting

Tue, 27 Apr 2021 12:00:00 EDT

Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation

Condition:   Placental Insufficiency
Interventions:   Drug: Aspirin;   Drug: placebo
Sponsor:   Sara Varea
Completed

Tue, 12 Jun 2012 12:00:00 EDT

Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients

Condition:   Nasopharyngeal Carcinoma
Interventions:   Radiation: Radiotherapy;   Drug: Concurrent chemotherapy;   Drug: Aspirin
Sponsor:   Sun Yat-sen University
Not yet recruiting

Mon, 25 Sep 2017 12:00:00 EDT

DS1040b/Aspirin Drug/Drug Interaction Study

Condition:   Acute Ischemic Stroke
Interventions:   Drug: DS-1040b;   Drug: Aspirin
Sponsor:   Daiichi Sankyo, Inc.
Completed

Tue, 25 Feb 2014 12:00:00 EST

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

Conditions:   Chronic Hypertension Complicating Pregnancy;   Pre-Eclampsia;   Intrauterine Growth Restriction;   Aspirin;   Perinatal Death;   Placental Abruption
Interventions:   Drug: Aspirin 150 mg;   Drug: Placebo
Sponsor:   Centre Hospitalier Intercommunal Creteil
Recruiting

Wed, 22 Apr 2020 12:00:00 EDT

Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)

Conditions:   Secondary Prevention;   Stroke;   Ischemic Heart Disease;   Coronary Heart Disease
Interventions:   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465);   Drug: Clopidogrel, Oral Anticoagulants, NSAIDs and SSRIs
Sponsor:   Bayer
Completed

Tue, 15 Sep 2015 12:00:00 EDT

To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects

Condition:   Thrombosis
Interventions:   Drug: Aspirin、clopidogrel、placebo or SHR2285;   Drug: Aspirin、ticagrelor、placebo or SHR2285
Sponsor:   Jiangsu HengRui Medicine Co., Ltd.
Recruiting

Wed, 30 Jun 2021 12:00:00 EDT

Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

Condition:   Peripheral Arterial Disease
Interventions:   Drug: Rivaroxaban;   Drug: Aspirin
Sponsors:   Poznan University of Medical Sciences;   Poznan University of Physical Education
Not yet recruiting

Thu, 12 Mar 2020 12:00:00 EDT

Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma

Condition:   Colorectal Adenoma
Interventions:   Drug: Aspirin;   Other: Laboratory Biomarker Analysis;   Other: Placebo Administration;   Other: Questionnaire Administration
Sponsor:   National Cancer Institute (NCI)
Active, not recruiting

Thu, 17 Nov 2016 12:00:00 EST

APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence

Condition:   Colon Adenomas
Intervention:   Drug: Aspirin
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Société Nationale Française de Gastroentérologie;   Ministry of Health, France;   Sanofi-Synthelabo
Terminated

Fri, 23 Sep 2005 12:00:00 EDT

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

Condition:   Barrett Esophagus
Interventions:   Drug: Aspirin;   Other: Laboratory Biomarker Analysis;   Other: Placebo Administration;   Other: Questionnaire Administration
Sponsor:   National Cancer Institute (NCI)
Active, not recruiting

Thu, 13 Aug 2015 12:00:00 EDT

IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes

Condition:   Pre-Gestational Diabetes
Interventions:   Drug: Aspirin;   Drug: Placebos
Sponsors:   Royal College of Surgeons, Ireland;   Health Research Board, Ireland
Unknown status

Mon, 02 Jul 2018 12:00:00 EDT

Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"

Conditions:   Atrial Fibrillation;   Coronary Artery Disease
Interventions:   Drug: Ticagrelor+Warfarin;   Drug: Clopidogrel+Aspirin+Warfarin
Sponsors:   Genshan Ma;   Zhongda Hospital
Unknown status

Fri, 01 Aug 2014 12:00:00 EDT

Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol

Condition:   Invitro Fertilization
Interventions:   Drug: cabergoline;   Drug: Aspirin;   Drug: GnRH agonist
Sponsor:   Cairo University
Unknown status

Mon, 28 Aug 2017 12:00:00 EDT

Does Low-Dose Aspirin Improve Outcome in In Vitro Fertilisation/Intra Cytoplasmatic Sperm Injection (IVF/ICSI)?

Condition:   Infertility
Interventions:   Drug: aspirin;   Drug: placebo
Sponsor:   University Hospital, Ghent
Completed

Wed, 26 Mar 2008 12:00:00 EDT

Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of Clopidogrel

Conditions:   Influence of Genotype of Drug Metabolizing Enzyme or Transporter on the Pharmacokinetics/Pharmacodynamics of Clopidogrel;   Influence of Aspirin on the Pharmacokinetics/Pharmacodynamics of Clopidogrel
Intervention:   Drug: Clopidogrel+Aspirin
Sponsor:   Seoul National University Hospital
Completed

Wed, 04 Jan 2012 12:00:00 EST

Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg

Conditions:   Aspirin;   Drug Safety;   Effects, Longterm
Intervention:   Drug: Acetylsalicylic acid (Aspirin, BAYE4465)
Sponsor:   Bayer
Completed

Tue, 21 Aug 2012 12:00:00 EDT

Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets

Conditions:   Gastric Ulcer;   Duodenal Ulcer
Intervention:   Drug: rabeprazole plus aspirin versus rabeprazole plus clopidogrel
Sponsor:   Taipei Veterans General Hospital, Taiwan
Unknown status

Wed, 23 Dec 2009 12:00:00 EST

Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation

Conditions:   Coronary Artery Disease;   Stent Thrombosis;   Myocardial Ischemia
Interventions:   Drug: Aspirin and Clopidogrel;   Drug: Aspirin
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Fédération Française de Cardiologie
Completed

Wed, 14 Jan 2009 12:00:00 EST

A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin

Conditions:   Osteoarthritis;   Peptic Ulcer
Interventions:   Drug: Lansoprazole and naproxen and aspirin;   Drug: Celecoxib and aspirin
Sponsor:   Takeda
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine

Condition:   Migraine Headaches
Interventions:   Drug: Aspirin, Acetaminophen, Caffeine pills;   Drug: Prochlorperazine 10mg
Sponsor:   Albert Einstein Healthcare Network
Terminated

Wed, 27 Jun 2012 12:00:00 EDT

The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia

Condition:   Endotoxemia
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   Radboud University
Completed

Tue, 04 Oct 2016 12:00:00 EDT

Hormones Inflammation and Thrombosis

Conditions:   Acute Coronary Syndrome;   Thrombosis
Intervention:   Drug: Aspirin 81 mg
Sponsor:   Johns Hopkins University
Terminated

Tue, 11 Jun 2013 12:00:00 EDT

Anti-Platelet Drugs and Brain-derived Neurotrophic Factor (BDNF) in Human Serum and Plasma

Condition:   Healthy Volunteers
Intervention:   Drug: Aspirin and Clopidogrel
Sponsor:   University of Rostock
Unknown status

Wed, 22 Dec 2010 12:00:00 EST

Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma

Condition:   Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell Carcinoma
Intervention:   Drug: Acetylsalicylic acid
Sponsor:   Hebei Medical University Fourth Hospital
Not yet recruiting

Wed, 03 Apr 2019 12:00:00 EDT

Study of Aspirin and TPA in Acute Ischemic Stroke

Condition:   Acute Ischemic Stroke
Intervention:   Drug: Aspirin
Sponsor:   Hadassah Medical Organization
Withdrawn

Thu, 04 Jan 2007 12:00:00 EST

Effects of Psyllium on Niacin Tolerability

Conditions:   Flushing;   Hyperlipidemias;   Dyslipidemias
Interventions:   Dietary Supplement: Psyllium;   Drug: Aspirin
Sponsor:   VA Greater Los Angeles Healthcare System
Completed

Tue, 12 Dec 2017 12:00:00 EST

Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis

Condition:   Intracranial Atherosclerosis
Interventions:   Procedure: Percutaneous transluminal angioplasty and stenting;   Drug: Aspirin plus clopidogrel
Sponsor:   The 476th Hospital of People's Liberation Army
Unknown status

Tue, 23 Feb 2016 12:00:00 EST

A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease

Condition:   Kawasaki Disease
Interventions:   Other: IVIG only;   Other: IVIG and Aspirin
Sponsor:   Chang Gung Memorial Hospital
Unknown status

Tue, 01 Nov 2016 12:00:00 EDT

Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

Condition:   Pharmacokinetics
Interventions:   Drug: Acetylsalicylic acid (Aspirin, BAY1019036);   Drug: Acetylsalicylic acid (Aspirin, BAYE4465)
Sponsor:   Bayer
Completed

Mon, 22 Feb 2010 12:00:00 EST

Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma

Condition:   Melanoma (Skin)
Interventions:   Drug: Aspirin 81 mg;   Drug: Aspirin 325mg
Sponsor:   University of Utah
Recruiting

Tue, 20 Aug 2019 12:00:00 EDT

Laboratory Aspirin Resistance in Diabetics and Non-Diabetics

Condition:   Drug Resistance
Intervention:   Drug: acetylsalicylic acid
Sponsor:   University of Aarhus
Completed

Mon, 26 Nov 2007 12:00:00 EST

BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 500 mg IV;   Drug: D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 250 mg IV;   Drug: Acetylsalicylic acid (Aspirin, BAYe4465) 300 mg Tablet
Sponsor:   Bayer
Completed

Fri, 29 May 2009 12:00:00 EDT

Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)

Condition:   Stroke
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid (Aspirin, BAY1019036);   Other: Rivaroxaban-Placebo;   Other: Aspirin-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Population Health Research Institute
Terminated

Wed, 10 Dec 2014 12:00:00 EST

Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms

Condition:   Unruptured Intracranial Aneurysms
Interventions:   Drug: Acetylsalicylic acid;   Other: intensive blood pressure control
Sponsors:   Universitätsmedizin Mannheim;   UMC Utrecht;   Schwiete Stiftung, Mannheim, Germany;   KKS Netzwerk;   University of Hamburg-Eppendorf
Recruiting

Fri, 24 Feb 2017 12:00:00 EST

Cilostazol Following Peripheral Endovascular Procedures

Condition:   Peripheral Arterial Disease
Interventions:   Drug: Cilostazol;   Drug: Aspirin
Sponsors:   Attikon Hospital;   University Hospital of Patras
Recruiting

Thu, 12 May 2016 12:00:00 EDT

Ticagrelor and Peripheral Arterial Disease

Condition:   Peripheral Arterial Disease
Interventions:   Procedure: Percutaneous Peripheral Intervention;   Device: Optical Coherence Tomography;   Other: Ankle Brachial Index;   Other: Six minute walk distance;   Drug: Aspirin;   Drug: Aspirin + Ticagrelor
Sponsors:   Arkansas Heart Hospital;   The University of Texas Health Science Center at San Antonio;   University of Alabama at Birmingham
Terminated

Thu, 02 Apr 2015 12:00:00 EDT

Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin

Condition:   Pharmacokinetics
Interventions:   Drug: Acetylsalicylic Acid (Aspirin BAY1019036);   Drug: Alka Seltzer Extra Strength;   Drug: Aspirin Migraine;   Drug: Aspirin Aspro
Sponsor:   Bayer
Completed

Fri, 05 Mar 2010 12:00:00 EST

Omega-3 and Aspirin in Periodontal Regeneration

Condition:   Periodontal Disease
Interventions:   Other: Regenerative therapy (omega 3 PUFA plus low dose aspirin);   Drug: Sugar pill
Sponsors:   October 6 University;   Cairo University
Completed

Fri, 30 Apr 2010 12:00:00 EDT

Clopidogrel/Aspirin Interaction Study

Condition:   Coronary Artery Disease
Interventions:   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   Population Health Research Institute
Completed

Tue, 13 Apr 2010 12:00:00 EDT

Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.

Condition:   To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come
Interventions:   Drug: Low molecular weight heparin;   Drug: Low dose aspirin;   Drug: Heparin & aspirin;   Other: NaCl
Sponsor:   Dr.Vandana Bansal
Unknown status

Fri, 16 Aug 2013 12:00:00 EDT

Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Cardiovascular Disease

Condition:   Type 2 Diabetic Patients
Interventions:   Drug: Rivaroxaban;   Drug: Aspirin
Sponsor:   GWT-TUD GmbH
Completed

Mon, 16 Jun 2014 12:00:00 EDT

Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed

Condition:   Colorectal Cancer
Interventions:   Drug: aspirin;   Other: placebo
Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)
Completed

Tue, 31 Aug 2004 12:00:00 EDT

A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs

Conditions:   Coronary Artery Disease;   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (BAY59-7939, Xarelto);   Drug: Acetylsalicylic acid
Sponsor:   Bayer
Recruiting

Tue, 26 May 2020 12:00:00 EDT

Platelet Reactivity in Acute Non-disabling Cerebrovascular Events

Conditions:   Stroke;   Ischemic Attack, Transient
Interventions:   Drug: Ticagrelor and Acetylsalicylic acid;   Drug: Clopidogrel and Acetylsalicylic acid
Sponsors:   Beijing Tiantan Hospital;   Beijing Municipal Science & Technology Commission
Completed

Thu, 23 Jul 2015 12:00:00 EDT

Impact of isoQUercetin and Aspirin on Platelet Function

Condition:   Cardiovascular Disease
Interventions:   Drug: Vehicle control;   Drug: Isoquercetin;   Drug: Aspirin;   Drug: Isoquercetin plus Aspirin
Sponsors:   University of Reading;   Biotechnology and Biological Sciences Research Council;   Quercegen Pharmaceuticals
Withdrawn

Mon, 15 Aug 2016 12:00:00 EDT

Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology

Conditions:   Sarcoma;   Soft Tissue Sarcoma;   Bone Sarcoma;   Bone Metastases;   Venous Thromboembolism;   Hematoma;   Anticoagulant-induced Bleeding
Interventions:   Drug: Aspirin 325mg;   Drug: Enoxaparin 40Mg/0.4mL Prefilled Syringe
Sponsors:   Massachusetts General Hospital;   Brigham and Women's Hospital;   Beth Israel Deaconess Medical Center
Enrolling by invitation

Wed, 09 Aug 2017 12:00:00 EDT

Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial

Condition:   Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage
Interventions:   Drug: Clopidogrel;   Drug: Clopidogrel+aspirin
Sponsor:   Shenyang Northern Hospital
Recruiting

Tue, 13 Feb 2018 12:00:00 EST

Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients

Condition:   Well-controlled Hypertension
Intervention:   Drug: Aspirin enteric coated pellests 100mg
Sponsors:   Boryung Pharmaceutical Co., Ltd;   Kyungpook National University Hospital;   The Catholic University of Korea;   Cheil General Hospital and Women's Healthcare Center;   Inje University;   Keimyung University;   Seoul National University Bundang Hospital;   Severance Hospital;   Yeungnam University Hospital
Completed

Wed, 11 Oct 2006 12:00:00 EDT

Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers

Condition:   Tobacco Use Disorder
Interventions:   Drug: Aspirin;   Other: Laboratory Biomarker Analysis;   Other: Placebo Administration;   Drug: Zileuton
Sponsor:   National Cancer Institute (NCI)
Completed

Wed, 28 Jan 2015 12:00:00 EST

Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion

Condition:   Habitual Abortion
Interventions:   Drug: Aspirin;   Drug: Klexane;   Drug: Klexane and ASA
Sponsors:   University of Helsinki;   Oulu University Hospital;   Karolinska University Hospital;   Leiden Hospital, Leiden, The Netherlands
Completed

Fri, 14 Aug 2009 12:00:00 EDT

The Value of Prednisolone With Aspirin Before Embryo Transfer in Intracytoplasmic Sperm Injection (ICSI) Cycles

Condition:   Infertility
Interventions:   Drug: prednisolone;   Drug: Acetyl Salicylic acid
Sponsor:   Kasr El Aini Hospital
Completed

Thu, 19 Apr 2018 12:00:00 EDT

Edoxaban for TIA and Acute Minor Stroke

Conditions:   Ischemia;   Stroke;   Cerebral Infarction
Interventions:   Drug: Aspirin;   Drug: edoxaban;   Drug: placebo
Sponsor:   Xijing Hospital
Unknown status

Wed, 20 Aug 2014 12:00:00 EDT

Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers

Condition:   Healthy
Interventions:   Drug: PA32540;   Drug: aspirin component of PA32540;   Drug: Ecotrin
Sponsor:   POZEN
Completed

Mon, 10 Mar 2008 12:00:00 EDT

Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid

Condition:   Atherosclerosis
Interventions:   Drug: Rivaroxaban (BAY59-7939, Xarelto);   Drug: Acetylsalicylic acid
Sponsors:   Bayer;   Janssen, LP
Completed

Mon, 19 Nov 2018 12:00:00 EST

STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation

Condition:   Coronary Artery Disease
Interventions:   Drug: Continuing aspirin;   Drug: Stopping aspirin
Sponsor:   Yonsei University
Terminated

Wed, 14 Jun 2017 12:00:00 EDT

Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis

Condition:   Complications Due to Heart Valve Prosthesis
Interventions:   Drug: Acetyl Salicylic Acid;   Drug: Warfarin;   Drug: Placebo (for Aspirin)
Sponsor:   Pharmacoeconomic Unit, Egypt
Unknown status

Fri, 27 Dec 2013 12:00:00 EST

Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling

Condition:   Embolic Stroke
Intervention:   Drug: Aspirin and clopidogrel
Sponsor:   Beijing Tiantan Hospital
Unknown status

Mon, 25 Aug 2014 12:00:00 EDT

Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People

Condition:   Diabetes Mellitus
Interventions:   Drug: Aspirin;   Drug: Atorvastatin;   Drug: Aspirin + Atorvastatin
Sponsor:   Fundacion GESICA
Completed

Wed, 19 Nov 2008 12:00:00 EST

Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation

Conditions:   Gastrointestinal Injury;   Ischemic Heart Disease
Interventions:   Drug: Aspirin + clopidogrel;   Drug: Clopidogrel monotherapy;   Drug: Aspirin monotherapy
Sponsors:   Shenyang Northern Hospital;   Changhai Hospital;   ANKON medical technologies (Shanghai)Co.,LTD
Recruiting

Mon, 26 Jun 2017 12:00:00 EDT

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Conditions:   Venous Thromboembolism;   Deep Venous Thrombosis;   Pulmonary Embolism;   Atherosclerosis
Intervention:   Drug: aspirin
Sponsor:   University Of Perugia
Unknown status

Thu, 22 Sep 2005 12:00:00 EDT

Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy

Conditions:   Recurrent Prostate Carcinoma;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions:   Drug: Aspirin;   Other: Laboratory Biomarker Analysis;   Drug: Metformin Hydrochloride;   Other: Placebo
Sponsors:   Rutgers, The State University of New Jersey;   National Cancer Institute (NCI);   Rutgers Cancer Institute of New Jersey
Terminated

Mon, 20 Apr 2015 12:00:00 EDT

Aspirin and Antiretroviral Therapy in HIV Infected Patients

Condition:   HIV Infection
Interventions:   Drug: Aspirin 325mg;   Drug: Antiretroviral therapy (ART)
Sponsor:   Hennepin Healthcare Research Institute
Terminated

Sun, 02 Nov 2008 12:00:00 EDT

Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets

Conditions:   Ticagrelor;   Aspirin;   Platelet Dysfunction Due to Drugs;   Transfusion
Intervention:   Drug: Antiplatelet treatment
Sponsor:   Hamilton Health Sciences Corporation
Unknown status

Thu, 29 Dec 2016 12:00:00 EST

Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery

Conditions:   Hepatocellular Carcinoma;   Recurrence
Interventions:   Drug: Aspirin;   Drug: Lamivudine
Sponsor:   Fudan University
Recruiting

Fri, 06 Sep 2013 12:00:00 EDT

Salicylic Augmentation in Depression

Conditions:   Depression;   Depressive Disorder;   Major Depressive Disorder;   Treatment Resistant Depression
Interventions:   Drug: Aspirin 325mg;   Drug: Placebo Oral Tablet
Sponsors:   Jessica Harder;   Columbia University
Recruiting

Mon, 15 May 2017 12:00:00 EDT

Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Conditions:   Coronary Artery Disease;   Myocardial Ischemia;   Acute Coronary Syndrome;   Heart Diseases;   Syndrome Heart Disease;   Cardiovascular Diseases;   Arteriosclerosis;   Arterial Occlusive Diseases;   Coronary Disease;   Vascular Diseases
Interventions:   Drug: Clopidogrel and Aspirin dual-antiplatelet therapy;   Drug: Aspirin monotherapy
Sponsors:   Harbin Medical University;   Chinese Society of Cardiology;   Lepu Medical Technology (Beijing) Co., Ltd.
Recruiting

Thu, 12 Nov 2020 12:00:00 EST

Study to Evaluate the Interaction Between Aspirin and Nexium

Condition:   Healthy Volunteers
Interventions:   Drug: Aspirin;   Drug: Esomeprazole
Sponsor:   AstraZeneca
Completed

Fri, 10 Sep 2010 12:00:00 EDT

A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

Condition:   Platelet Aggregation
Interventions:   Drug: Plavix® and PA32540;   Drug: EC aspirin (Bayer®) ,EC omeprazole (Prilosec®) , Clopidogrel (Plavix®)
Sponsor:   POZEN
Completed

Mon, 19 Mar 2012 12:00:00 EDT

Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19

Conditions:   Severe Acute Respiratory Syndrome;   Ventilation Pneumonitis
Interventions:   Drug: Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets;   Other: Ivermectin 5 mg/mL oral solution, Dexamethasone 4-mg injection, Aspirin 250 mg tablets;   Other: Ivermectin 5 MG/ML oral solution, Dexamethasone 4-mg injection, Enoxaparin injection. Inpatient treatment with mechanical ventilation in ICU.
Sponsor:   Eurnekian Public Hospital
Completed

Thu, 11 Jun 2020 12:00:00 EDT

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection

Condition:   Ischemic Stroke
Interventions:   Drug: aspirin;   Drug: warfarin
Sponsor:   University of California, San Diego
Withdrawn

Wed, 14 Dec 2005 12:00:00 EST

Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

Conditions:   Transient Ischemic Attack;   Stroke;   Aspirin;   Clopidogrel
Intervention:   Drug: aspirin versus clopidogrel
Sponsor:   University of California, San Diego
Withdrawn

Tue, 15 Aug 2006 12:00:00 EDT

A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin

Condition:   Healthy
Interventions:   Drug: aspirin;   Drug: omeprazole
Sponsor:   POZEN
Completed

Thu, 01 Mar 2007 12:00:00 EST

Pharmacogenomics of Antiplatelet Response - II (PARes-II)

Condition:   Atherothrombosis
Intervention:   Drug: Aspirin
Sponsor:   Johns Hopkins University
Completed

Wed, 10 Jul 2013 12:00:00 EDT

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

Conditions:   Current Smoker;   Former Smoker;   Multiple Pulmonary Nodules;   Tobacco Use Disorder
Interventions:   Drug: Aspirin;   Other: Laboratory Biomarker Analysis;   Other: Placebo
Sponsor:   National Cancer Institute (NCI)
Completed

Mon, 23 Jun 2014 12:00:00 EDT

Pharmacological Study That Measures Omeprazole Effect on Aspirins Absorption in Healthy Volunteers

Conditions:   Aspirin Blood Level;   Proton Pump Inhiditor Treatment
Intervention:   Drug: aspirin and omeprazole
Sponsor:   Assaf-Harofeh Medical Center
Completed

Tue, 02 Feb 2010 12:00:00 EST

Efficacy Study of Clopidogrel in High-risk Population With Acute Non-disabling Cerebrovascular Events Ⅱ

Conditions:   Acute Nondisabling Ischemic Stroke;   Transient Ischemic Attack
Interventions:   Drug: Tagrelor combined with aspirin;   Drug: Clopidogrel combined with aspirin
Sponsors:   Peking University Third Hospital;   Beijing Tiantan Hospital
Recruiting

Wed, 07 Jul 2021 12:00:00 EDT

Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator

Conditions:   Complication of Cardiac Defibrillator;   Disorder of Cardiac Pacemaker System;   Venous Occlusion
Interventions:   Drug: placebo;   Drug: Aspirin 80 mg daily;   Drug: Clopidogrel 75 mg daily
Sponsor:   Shahid Beheshti University of Medical Sciences
Unknown status

Tue, 06 Jan 2015 12:00:00 EST

Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit

Condition:   Critical Illness
Interventions:   Drug: Acetylsalicylic acid lysinate;   Drug: 0.9% sodium-chloride solution
Sponsor:   Medical University of Vienna
Terminated

Thu, 06 Nov 2014 12:00:00 EST

Benign Acute Pericarditis: Brief Versus Longer Treatment Using Aspirin

Condition:   Pericarditis
Interventions:   Drug: Aspirin;   Drug: placebo
Sponsors:   University Hospital, Brest;   Ministry of Health, France
Terminated

Mon, 27 Jul 2009 12:00:00 EDT

Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)

Condition:   Cerebral Infarction
Interventions:   Drug: MCI-9042;   Drug: Aspirin
Sponsor:   Mitsubishi Tanabe Pharma Corporation
Completed

Fri, 12 Aug 2005 12:00:00 EDT

Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial

Condition:   Coronary Artery Disease
Interventions:   Drug: aspirin;   Drug: clopidogrel
Sponsors:   Intermountain Health Care, Inc.;   Bristol-Myers Squibb;   Sanofi-Synthelabo
Completed

Fri, 23 Jun 2006 12:00:00 EDT

Efficacy and Safety of Aspirin Therapy With CABG

Condition:   Coronary Heart Disease
Interventions:   Drug: acetylsalicylic acid started for 24 hours before surgery;   Drug: acetylsalicylic acid stayed for 5 days before surgery
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Unknown status

Mon, 24 Oct 2016 12:00:00 EDT

Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery

Condition:   Coronary Arteriosclerosis
Intervention:   Drug: Aspirin
Sponsors:   Centro Cardiologico Monzino;   Catholic University, Italy;   University of Chieti
Unknown status

Tue, 08 Nov 2011 12:00:00 EST

Peri-vascular Adipose Tissue Inflammation Evaluated Using Coronary CT Angiography

Condition:   Cardiovascular Risk Factor
Intervention:   Drug: aspirin and atorvastatin
Sponsors:   University of Leicester;   University of Oxford;   British Heart Foundation;   National Institute for Health Research, United Kingdom
Recruiting

Fri, 29 Nov 2019 12:00:00 EST

Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients

Condition:   Systemic Sclerosis
Interventions:   Drug: Acetylsalicylic acid;   Drug: Placebo oral capsule
Sponsor:   Federal University of São Paulo
Recruiting

Fri, 15 Jun 2018 12:00:00 EDT

Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion

Condition:   Retinal Vein Occlusion
Interventions:   Drug: parnaparin;   Drug: aspirin
Sponsors:   Università degli Studi dell'Insubria;   Alfa Wassermann, Bologna, Italy
Terminated

Tue, 12 Aug 2008 12:00:00 EDT

Antiplatelet Therapy for Silent Brain Infarction

Condition:   Brain Infarction
Interventions:   Drug: Aspirin;   Drug: Placebo Oral Tablet
Sponsor:   First People's Hospital of Shenyang
Not yet recruiting

Tue, 24 Oct 2017 12:00:00 EDT

A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer

Condition:   Breast Cancer
Interventions:   Drug: Avelumab;   Drug: Aspirin;   Drug: Lansoprazole
Sponsors:   The Christie NHS Foundation Trust;   University of Manchester
Not yet recruiting

Thu, 05 Dec 2019 12:00:00 EST

The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers

Condition:   Healthy
Interventions:   Drug: Acetaminophen - 4 grams per day + Placebo;   Drug: Aspirin - 325 mg per day + Placebo;   Drug: Acetaminophen 4 gram per day + Aspirin 325 mg per day
Sponsor:   University of Illinois at Chicago
Completed

Wed, 16 Jan 2008 12:00:00 EST

Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI

Conditions:   Aortic Valve Stenosis;   Stroke
Intervention:   Drug: aspirin+clopidogrel (Duoplavin)
Sponsor:   Andres Iñiguez Romo, MD, PhD
Completed

Tue, 17 Jul 2012 12:00:00 EDT

Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: aspirin;   Drug: Levofloxacin
Sponsor:   West China Hospital
Unknown status

Mon, 02 May 2016 12:00:00 EDT

Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis

Condition:   Relapsing-Remitting Multiple Sclerosis
Interventions:   Drug: dimethyl fumarate;   Drug: acetylsalicylic acid;   Drug: ASA-Placebo
Sponsor:   Biogen
Completed

Tue, 18 Mar 2014 12:00:00 EDT

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

Condition:   Peripheral Artery Disease (PAD)
Interventions:   Drug: Ticagrelor;   Drug: Comparator
Sponsors:   AstraZeneca;   CPC Clinical Research
Terminated

Thu, 28 Aug 2014 12:00:00 EDT

Clopidogrel and Aspirin for the Treatment of Polycythemia Vera

Condition:   Polycythemia Vera
Interventions:   Drug: Clopidogrel (Plavix);   Drug: Placebo;   Drug: Aspirin
Sponsors:   Ronald Hoffman;   Myeloproliferative Disorders-Research Consortium;   National Cancer Institute (NCI)
Withdrawn

Thu, 16 Jul 2009 12:00:00 EDT

Anticoagulation for Aortic Bioprosthesis (ANTIPRO)

Conditions:   Aortic Valve Stenosis;   Aortic Valve Disease;   Aortic Valve Insufficiency;   Aortic Valve Regurgitation
Interventions:   Drug: Warfarin;   Drug: Aspirin
Sponsors:   Instituto Nacional de Cirugia Cardiaca, Uruguay;   Universidad de la Republica
Completed

Thu, 17 Jan 2019 12:00:00 EST

AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study

Conditions:   Antiphospholipid Syndrome in Pregnancy;   Pregnancy Loss
Interventions:   Drug: Aspirin 81 mg;   Drug: Low-molecular-weight heparin
Sponsor:   Ottawa Hospital Research Institute
Terminated

Tue, 04 Apr 2017 12:00:00 EDT

Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19

Conditions:   COVID-19;   Thrombosis Pulmonary
Interventions:   Drug: Acetylsalicylic acid;   Drug: Placebo
Sponsor:   Azienda Ospedaliera Universitaria Integrata Verona
Not yet recruiting

Mon, 22 Mar 2021 12:00:00 EDT

Implementation of First-trimester Screening and preventiOn of pREeClAmpSia Trial (FORECAST)

Condition:   Pre-Eclampsia
Intervention:   Other: Low-dose aspirin in women with high risk of preeclampsia
Sponsor:   Chiu Yee Liona Poon
Recruiting

Wed, 08 May 2019 12:00:00 EDT

ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery

Conditions:   Graft Patency;   Coronary Artery Bypass Grafting Surgery;   Hypercoagulability;   Thrombosis
Interventions:   Drug: Clopidogrel+acetylsalicylic acid;   Drug: acetylsalicylic acid
Sponsor:   Rigshospitalet, Denmark
Unknown status

Tue, 12 Jan 2010 12:00:00 EST

Residual Platelet Reactivity in Patients on Antiplatelet Therapy After Carotid Angioplasty With Stenting

Condition:   Carotid Artery Disease
Intervention:   Drug: Aspirin plus clopidogrel
Sponsors:   Azienda Ospedaliera di Perugia;   University Of Perugia
Unknown status

Mon, 10 Oct 2011 12:00:00 EDT

Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome

Conditions:   STEMI;   NSTEMI;   Unstable Angina
Interventions:   Drug: Ticagrelor 90mg;   Drug: Ticagrelor 60mg;   Drug: Aspirin
Sponsors:   Collegium Medicum w Bydgoszczy;   Medical Research Agency (Poland)
Not yet recruiting

Fri, 22 Jan 2021 12:00:00 EST

TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI

Condition:   Acute Myocardial Infarction
Interventions:   Drug: Aspirin+Ticagrelor;   Drug: Aspirin+Clopidogrel
Sponsors:   The Catholic University of Korea;   Chonnam National University Hospital
Completed

Mon, 23 Dec 2013 12:00:00 EST

Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology

Conditions:   Bone Metastases;   Musculoskeletal Cancer;   Soft Tissue Sarcoma;   Thromboembolism
Interventions:   Drug: acetylsalicylic acid;   Drug: enoxaparin;   Device: PCD
Sponsor:   Ohio State University Comprehensive Cancer Center
Completed

Mon, 01 Oct 2012 12:00:00 EDT

A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer

Condition:   Breast Cancer
Interventions:   Drug: Avelumab;   Drug: Aspirin;   Drug: Lansoprazole (Proton Pump Inhibitor)
Sponsors:   The Christie NHS Foundation Trust;   University of Manchester
Withdrawn

Mon, 07 Jan 2019 12:00:00 EST

Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

Conditions:   Colon Cancer;   Precancerous Condition;   Rectal Cancer
Interventions:   Drug: acetylsalicylic acid;   Drug: placebo;   Other: laboratory biomarker analysis
Sponsor:   National Cancer Institute (NCI)
Completed

Thu, 03 May 2007 12:00:00 EDT

Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma

Condition:   Melanoma (Skin)
Interventions:   Drug: Aspirin 81 mg;   Drug: Aspirin 325mg;   Drug: Placebo oral tablet
Sponsor:   University of Utah
Recruiting

Mon, 26 Aug 2019 12:00:00 EDT

ASPREE Cancer Endpoints Study

Condition:   Cancer
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   Hennepin Healthcare Research Institute;   National Cancer Institute (NCI);   National Institute on Aging (NIA);   Monash University;   Berman Center for Outcomes and Clinical Research;   National Health and Medical Research Council, Australia;   Bayer
Active, not recruiting

Thu, 24 Oct 2013 12:00:00 EDT

Evaluate Onset of Action of a Fast Release Aspirin

Condition:   Healthy Subjects
Interventions:   Drug: Acetylsalicyclic acid (Fast release Aspirin, BAY1019036);   Drug: Acetaminophen (Tylenol extra strength);   Drug: Placebo
Sponsor:   Bayer
Completed

Fri, 19 Aug 2011 12:00:00 EDT

Identification of Critical Thermal Environments for Aged Adults

Condition:   Aging
Interventions:   Drug: Low dose ASA;   Other: Control
Sponsor:   Penn State University
Recruiting

Tue, 25 Feb 2020 12:00:00 EST

Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain

Condition:   Pharyngitis
Interventions:   Drug: Acetylsalicylic Acid (Aspirin, BAY1019036) + placebo;   Drug: Acetaminophen + placebo;   Drug: Placebo
Sponsor:   Bayer
Completed

Mon, 17 Oct 2011 12:00:00 EDT

The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers

Condition:   Healthy
Interventions:   Drug: aspirin;   Drug: celecoxib;   Drug: aspirin + celecoxib;   Drug: aspirin + clopidogrel;   Drug: aspirin + clopidogrel + celecoxib
Sponsor:   Seoul National University Hospital
Completed

Thu, 16 Apr 2009 12:00:00 EDT

Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events

Conditions:   Ischemic Stroke;   TIA
Interventions:   Drug: Apixaban;   Drug: Clopidogrel;   Drug: Aspirin;   Drug: placebo
Sponsor:   Xijing Hospital
Unknown status

Fri, 16 Aug 2013 12:00:00 EDT

Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer

Condition:   Colorectal Cancer
Intervention:   Drug: acetylsalicylic acid
Sponsors:   Instituto de Investigación Sanitaria Aragón;   Instituto de Salud Carlos III;   G. d'Annunzio University;   Hospital Clínico Universitario Lozano Blesa
Unknown status

Tue, 21 May 2019 12:00:00 EDT

Aspirin/Folate Prevention of Large Bowel Polyps

Conditions:   Colorectal Cancer;   Polyps;   Adenomas
Interventions:   Drug: Aspirin;   Drug: Folate
Sponsors:   Dartmouth-Hitchcock Medical Center;   National Cancer Institute (NCI)
Completed

Thu, 05 Jan 2006 12:00:00 EST

Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty

Condition:   Deep Vein Thrombosis
Interventions:   Device: extended compression;   Other: Aspirin
Sponsor:   TriHealth Inc.
Completed

Thu, 03 Apr 2014 12:00:00 EDT

Genetic and Dietary Predictors of Anti-platelet Response

Condition:   Platelet Function
Intervention:   Drug: Aspirin
Sponsors:   University of Washington;   Southcentral Foundation;   University of Montana;   Oregon Health and Science University;   National Institute of General Medical Sciences (NIGMS)
Active, not recruiting

Thu, 02 Jul 2020 12:00:00 EDT

Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet Action

Condition:   Healthy Volunteers
Intervention:   Drug: Acetylsalicylic acid
Sponsor:   Aragon Institute of Health Sciences
Completed

Wed, 12 Feb 2014 12:00:00 EST

Maintenance of an Antiaggregation by Acetylsalicylic Acid, While a Extracorporeal Lithotripsy Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study

Conditions:   Renal Lithiasis;   Antiplatelet;   Hematoma
Intervention:   Other: acetylsalicylic acid (below or equal to) 250 mg
Sponsor:   University Hospital, Clermont-Ferrand
Recruiting

Mon, 19 Feb 2018 12:00:00 EST

Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients

Condition:   Coronary Arteriosclerosis
Interventions:   Drug: modified-release dipyridamole/aspirin;   Drug: aspirin
Sponsor:   Boehringer Ingelheim
Completed

Thu, 11 Aug 2005 12:00:00 EDT

Induction of Gut Permeability by an Oral Vaccine

Conditions:   Intestinal Permeability;   Inflammation;   Vaccine;   Typhoid Fever
Interventions:   Biological: Vivotif Typhoid Oral Vaccine;   Drug: Aspirin (Positive Control)
Sponsor:   USDA, Western Human Nutrition Research Center
Recruiting

Tue, 10 Sep 2019 12:00:00 EDT

Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine

Condition:   Pain, Migraine
Interventions:   Drug: Aspirin, acetaminophen and caffeine;   Drug: Sumatriptan;   Drug: Placebo
Sponsor:   Novartis
Completed

Thu, 25 Nov 2010 12:00:00 EST

Role of Anti-platelet in Treatment of Acute Ischemic Stroke

Condition:   Stroke
Intervention:   Drug: Aspirin
Sponsor:   Assiut University
Unknown status

Wed, 30 Aug 2017 12:00:00 EDT

Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

Conditions:   Type-2 Diabetes Mellitus;   Coronary Artery Disease
Interventions:   Drug: Ticagrelor + Aspirin;   Drug: Clopidogrel + Aspirin
Sponsors:   Juan J Badimon;   AstraZeneca
Completed

Thu, 04 Apr 2013 12:00:00 EDT

Preventive Application of GnRH Antagonist on Early OHSS

Conditions:   Ovarian Hyperstimulation Syndrome;   GnRH Antagonist;   Aspirin;   Vascular Endothelial Growth Factor;   Pigment Epithelium Derived Factor
Interventions:   Drug: GnRH antagonist;   Drug: aspirin
Sponsor:   First Affiliated Hospital, Sun Yat-Sen University
Unknown status

Thu, 15 Jun 2017 12:00:00 EDT

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

Condition:   Healthy
Interventions:   Drug: PA32540;   Drug: PA32540 and celecoxib;   Drug: aspirin and [NSAID]
Sponsor:   POZEN
Completed

Thu, 19 Jun 2008 12:00:00 EDT

Improving Aspirin Use in Diabetes: A Cluster Randomized Trial

Condition:   Diabetes Mellitus
Interventions:   Behavioral: Electronic prompt plus patient-directed intervention;   Behavioral: Electronic prompt to clinician to prescribe aspirin
Sponsor:   Northwestern University
Completed

Wed, 07 Dec 2005 12:00:00 EST

Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent

Condition:   ANEURYSM CORONARY ARTERY
Interventions:   Drug: Clopirin 1;   Drug: Clopidogrel-Aspirin(co-administration) 1;   Drug: Clopirin 2;   Drug: Clopidogrel-Aspirin(co-administration) 2
Sponsor:   Jeil Pharmaceutical Co., Ltd.
Completed

Tue, 07 Apr 2015 12:00:00 EDT

Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.

Condition:   Cancer
Interventions:   Drug: Acetylsalicylic acid + loperamide;   Drug: diosmectite + loperamide
Sponsors:   Centre Francois Baclesse;   Ligue contre le cancer, France;   Canceropôle Nord Ouest
Withdrawn

Tue, 23 Dec 2014 12:00:00 EST

To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects

Conditions:   Pharmacodynamic and Pharmacokinetic Interaction;   Healthy Subjects
Interventions:   Drug: Darexaban;   Drug: Acetyl Salicylic Acid (ASA)
Sponsor:   Astellas Pharma Inc
Completed

Mon, 29 Aug 2011 12:00:00 EDT

The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease

Condition:   Atherosclerosis
Interventions:   Drug: clopidogrel and aspirin;   Drug: aspirin
Sponsor:   China National Center for Cardiovascular Diseases
Unknown status

Tue, 21 Oct 2008 12:00:00 EDT

Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)

Condition:   Chagas Disease With Heart Failure
Intervention:   Drug: Aspirin
Sponsors:   Federal University of Bahia;   National Institutes of Health (NIH);   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting

Thu, 26 Jul 2012 12:00:00 EDT

The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)

Condition:   Peripheral Arterial Disease
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   Arteriogenesis Competence Network
Completed

Mon, 19 Sep 2005 12:00:00 EDT

Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study

Conditions:   Coronary Artery Disease;   Coronary Artery Bypass Grafting
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsors:   Hamilton Health Sciences Corporation;   Bristol-Myers Squibb
Completed

Mon, 29 May 2006 12:00:00 EDT

Comparative Effects of Aspirin and NHP-544C

Condition:   Healthy
Interventions:   Drug: Bradykinin;   Drug: Aspirin 81 mg;   Drug: Aspirin 162 mg;   Drug: NHP544-C 81 mg;   Drug: NHP544C 162 mg;   Drug: Placebo
Sponsor:   Vanderbilt University
Completed

Mon, 14 Jul 2014 12:00:00 EDT

Patent Foramen Ovale in Cryptogenic Stroke Study

Conditions:   Ischemic Stroke;   Patent Foramen Ovale
Interventions:   Drug: Warfarin;   Drug: Aspirin
Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)
Completed

Fri, 13 Jun 2008 12:00:00 EDT

The Effects of DHA on Periodontitis

Conditions:   Periodontitis;   Gingivitis;   Inflammation
Interventions:   Drug: Aspirin;   Drug: Docosahexaenoic acid;   Drug: Placebo (for Docosahexaenoic acid)
Sponsors:   Beth Israel Deaconess Medical Center;   National Center for Research Resources (NCRR);   Harvard Medical School
Completed

Wed, 06 Nov 2013 12:00:00 EST

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

Conditions:   Ventricular Tachycardia;   Premature Ventricular Contraction;   Stroke
Interventions:   Drug: DOAC;   Drug: Aspirin
Sponsors:   Kansas City Heart Rhythm Institute;   Kansas City Heart Rhythm Research Foundation
Completed

Thu, 28 Jan 2016 12:00:00 EST

JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme

Condition:   Cerebrovascular Accident
Interventions:   Drug: Aggrenox capsule;   Other: Acetylsalicylic Acid (ASA)
Sponsor:   Boehringer Ingelheim
Completed

Thu, 06 Apr 2006 12:00:00 EDT

Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate

Condition:   Healthy
Interventions:   Drug: BG00012 (dimethyl fumarate);   Drug: BG00012 placebo;   Drug: ASA;   Drug: ASA placebo
Sponsor:   Biogen
Completed

Mon, 02 Apr 2012 12:00:00 EDT

Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel

Condition:   Coronary Artery Disease
Interventions:   Drug: Edoxaban 60 mg;   Drug: Edoxaban 30 mg;   Drug: Clopidogrel 75 mg;   Drug: Aspirin 81 mg
Sponsors:   University of Florida;   Daiichi Sankyo, Inc.
Completed

Mon, 05 Oct 2015 12:00:00 EDT

Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting

Conditions:   Coronary Artery Disease;   Aspirin Resistance
Intervention:   Drug: Clopidogrel
Sponsor:   University of Zagreb
Completed

Fri, 09 Jul 2010 12:00:00 EDT

Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization

Conditions:   Peripheral Arterial Disease;   Endovascular Procedures
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   University Hospitals Cleveland Medical Center
Withdrawn

Tue, 05 May 2015 12:00:00 EDT

Asprin Dosing Estimator in Healthy Adults

Condition:   Aspirin Sensitivity
Intervention:   Drug: Aspirin
Sponsors:   University of Utah;   University of Colorado, Denver
Recruiting

Wed, 31 Jul 2019 12:00:00 EDT

COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke

Condition:   Stroke
Interventions:   Drug: Clopidogrel;   Drug: Clopidogrel placebo;   Drug: Aspirin
Sponsors:   Sanofi;   Bristol-Myers Squibb
Completed

Wed, 24 Dec 2008 12:00:00 EST

Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

Conditions:   Myeloproliferative Neoplasm;   Essential Thrombocythemia;   JAK2 Mutation;   Polycythemia Vera;   Primary Myelofibrosis;   Venous Thromboembolism
Interventions:   Drug: Apixaban 2.5 MG Oral Tablet [ELIQUIS];   Drug: Aspirin 81 mg
Sponsors:   Ottawa Hospital Research Institute;   Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network;   the Association médicale universitaire de l'Hôpital Montfort (AMUHM);   Canadian Society of Hematology
Recruiting

Tue, 28 Jan 2020 12:00:00 EST

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

Condition:   Coronary Heart Disease
Interventions:   Drug: aspirin + pregrel (Clopidogrel resinate);   Drug: aspirin + placebo;   Drug: aspirin + plavix (Clopidogrel bisulfate)
Sponsors:   Seoul National University Hospital;   CKD Pharmaceutical Limited
Completed

Tue, 28 Jul 2009 12:00:00 EDT

Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy

Condition:   Breast Cancer
Intervention:   Drug: Cyclophosphamide and Methotrexate and Aspirin
Sponsors:   University of Vermont;   Maimonides Medical Center;   Dartmouth-Hitchcock Medical Center
Unknown status

Tue, 05 Jun 2012 12:00:00 EDT

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study

Condition:   Acute Coronary Syndrome
Interventions:   Drug: No aspirin;   Drug: 1-month DAPT
Sponsor:   Kyoto University, Graduate School of Medicine
Recruiting

Fri, 30 Oct 2020 12:00:00 EDT

3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation

Condition:   Coronary Artery Disease
Interventions:   Drug: Aspirin;   Drug: Thienopyridine
Sponsor:   Teikyo University
Unknown status

Tue, 19 Jul 2016 12:00:00 EDT

Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events

Conditions:   Polyvascular Disease;   Cardiovascular Disease
Interventions:   Drug: aspirin;   Drug: clopidogrel;   Drug: clopidogrel plus aspirin
Sponsor:   Catholic University of the Sacred Heart
Unknown status

Mon, 20 Oct 2008 12:00:00 EDT

Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache.

Condition:   Treatment of Episodic Tension Headache
Interventions:   Drug: Association: acetylsalicylic acid (500mg), sodium bicarbonate (1625) and citric acid (965);   Drug: Aspirin - Bayer
Sponsor:   Azidus Brasil
Unknown status

Fri, 13 Nov 2009 12:00:00 EST

Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia

Condition:   Critical Limb Ischemia
Interventions:   Drug: rivaroxaban plus aspirin;   Drug: clopidogrel plus aspirin
Sponsors:   Ottawa Hospital Research Institute;   The Ottawa Hospital
Completed

Thu, 09 Oct 2014 12:00:00 EDT

Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus

Conditions:   Barrett Esophagus;   Esophageal Cancer
Interventions:   Drug: acetylsalicylic acid;   Drug: esomeprazole magnesium;   Other: placebo
Sponsor:   National Cancer Institute (NCI)
Completed

Thu, 17 May 2007 12:00:00 EDT

Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension

Conditions:   High-Normal Blood Pressure;   Mild Essential Hypertension
Interventions:   Drug: Aspirin 100 mg;   Device: Ambulatory blood pressure monitoring;   Procedure: Chronotherapy, timing of medication;   Drug: Placebo
Sponsors:   University of Vigo;   Hospital Clinico Universitario de Santiago;   Bayer
Terminated

Tue, 20 Mar 2007 12:00:00 EDT

Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers

Condition:   Healthy
Interventions:   Drug: intravenous diclofenac sodium (DIC075V);   Drug: ketorolac;   Drug: oral diclofenac (Cataflam);   Drug: aspirin
Sponsor:   Javelin Pharmaceuticals
Completed

Wed, 24 Oct 2007 12:00:00 EDT

Antiplatelet Therapy in HIV

Conditions:   HIV;   Cardiovascular Diseases;   Inflammation
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   NYU Langone Health
Completed

Thu, 24 Sep 2015 12:00:00 EDT

Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167)

Condition:   Healthy Volunteers
Interventions:   Drug: Placebo (to match Aspirin);   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Comparator: Placebo (to match Clopidogrel)
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Thu, 22 Apr 2010 12:00:00 EDT

DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease

Conditions:   Colorectal Cancer;   Colon Cancer
Interventions:   Drug: Aspirin;   Drug: Vitamin D;   Dietary Supplement: Diet;   Other: Physical Activity;   Behavioral: Behavioral Support Counseling Sessions
Sponsor:   M.D. Anderson Cancer Center
Not yet recruiting

Sun, 05 Sep 2021 12:00:00 EDT

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

Condition:   Coronary Artery Disease
Interventions:   Drug: Ticagrelor Tablets;   Drug: Clopidogrel (over encapsulated) capsule;   Drug: Aspirin Tablets
Sponsor:   AstraZeneca
Completed

Wed, 12 Sep 2007 12:00:00 EDT

[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]

Conditions:   Acute Ischaemic Stroke;   Transient Ischaemic Attack
Interventions:   Drug: ticagrelor;   Drug: Acetylsalicylic acid (ASA)
Sponsor:   AstraZeneca
Completed

Tue, 26 Nov 2013 12:00:00 EST

A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach

Condition:   Analgesics
Intervention:   Drug: aspirin, acetaminophen, ibuprofen, naproxen, celecoxib, rofecoxib
Sponsor:   Johnson & Johnson Consumer and Personal Products Worldwide
Completed

Mon, 05 Dec 2005 12:00:00 EST

Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer

Conditions:   Cardiovascular Diseases;   Cerebrovascular Disorders;   Coronary Disease;   Heart Diseases;   Myocardial Infarction;   Myocardial Ischemia;   Vascular Diseases
Interventions:   Drug: Aspirin;   Drug: Vitamin E;   Behavioral: Placebo
Sponsors:   Brigham and Women's Hospital;   National Cancer Institute (NCI);   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 28 Oct 1999 12:00:00 EDT

Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection

Condition:   Spontaneous Coronary Artery Dissection
Intervention:   Drug: Beta blocker, aspirin, clopidogrel
Sponsors:   Spanish Society of Cardiology;   Instituto de Investigación Sanitaria Hospital Universitario de la Princesa;   Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Not yet recruiting

Tue, 20 Apr 2021 12:00:00 EDT

the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy

Condition:   Coronary Atherosclerosis
Interventions:   Drug: aspirin 100mg/d therapy;   Drug: aspirin 100mg/2d therapy;   Drug: aspirin 100mg/3d therapy;   Drug: aspirin 50mg bid therapy;   Drug: aspirin 75mg/d therapy;   Drug: aspirin 50mg/d therapy;   Drug: indobufen 100mg bid therapy
Sponsor:   The First Affiliated Hospital with Nanjing Medical University
Unknown status

Thu, 27 Jul 2017 12:00:00 EDT

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Conditions:   Intracerebral Hemorrhage;   Atrial Fibrillation
Interventions:   Drug: Apixaban;   Drug: Aspirin
Sponsors:   Yale University;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting

Mon, 08 Apr 2019 12:00:00 EDT

Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes

Conditions:   Type 2 Diabetes Mellitus;   Carotid Atherosclerosis
Interventions:   Drug: Cilostazol;   Drug: Aspirin
Sponsor:   Seoul National University Bundang Hospital
Completed

Mon, 14 Aug 2017 12:00:00 EDT

Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions

Condition:   Ulcers, Duodenal and Gastric
Interventions:   Drug: Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one;   Drug: Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two;   Drug: ASA 100 mg tablet;   Drug: Pantoprazole 20 mg gastro-resistant tablet
Sponsors:   GlaxoSmithKline;   Piramal Clinical Research (Hyderabad, India)
Completed

Mon, 06 May 2013 12:00:00 EDT

Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia

Condition:   Dyslipidemia
Interventions:   Drug: niacin extended-release (NER);   Drug: aspirin (ASA);   Drug: aspirin placebo (ASA Pbo)
Sponsor:   Abbott
Completed

Fri, 29 Feb 2008 12:00:00 EST

A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients.

Condition:   Tertiary Prevention in Colon Cancer
Interventions:   Drug: Aspirin (ASA) + Metformin (MET);   Drug: ASA;   Drug: MET;   Drug: Placebos
Sponsor:   Ente Ospedaliero Ospedali Galliera
Unknown status

Thu, 09 Feb 2017 12:00:00 EST

Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately

Condition:   Peptic Ulcer Disease
Interventions:   Drug: Esomeprazole/ASA Fixed Combination;   Drug: Esomeprazole - Nexium;   Drug: ASA
Sponsor:   AstraZeneca
Completed

Tue, 20 Oct 2009 12:00:00 EDT

Enhanced Firefighter Rehab Trial: The Role of Aspirin in Preventing Heat Stress Induced Platelet Activation

Condition:   Heat Stress Disorders
Interventions:   Drug: Daily aspirin (ASA);   Other: Active cooling;   Drug: Acute aspirin (ASA);   Other: Passive cooling;   Drug: Daily placebo;   Drug: Acute placebo
Sponsors:   Dave Hostler;   Federal Emergency Management Administration;   Eyemarker Systems, Inc
Completed

Wed, 10 Feb 2010 12:00:00 EST

The International Polycap Study 3 (TIPS-3)

Conditions:   Cardiovascular Disease;   Fractures;   Cancers
Interventions:   Drug: Polycap;   Drug: Aspirin;   Drug: Vitamin D;   Drug: Matching Placebo
Sponsors:   Population Health Research Institute;   Cadila Pharnmaceuticals;   Wellcome Trust;   Canadian Institutes of Health Research (CIHR);   Heart and Stroke Foundation of Ontario
Completed

Fri, 20 Jul 2012 12:00:00 EDT

Topical Analgesic Versus Saline Mouth Rinses in Post Extraction Healing

Condition:   Tooth Extraction Site Healing
Interventions:   Drug: Aspirin Powder;   Drug: Normal saline
Sponsor:   Aga Khan University
Completed

Wed, 26 Apr 2017 12:00:00 EDT

Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)

Condition:   Mild Cognitive Impairment
Interventions:   Drug: Aspirin;   Drug: Cilostazol
Sponsor:   Huashan Hospital
Unknown status

Fri, 07 Jun 2013 12:00:00 EDT

Primary Thrombocythaemia 1 Trial

Conditions:   Thrombocythemia;   Myeloproliferative Disorder
Interventions:   Drug: Hydroxyurea;   Drug: Aspirin
Sponsors:   University of Cambridge;   Cambridge University Hospitals NHS Foundation Trust;   Institute of Cancer Research, United Kingdom
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Patent Foramen Ovale (PFO) Closure at the Time of Endovascular Cardiac Electronic Device Implantation

Condition:   Foramen Ovale, Patent
Interventions:   Drug: Aspirin;   Device: Cardiovascular Implantable Device (CIED);   Device: Gore Cardioform Septal Occluder
Sponsor:   Mayo Clinic
Withdrawn

Fri, 28 Jul 2017 12:00:00 EDT

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)

Condition:   Systemic Lupus Erythematosus
Interventions:   Drug: extended release dipyridamole 200mg/aspirin 25mg;   Drug: 81mg aspirin
Sponsor:   Oklahoma Medical Research Foundation
Terminated

Fri, 01 Feb 2013 12:00:00 EST

Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)

Condition:   Cerebral Infarction
Interventions:   Drug: Cilostazol;   Drug: Aspirin
Sponsor:   Otsuka Pharmaceutical Co., Ltd.
Completed

Thu, 06 Oct 2005 12:00:00 EDT

Measurement of Platelet Dense Granule Release in Healthy Volunteers

Condition:   Platelet Aggregation
Intervention:   Drug: Aspirin
Sponsor:   Vanderbilt University
Withdrawn

Tue, 21 Jul 2009 12:00:00 EDT

A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients

Condition:   Breast Neoplasms
Interventions:   Drug: Plavix;   Drug: Aspirin
Sponsors:   Washington University School of Medicine;   Barnes-Jewish Hospital
Terminated

Wed, 07 Dec 2005 12:00:00 EST

Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache

Condition:   Headache
Interventions:   Drug: Acetylsalicylic acid (Aspirin, BAY1019036);   Drug: Acetaminophen;   Drug: Placebo
Sponsor:   Bayer
Terminated

Tue, 13 Mar 2012 12:00:00 EDT

A Different Approach to Preventing Thrombosis

Conditions:   Venous Thromboembolism;   Pulmonary Embolism
Interventions:   Drug: VTE prophylaxis with Enoxaparin 30mg BID;   Drug: VTE prophylaxis with Aspirin 81mg BID
Sponsor:   University of Maryland, Baltimore
Completed

Tue, 17 May 2016 12:00:00 EDT

Comparison of Topical Analgesic With Saline Rinses in Post Extraction Healing

Conditions:   Periodontitis;   Dental Caries;   Hypertension
Interventions:   Drug: analgesic mouth rinses (dissolved Aspirin);   Drug: Normal saline rinses.
Sponsor:   Aga Khan University
Completed

Mon, 03 Oct 2016 12:00:00 EDT

Efficacy of Clopidogrel on Incidence of Silent Brain Infarction

Condition:   Silent Brain Infarction
Interventions:   Drug: Clopidogrel treatment;   Drug: Aspirin treatment
Sponsor:   VA Office of Research and Development
Not yet recruiting

Wed, 06 Jan 2021 12:00:00 EST

MonotherApy of Low-does TicagrElor After Percutaneous Coronary Intervention

Conditions:   Acute Coronary Syndrome;   Percutaneous Coronary Intervention;   High Bleeding Risk
Interventions:   Drug: Standard-Does Ticagrelor plus aspirin;   Drug: Low-Does Ticagrelor monotherapy
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting

Thu, 24 Jun 2021 12:00:00 EDT

STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery

Condition:   Thrombosis
Intervention:   Drug: aspirin 75 mg/day
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Sanofi-Synthelabo
Completed

Mon, 19 Sep 2005 12:00:00 EDT

Aspirin-Myocardial Infarction Study (AMIS)

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Infarction;   Myocardial Ischemia
Intervention:   Drug: aspirin
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 28 Oct 1999 12:00:00 EDT

Aspirin Responsiveness in Women With Coronary Artery Disease

Condition:   CAD
Intervention:  
Sponsor:   Creighton University
Completed

Mon, 01 Aug 2011 12:00:00 EDT

Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects

Condition:   Bioequivalence Study
Interventions:   Drug: D961S;   Drug: Esomeprazole;   Drug: Buffered acetylsalicylic acid
Sponsor:   AstraZeneca
Completed

Mon, 19 Dec 2011 12:00:00 EST

Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES

Condition:   Coronary Artery Disease
Interventions:   Drug: P2Y12 antagonist monotherapy;   Drug: aspirin plus P2Y12 antagonist
Sponsor:   Samsung Medical Center
Unknown status

Wed, 05 Mar 2014 12:00:00 EST

Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke

Condition:   Stroke
Intervention:   Drug: Aspirin, Dipyradimole, Clopidogrel
Sponsor:   University of Nottingham
Terminated

Thu, 09 Aug 2012 12:00:00 EDT

Pharmacodynamic and Pharmacokinetic Study of PL-ASA

Condition:   Healthy Volunteers
Intervention:   Drug: PL-ASA
Sponsor:   PLx Pharma
Active, not recruiting

Tue, 23 Mar 2021 12:00:00 EDT

Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate

Condition:   Adverse Effect of Antithrombotic Drugs
Interventions:   Drug: acetylsalicylic acid;   Drug: prasugrel;   Drug: lysine acetylsalicylate
Sponsors:   David Vivas;   St Carlos Hospital, Madrid, Spain
Completed

Wed, 17 Sep 2014 12:00:00 EDT

Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain

Condition:   Low Back Pain
Interventions:   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465);   Drug: Ibuprofen;   Drug: Placebo
Sponsor:   Bayer
Completed

Wed, 09 Dec 2009 12:00:00 EST

Hemostasis in COVID-19: an Adaptive Clinical Trial

Condition:   COVID-19
Interventions:   Drug: acetylsalicylic acid;   Drug: Unfractionated heparin nebulized
Sponsor:   University of Sao Paulo General Hospital
Recruiting

Fri, 10 Jul 2020 12:00:00 EDT

TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)

Condition:   Central Retinal Artery Occlusion
Interventions:   Drug: Intravenous injection of Tenecteplase and one dose of placebo tablet;   Drug: One tablet of Acetylsalicylic Acid and one dose of IV placebo
Sponsor:   Oslo University Hospital
Recruiting

Wed, 26 Aug 2020 12:00:00 EDT

Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke

Condition:   Acute Ischemic Stroke
Intervention:   Drug: aspirin,chinese herbs;
Sponsor:   Guangzhou University of Traditional Chinese Medicine
Completed

Wed, 26 Aug 2009 12:00:00 EDT

Nobori Dual Antiplatelet Therapy as Appropriate Duration

Condition:   Coronary Artery Disease
Interventions:   Drug: Aspirin or thienopyridine;   Drug: Aspirin and thienopyridine
Sponsor:   Associations for Establishment of Evidence in Interventions
Completed

Mon, 23 Jan 2012 12:00:00 EST

A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression

Condition:   Prostate Cancer
Interventions:   Drug: High dose Aspirin & Vitamin D;   Drug: High dose Aspirin, Vitamin D placebo;   Drug: Low dose Aspirin , Vitamin D;   Drug: Low dose Aspirin, Vitamin D placebo;   Drug: Aspirin Placebo, Vitamin D;   Drug: Aspirin placebo, Vitamin D placebo
Sponsors:   Queen Mary University of London;   Barts and the London School of Medicine and Dentistry;   Cancer Research UK
Completed

Thu, 06 Apr 2017 12:00:00 EDT

The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: Warfarin;   Drug: aspirin
Sponsor:   Nanjing Medical University
Completed

Thu, 22 Sep 2011 12:00:00 EDT

Randomized Trial of Aspirin and Cataracts in U.S. Physicians

Condition:   Cataract
Intervention:   Drug: Aspirin
Sponsor:   National Eye Institute (NEI)
Terminated

Fri, 24 Sep 1999 12:00:00 EDT

Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Stroke
Interventions:   Drug: Apixaban;   Drug: aspirin
Sponsors:   Population Health Research Institute;   Bristol-Myers Squibb;   Pfizer;   Medtronic;   Canadian Institutes of Health Research (CIHR)
Active, not recruiting

Tue, 10 Sep 2013 12:00:00 EDT

A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia

Conditions:   Esophageal Cancer;   Precancerous Condition
Interventions:   Drug: Esomeprazole;   Drug: Aspirin
Sponsors:   University of Oxford;   AstraZeneca
Unknown status

Thu, 27 Jul 2006 12:00:00 EDT

Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial

Condition:   Pregnancy Induced Hypertension
Interventions:   Drug: Combined aspirin and multinutrient supplement;   Other: Daily text reminder text messages
Sponsors:   UMC Utrecht;   Ghana Health Services;   University of Ghana
Unknown status

Wed, 11 Dec 2013 12:00:00 EST

Aggrenox To Treat Acute Covid-19

Condition:   Covid19
Interventions:   Drug: Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally AND Standard of care;   Other: Standard of care
Sponsors:   Rutgers, The State University of New Jersey;   Boehringer Ingelheim
Recruiting

Mon, 01 Jun 2020 12:00:00 EDT

Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)

Conditions:   Cirrhosis;   Splenectomy; Status;   Venous Thrombosis;   Hypertension, Portal
Interventions:   Drug: Apixaban;   Drug: Warfarin;   Drug: Aspirin;   Drug: Dipyridamole;   Drug: Low molecular weight heparin
Sponsor:   Yangzhou University
Recruiting

Fri, 27 Nov 2020 12:00:00 EST

A Study of Aleglitazar in Combination With Aspirin in Healthy Volunteers

Condition:   Healthy Volunteer
Interventions:   Drug: aleglitazar;   Drug: aspirin;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed

Wed, 25 Aug 2010 12:00:00 EDT

Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting

Condition:   Coronary Artery Disease
Interventions:   Drug: clopidogrel napadisilate + aspirin;   Drug: clopidogrel bisulfate + aspirin
Sponsors:   Seoul National University Hospital;   Hanmi Pharmaceutical co., ltd.
Completed

Wed, 25 Apr 2012 12:00:00 EDT

Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM

Conditions:   Tuberculosis Meningitis;   HIV-1-infection
Interventions:   Drug: Linezolid;   Drug: High dose rifampicin;   Drug: Aspirin;   Drug: Standard of Care anti-tuberculous therapy;   Drug: Dexamethasone
Sponsor:   University of Cape Town
Completed

Thu, 25 Apr 2019 12:00:00 EDT

Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk

Conditions:   Coronary Artery Disease (CAD);   Peripheral Arterial Disease (PAD)
Intervention:   Drug: Rivaroxaban 2.5 MG [Xarelto]
Sponsors:   Maatschap Cardiologie Zwolle;   Diagram B.V.
Recruiting

Mon, 15 Feb 2021 12:00:00 EST

Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus

Conditions:   Atherosclerosis;   Thromboembolism;   Systemic Lupus Erythematosus
Interventions:   Drug: Rosuvastatin;   Drug: placebo;   Drug: aspirin
Sponsors:   Tuen Mun Hospital;   AstraZeneca
Completed

Mon, 04 Sep 2006 12:00:00 EDT

The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction

Condition:   Intrauterine Growth Restriction
Interventions:   Drug: Low dose aspirin;   Drug: Omega 3
Sponsor:   Assiut University
Completed

Wed, 02 Mar 2016 12:00:00 EST

3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI

Condition:   ST Elevation Myocardial Infarction
Interventions:   Drug: ticagrelor monotherapy;   Drug: Aspirin with P2Y12 receptor inhibitor
Sponsor:   Dong-A University
Recruiting

Wed, 30 Sep 2020 12:00:00 EDT

Edoxaban in Peripheral Arterial Disease

Condition:   Peripheral Arterial Disease
Interventions:   Drug: edoxaban;   Drug: Clopidogrel;   Drug: Aspirin
Sponsors:   Daiichi Sankyo, Inc.;   UMC Utrecht
Completed

Fri, 01 Mar 2013 12:00:00 EST

Characteristics of Patients Diagnosed With NSAID Sensitivity in Thailand

Conditions:   Aspirin Sensitivity;   Aspirin-exacerbated Respiratory Disease;   Aspirin-Induced Angioedema-Urticaria;   Aspirin Allergy;   NSAID-Induced Asthma;   NSAID-Induced Angioedema-Urticaria;   NSAID-Induced Anaphylactoid Reaction;   Aspirin-Induced Anaphylactoid Reaction
Intervention:   Drug: aspirin, NSAIDs, paracetamol
Sponsor:   Chulalongkorn University
Unknown status

Thu, 21 Feb 2019 12:00:00 EST

Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms

Condition:   Insomnia
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   Beth Israel Deaconess Medical Center
Completed

Mon, 20 Oct 2014 12:00:00 EDT

Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer

Condition:   Adenomatous Polyp
Interventions:   Drug: Aspirin;   Drug: Eflornithine;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Telephone-Based Intervention
Sponsor:   National Cancer Institute (NCI)
Completed

Thu, 24 Sep 2009 12:00:00 EDT

Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention

Conditions:   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions:   Drug: Berberine;   Drug: Standard treatment;   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   Peking Union Medical College Hospital
Recruiting

Wed, 20 Dec 2017 12:00:00 EST

PGE2/IL-22 Pathway in Various Forms of Eczema

Condition:   Eczema
Intervention:   Drug: Aspirin 300mg
Sponsor:   NHS Lothian
Not yet recruiting

Mon, 21 Oct 2019 12:00:00 EDT

Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study

Conditions:   Cardiovascular Disease Risk in HIV Patients;   Endothelial Function
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   University of Pittsburgh;   Fogarty International Center of the National Institute of Health;   University of North Carolina
Completed

Fri, 27 Mar 2015 12:00:00 EDT

Coronary Artery Disease After Heart Transplantation

Conditions:   Coronary Artery Disease in Transplanted Heart (Diagnosis);   Platelet Dysfunction
Interventions:   Drug: Aspirin 75mg;   Other: Extracorporeal photopheresis
Sponsor:   Aarhus University Hospital
Recruiting

Wed, 11 Jul 2018 12:00:00 EDT

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Condition:   Acute Coronary Syndromes
Interventions:   Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
Sponsors:   Bristol-Myers Squibb;   Pfizer;   Duke Clinical Research Institute
Completed

Tue, 14 Apr 2015 12:00:00 EDT

Effects of Pioglitazone on Platelet Function

Conditions:   Diabetes;   Platelet Function;   Healthy
Interventions:   Drug: Aspirin;   Drug: Pioglitazone
Sponsor:   University of Rochester
Completed

Fri, 13 Mar 2009 12:00:00 EDT

Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke

Condition:   Ischemic Stroke
Interventions:   Drug: clopidogrel;   Drug: Aspirin
Sponsor:   General Hospital of Shenyang Military Region
Recruiting

Tue, 16 Aug 2016 12:00:00 EDT

Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer

Conditions:   Colo-rectal Cancer;   Metastatic Cancer
Interventions:   Drug: Regorafenib;   Drug: Cyclophosphamide;   Drug: Capecitabine;   Drug: Aspirin
Sponsors:   Centre Hospitalier Universitaire de Besancon;   Bayer
Active, not recruiting

Tue, 01 Sep 2020 12:00:00 EDT

Effects of ASA on Prostate Tissue

Condition:   Prostate Cancer
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   University of Washington;   Fred Hutchinson Cancer Research Center
Completed

Thu, 06 Oct 2005 12:00:00 EDT

Platelet Reactivity in PAD Undergoing Percutaneous Angioplasty

Conditions:   Peripheral Artery Disease;   Critical Limb Ischemia;   Claudication, Intermittent
Intervention:   Drug: Aspirin 300mg and Clopidogrel 300mg
Sponsor:   Clinical Centre of Serbia
Recruiting

Mon, 18 Nov 2019 12:00:00 EST

A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet

Condition:   Healthy Volunteers
Interventions:   Drug: TAK-438ASA;   Drug: TAK-438;   Drug: Aspirin
Sponsor:   Takeda
Completed

Wed, 07 Mar 2018 12:00:00 EST

Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction

Condition:   Intrauterine Growth Restriction
Interventions:   Drug: Sildenafil citrate;   Drug: Aspirin
Sponsor:   Assiut University
Unknown status

Tue, 09 Feb 2016 12:00:00 EST

Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery

Condition:   Antiplatelet Drugs
Interventions:   Drug: Aspirin only;   Drug: No antiplatelet therapy
Sponsors:   Jung-min Ahn;   CardioVascular Research Foundation, Korea
Recruiting

Mon, 13 Jun 2016 12:00:00 EDT

Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease

Condition:   Asthma, Aspirin-induced
Intervention:  
Sponsor:   Montefiore Medical Center
Active, not recruiting

Tue, 22 Mar 2011 12:00:00 EDT

Resistance to Antithrombotic Therapy

Conditions:   Atherosclerosis;   Angioplasty
Interventions:   Drug: aspirin;   Drug: clopidogrel
Sponsor:   Medical University of Vienna
Completed

Tue, 10 Mar 2009 12:00:00 EDT

Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery

Conditions:   Coronary Artery Bypass Graft Triple Vessel;   Myocardial Ischemia;   Thrombosis;   Antithrombotic Drugs [Platelet-aggregation Inhibitors] Causing Adverse Effects in Therapeutic Use
Intervention:  
Sponsor:   University Hospital, Basel, Switzerland
Completed

Wed, 04 Aug 2010 12:00:00 EDT

Biosynthesis of PGD2 in Vivo

Condition:   Hyperlipidemia
Interventions:   Drug: Aspirin;   Drug: Placebo;   Drug: Niacin
Sponsor:   University of Pennsylvania
Completed

Wed, 12 Jan 2011 12:00:00 EST

ASCEND: A Study of Cardiovascular Events iN Diabetes

Condition:   Diabetes Mellitus
Interventions:   Drug: Aspirin;   Drug: Omega-3 Ethyl Esters;   Drug: Placebo Aspirin;   Drug: Placebo Omega-3 Ethyl Esters
Sponsors:   University of Oxford;   British Heart Foundation;   Bayer;   Medical Research Council;   Solvay Pharmaceuticals;   Abbott;   Mylan
Active, not recruiting

Thu, 25 Aug 2005 12:00:00 EDT

Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)

Condition:   Peripheral Arterial Disease
Interventions:   Drug: iloprost;   Drug: Standard Treatment (aspirin.....),
Sponsor:   Fadoi Foundation, Italy
Completed

Wed, 31 Oct 2012 12:00:00 EDT

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

Condition:   Dyslipidemia
Interventions:   Drug: Niacin extended-release (NER);   Drug: Niacin extended-release (NER) placebo;   Drug: Aspirin (ASA);   Drug: Aspirin (ASA) placebo
Sponsor:   Abbott
Completed

Fri, 07 Mar 2008 12:00:00 EST

Impact of Combination of Clopidogrel With Aspirin on Postoperative Bleeding in Coronary Surgical Patients

Conditions:   Coronary Surgery;   Hemorrhage
Intervention:  
Sponsor:   Groupe Hospitalier Pitie-Salpetriere
Completed

Thu, 07 Oct 2010 12:00:00 EDT

A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

Conditions:   Acute Ischemic Stroke;   Transient Ischemic Attack (TIA)
Interventions:   Drug: BMS-986177;   Other: Placebo;   Drug: Clopidogrel;   Drug: Aspirin
Sponsors:   Bristol-Myers Squibb;   Janssen, LP
Recruiting

Thu, 06 Dec 2018 12:00:00 EST

The Carotid and Middle Cerebral Artery Occlusion Surgery Study

Conditions:   Carotid Artery Occlusion;   Middle Cerebral Artery Occlusion;   Stroke
Interventions:   Procedure: bypass surgery;   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   Xuanwu Hospital, Beijing
Active, not recruiting

Tue, 01 Jan 2013 12:00:00 EST

Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities

Condition:   Peripheral Arterial Disease
Interventions:   Drug: Clopidogrel;   Drug: Acetylsalicylic acid (ASA)
Sponsor:   University of Texas Southwestern Medical Center
Completed

Fri, 15 Aug 2014 12:00:00 EDT

Investigation of Platelet Function and Aspirin Resistance in Chronic Dialysis Patient

Condition:   End Stage Renal Disease
Intervention:  
Sponsor:   National Taiwan University Hospital
Unknown status

Mon, 11 Jan 2010 12:00:00 EST

Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

Conditions:   Acute Coronary Syndrome;   Percutaneous Coronary Intervention
Interventions:   Procedure: Percutaneous coronary intervention;   Drug: Ticagrelor plus aspirin
Sponsor:   Fujian Medical University
Recruiting

Wed, 08 Apr 2020 12:00:00 EDT

Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement

Condition:   Aortic Stenosis
Interventions:   Device: TAVR;   Other: Warfarin plus Aspirin;   Other: Aspirin Only
Sponsor:   Medstar Health Research Institute
Active, not recruiting

Thu, 14 Jun 2018 12:00:00 EDT

Effect of EECP on Anterior Ischemic Optic Neuropathy

Condition:   Anterior Ischemic Optic Neuropathy
Interventions:   Device: Enhanced external counterpulsation;   Drug: Aspirin
Sponsor:   First Affiliated Hospital, Sun Yat-Sen University
Unknown status

Tue, 15 Jan 2013 12:00:00 EST

Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH

Condition:   Healthy
Interventions:   Drug: Aggrenox;   Drug: Dipyridamole;   Drug: Aspirin;   Drug: Lansoprazole
Sponsor:   Boehringer Ingelheim
Completed

Mon, 29 Sep 2014 12:00:00 EDT

PREVENTion of Clot in Orthopaedic Trauma

Conditions:   Blood Clot;   Trauma
Interventions:   Drug: Acetylsalicylic acid;   Drug: Low Molecular Weight Heparin (LMWH)
Sponsors:   Major Extremity Trauma Research Consortium;   Patient-Centered Outcomes Research Institute
Recruiting

Tue, 06 Dec 2016 12:00:00 EST

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

Condition:   Polycythemia Vera (PV)
Interventions:   Drug: P1101;   Drug: Low-dose aspirin;   Procedure: Phlebotomy
Sponsor:   PharmaEssentia Japan K.K.
Active, not recruiting

Mon, 02 Dec 2019 12:00:00 EST

Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor monotherapy;   Drug: Ticagrelor with Aspirin DAPT(dual antiplatelet treatment)
Sponsor:   Yonsei University
Recruiting

Fri, 10 Jul 2015 12:00:00 EDT

Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers

Condition:   Healthy
Interventions:   Drug: Asasantin®;   Drug: Acetylsalicylic acid low dose;   Drug: Acetylsalicylic acid high dose
Sponsor:   Boehringer Ingelheim
Completed

Mon, 20 Oct 2014 12:00:00 EDT

Impact of COX2 on Sera Biomarkers From Obese Subjects

Condition:   Breast Cancer Survivors
Interventions:   Drug: Aspirin;   Dietary Supplement: Omega 3 FFA
Sponsor:   The University of Texas Health Science Center at San Antonio
Completed

Thu, 13 Feb 2014 12:00:00 EST

Type 2 Diabetes Mellitus and Atherosclerosis

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsors:   University of Roma La Sapienza;   University of Rome Tor Vergata
Unknown status

Tue, 30 Nov 2010 12:00:00 EST

Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold

Condition:   Common Cold
Interventions:   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465);   Drug: Pseudoephedrine;   Drug: Placebo
Sponsor:   Bayer
Completed

Fri, 21 Aug 2009 12:00:00 EDT

AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation

Condition:   Aortic Stenosis
Interventions:   Drug: Acetylsalicylic acid;   Drug: Apixaban;   Drug: Rivaroxaban;   Drug: Edoxaban
Sponsors:   Oslo University Hospital;   University of Oslo
Not yet recruiting

Sun, 05 Sep 2021 12:00:00 EDT

Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold

Conditions:   Common Cold;   Pharyngitis;   Tonsillitis
Interventions:   Drug: Acetylsalicylic acid (Aspirin, BAYE4465);   Drug: Paracetamol;   Drug: Placebo
Sponsor:   Bayer
Completed

Fri, 04 Nov 2011 12:00:00 EDT

PTRG-DES Consortium

Conditions:   Coronary Artery Disease;   Clopidogrel, Poor Metabolism of;   Platelet Dysfunction;   Stent Thrombosis
Intervention:   Drug: Clopidogrel Tablets
Sponsors:   Gyeongsang National University Hospital;   Korean Society of Interventional Cardiology
Completed

Tue, 02 Feb 2021 12:00:00 EST

Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps

Condition:   Colorectal Cancer
Interventions:   Dietary Supplement: folic acid;   Drug: acetylsalicylic acid
Sponsor:   Queen's Medical Centre
Unknown status

Tue, 01 Jul 2003 12:00:00 EDT

Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)

Condition:   Cardiovascular Disease
Interventions:   Behavioral: Pre-visit Summary;   Behavioral: Clinical Decision Sharing Tool
Sponsors:   Geisinger Clinic;   Agency for Healthcare Research and Quality (AHRQ)
Completed

Tue, 22 Sep 2009 12:00:00 EDT

Clopidogrel for Acute Ischaemia of Recent Onset

Condition:   Ischemic Cerebrovascular Accident
Interventions:   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   Ain Shams University
Completed

Wed, 18 May 2016 12:00:00 EDT

Aortic Arch Related Cerebral Hazard Trial (ARCH)

Conditions:   Brain Infarction;   Transient Ischemic Attack;   Embolism
Interventions:   Drug: Warfarin;   Drug: Clopidogrel-aspirin
Sponsors:   Assistance Publique - Hôpitaux de Paris;   National Health and Medical Research Council, Australia;   Sanofi;   Bristol-Myers Squibb
Completed

Mon, 10 Oct 2005 12:00:00 EDT

VISSIT Intracranial Stent Study for Ischemic Therapy

Conditions:   Ischemic Stroke;   Transient Ischemic Attack
Interventions:   Device: Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel);   Drug: Aspirin and Clopidogrel (Medical therapy)
Sponsor:   Codman & Shurtleff
Terminated

Wed, 31 Dec 2008 12:00:00 EST

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Drug: Clopidogrel;   Drug: Prasugrel;   Drug: ticagrelor;   Drug: aspirin;   Drug: rivaroxaban
Sponsors:   University of Florida;   Janssen, LP
Recruiting

Fri, 05 Jul 2019 12:00:00 EDT

The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Acute Cerebral Infarction

Condition:   Cerebral Infarction
Interventions:   Biological: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#);   Drug: Aspirin Tablet
Sponsor:   Sclnow Biotechnology Co., Ltd.
Suspended

Wed, 14 Jun 2017 12:00:00 EDT

the Safety and Efficacy of Antiplatelet Therapy in Patients of CAA

Condition:   Cerebral Amyloid Angiopathy
Intervention:   Drug: Aspirin/Clopidogrel
Sponsor:   Shenzhen Second People's Hospital
Not yet recruiting

Fri, 04 Dec 2020 12:00:00 EST

The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol

Condition:   Clopidogrel Non-Responsiveness
Interventions:   Drug: aspirin, clopidogrel;   Drug: aspirin, clopidogrel, cilostazol
Sponsor:   Samsung Medical Center
Completed

Thu, 21 Feb 2008 12:00:00 EST

Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency

Conditions:   Alpha-1 Antitrypsin Deficiency;   Emphysema;   Chronic Obstructive Pulmonary Disease
Interventions:   Drug: Aspirin;   Drug: Placebo;   Other: Withdrawal from alpha1 antitrypsin replacement therapy
Sponsors:   Columbia University;   Alpha-1 Foundation;   Stony Wold-Herbert Fund, Inc.
Completed

Wed, 04 Jan 2017 12:00:00 EST

Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS

Condition:   Ovarian Hyperstimulation Syndrome
Interventions:   Drug: letrozole;   Drug: Aspirin
Sponsor:   First Affiliated Hospital, Sun Yat-Sen University
Completed

Mon, 01 Feb 2016 12:00:00 EST

Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis

Condition:   Saphenous Vein Graft Disease
Interventions:   Drug: Aspirin;   Drug: Ticagrelor
Sponsors:   Boca Raton Regional Hospital;   AstraZeneca;   Ottawa Heart Institute Research Corporation
Active, not recruiting

Tue, 04 Feb 2014 12:00:00 EST

Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: Acetylsalicylic acid;   Drug: Atorvastatin
Sponsors:   Gustave Roussy, Cancer Campus, Grand Paris;   National Cancer Institute, France
Recruiting

Mon, 28 Jan 2019 12:00:00 EST

Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM

Condition:   Coronary Artery Disease
Interventions:   Drug: Cilostazol;   Drug: Aspirin
Sponsor:   Seoul National University Bundang Hospital
Completed

Thu, 16 Oct 2014 12:00:00 EDT

Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke

Condition:   Acute Ischemic Stroke
Interventions:   Drug: DLBS1033;   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   Dexa Medica Group
Completed

Wed, 13 Feb 2013 12:00:00 EST

Microvascular Function Assessment in Healthy Subjects

Condition:   Physiology of Microvascular Skin
Interventions:   Drug: acetylsalicilic acids (Aspirin);   Drug: Placebo
Sponsor:   University Hospital, Angers
Completed

Fri, 06 Apr 2012 12:00:00 EDT

Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy

Conditions:   Urolithiasis;   Renal Hematoma
Interventions:   Drug: Acetylsalicylic acid;   Drug: low molecular weight heparin
Sponsor:   Kantonsspital Winterthur KSW
Completed

Tue, 23 Aug 2016 12:00:00 EDT

Dabigatran Following Transient Ischemic Attack and Minor Stroke

Conditions:   Transient Ischemic Attack;   Minor Ischemic Stroke
Interventions:   Drug: Dabigatran;   Drug: Acetylsalicylic acid
Sponsor:   University of Alberta
Completed

Thu, 20 Nov 2014 12:00:00 EST

Coronavirus Response - Active Support for Hospitalised Covid-19 Patients

Condition:   Covid-19
Interventions:   Drug: Aspirin;   Drug: Losartan;   Drug: Simvastatin
Sponsor:   London School of Hygiene and Tropical Medicine
Withdrawn

Mon, 13 Apr 2020 12:00:00 EDT

A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients

Condition:   Acute Coronary Syndrome Patients With Diabetes After PCI
Interventions:   Drug: Ticagrelor;   Drug: Aspirin
Sponsor:   Shanghai Tong Ren Hospital
Recruiting

Fri, 13 Mar 2020 12:00:00 EDT

Enterprise Stent Implantation in the Treatment of Carotid Artery Stenosis With Ischemic Stroke

Condition:   Carotid Artery Stenosis
Interventions:   Device: Enterprise stent implantation;   Drug: Only aspirin medication
Sponsor:   Beijing Chao Yang Hospital
Completed

Thu, 16 Jun 2016 12:00:00 EDT

Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold

Conditions:   Common Cold;   Pharyngitis;   Tonsillitis
Interventions:   Drug: Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain;   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465);   Drug: Lidocain;   Drug: Placebo
Sponsor:   Bayer
Completed

Thu, 26 May 2011 12:00:00 EDT

Optimum Platelet Inhibition After Coronary Bypass Surgery

Condition:   Ischemic Heart Disease
Intervention:   Drug: Aspirin, Clopidogrel
Sponsor:   Papworth Hospital NHS Foundation Trust
Completed

Tue, 06 Dec 2005 12:00:00 EST

RACIN in Patients With Advanced TIL-negative Solid Tumors

Condition:   Solid Tumor, Adult
Intervention:   Combination Product: Low dose irradiation + Nivolumab + Ipilimumab or Cyclophosphamide + Aspirin/Celecoxib
Sponsor:   Centre Hospitalier Universitaire Vaudois
Recruiting

Thu, 01 Nov 2018 12:00:00 EDT

Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model

Condition:   Mood Disorder
Interventions:   Drug: Aspirin;   Drug: Atorvastatin
Sponsor:   Taipei Veterans General Hospital, Taiwan
Recruiting

Mon, 28 Dec 2020 12:00:00 EST

Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action

Condition:   Colorectal Cancer
Interventions:   Drug: Acetylsalicylic acid;   Procedure: Screening colonoscopy
Sponsors:   Aragon Institute of Health Sciences;   G. d'Annunzio University;   Catholic University, Italy
Unknown status

Tue, 29 Apr 2014 12:00:00 EDT

The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial

Conditions:   Stroke;   Transient Ischemic Attack
Interventions:   Drug: Butylphthalide Soft Capsules;   Drug: Aspirin
Sponsor:   Peking Union Medical College Hospital
Unknown status

Tue, 29 Jul 2008 12:00:00 EDT

Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery

Conditions:   Coronary Artery Bypass;   Antiplatelet Agents
Interventions:   Drug: Aspirin;   Drug: Ticagrelor
Sponsor:   Ruijin Hospital
Completed

Mon, 28 Jul 2014 12:00:00 EDT

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Condition:   Unsuspected Pulmonary Embolism
Intervention:   Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
Sponsor:   G. d'Annunzio University
Completed

Fri, 16 Nov 2012 12:00:00 EST

Perioperative Aspirin Response in Patients Undergoing Vascular Surgery

Condition:   Vascular Surgery Patient With PAD / Carotid Stenosis
Intervention:   Drug: Whole blood aggregometry before and after vascular treatment (ASA/ Clopidogrel).
Sponsor:   St. Josef Hospital Bochum
Completed

Mon, 16 Jul 2018 12:00:00 EDT

Pre-operative Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair

Condition:   No Conditions. Focus of the Study is to Assess the Need to Stop Aspirin Before Laparoscopic Inguinal Hernia Repair
Intervention:   Procedure: Laparoscopic inguinal hernia repair
Sponsor:   National University Hospital, Singapore
Unknown status

Fri, 13 Nov 2015 12:00:00 EST

ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts

Conditions:   Coronary Artery Disease;   Chronic Obstructive Pulmonary Disease
Interventions:   Drug: Aspirin 100 mg;   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsor:   University Hospital of Ferrara
Completed

Tue, 11 Aug 2015 12:00:00 EDT

Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.

Condition:   Coronary Artery Disease
Interventions:   Drug: Asprin;   Drug: Clopidogrel
Sponsor:   Neil Kleiman, MD
Withdrawn

Wed, 11 Nov 2009 12:00:00 EST

A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke

Condition:   Stroke
Interventions:   Drug: Alteplase;   Drug: Alteplase Placebo;   Drug: Aspirin;   Drug: Aspirin Placebo
Sponsor:   Genentech, Inc.
Terminated

Wed, 26 Feb 2014 12:00:00 EST

Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation

Conditions:   Coronary Artery Disease;   Atrial Fibrillation
Interventions:   Drug: aspirin;   Drug: clopidogrel;   Drug: oral anticoagulation
Sponsor:   Deutsches Herzzentrum Muenchen
Unknown status

Tue, 21 Oct 2008 12:00:00 EDT

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

Condition:   Colorectal Cancer
Interventions:   Drug: Acetylsalicylic acid (Aspirin);   Drug: Sulindac;   Drug: Ursodiol;   Other: Sulindac Placebo
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Terminated

Fri, 06 Jun 2003 12:00:00 EDT

Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy

Condition:   Coronary Heart Disease
Interventions:   Drug: ticagrelor;   Drug: Aspirin
Sponsor:   Yong Huo
Completed

Mon, 18 Aug 2014 12:00:00 EDT

Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

Conditions:   High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions:   Drug: PEGASYS;   Drug: Aspirin
Sponsors:   Ronald Hoffman;   Myeloproliferative Disorders-Research Consortium;   National Cancer Institute (NCI);   Roche Pharma AG
Completed

Tue, 14 Dec 2010 12:00:00 EST

Migraine Relief After Patent Foramen Ovale Closure: a Single Center Analysis

Conditions:   Platelet Aggregation, Spontaneous;   Migraine With Aura;   Patent Foramen Ovale
Intervention:   Device: patent foramen ovale closure
Sponsor:   Centro Cardiologico Monzino
Unknown status

Fri, 11 May 2018 12:00:00 EDT

A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)

Conditions:   Primary Hypercholesterolemia;   Mixed Hyperlipidemia
Interventions:   Drug: niacin (+) laropiprant;   Drug: Comparator: aspirin;   Drug: Comparator: clopidogrel;   Drug: Comparator: laropiprant;   Drug: Comparator: placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Wed, 11 Nov 2009 12:00:00 EST

Sleep and Inflammatory Resolution Pathway

Conditions:   Inflammatory Response;   Inflammation;   Sleep;   Sleep Restriction
Interventions:   Drug: Aspirin;   Drug: Placebo
Sponsor:   Beth Israel Deaconess Medical Center
Recruiting

Tue, 19 Dec 2017 12:00:00 EST

Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation

Conditions:   Acute Coronary Syndromes;   Percutaneous Coronary Intervention;   Clopidogrel Low Responsiveness
Interventions:   Drug: aspirin, clopidogrel;   Drug: aspirin, clopidogrel, cilostazol
Sponsor:   Shenyang Northern Hospital
Completed

Mon, 29 Mar 2010 12:00:00 EDT

Effect Of Aspirin Preoperative on Postoperative Cognitive Dysfunction In Elderly Patients Undergoing Knee Arthroplasty

Conditions:   Elective Surgery;   Postoperative Cognitive Dysfunction;   Knee Arthroplasty
Intervention:  
Sponsor:   Xuzhou Medical University
Not yet recruiting

Mon, 13 Jan 2020 12:00:00 EST

Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)

Conditions:   Asthma, Aspirin-Induced;   Aspirin Exacerbated Asthma
Interventions:   Drug: Placebo Oral Tablet;   Drug: Prasugrel Oral Tablet
Sponsors:   Elliot Israel, MD;   Brigham and Women's Hospital
Completed

Mon, 14 May 2012 12:00:00 EDT

Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients

Condition:   Ischemic Stroke
Intervention:   Drug: Aspirin, Clopidogrel
Sponsor:   Yuhan Corporation
Recruiting

Wed, 30 Jan 2019 12:00:00 EST

Pharmacogenomics of Antiplatelet Response - I

Conditions:   Platelet Aggregation;   Platelet Transcriptome;   Coronary Artery Disease
Interventions:   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   Johns Hopkins University
Completed

Wed, 20 Mar 2013 12:00:00 EDT

A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI

Condition:   Aortic Valve Stenosis
Interventions:   Drug: Ticagrelor plus ASA;   Drug: Clopidogrel plus ASA
Sponsor:   University of Athens
Completed

Mon, 12 Dec 2016 12:00:00 EST

AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE

Conditions:   Atrial Fibrillation;   Atrial Appendage;   Anticoagulants;   Stroke;   Platelet Aggregation Inhibitors
Interventions:   Drug: Double antiplatelet therapy;   Drug: Aspirin;   Device: Brain MRI;   Other: Neurological tests
Sponsor:   University Hospital, Bordeaux
Not yet recruiting

Mon, 15 Mar 2021 12:00:00 EDT

Outpatient Liquid Aspirin (OLA)

Condition:   Covid19
Intervention:   Drug: ASA
Sponsors:   Louisiana State University Health Sciences Center in New Orleans;   Innovate UK
Not yet recruiting

Wed, 23 Jun 2021 12:00:00 EDT

Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)

Conditions:   Antiplatelet Therapy;   Hemorrhagic Infarction
Interventions:   Drug: Early aspirin Therapy;   Drug: Non-Early aspirin Therapy
Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Shaoxing People's Hospital;   First Affiliated Hospital of Jiaxing University;   Huizhou Municipal Central Hospital;   The Second Affiliated Hospital of Jiaxing University;   Jinhua Central Hospital;   Taizhou Hospital;   Ningbo Medical Center Lihuili Hospital;   Ningbo No.2 Hospital;   Lishui Country People's Hospital;   Wenzhou Central Hospital;   The Fourth Affiliated Hospital of Zhejiang University School of Medicine;   Shenzhen Second People's Hospital;   The Affiliated Hospital of Xuzhou Medical University
Recruiting

Tue, 10 Nov 2020 12:00:00 EST

CES1 Carriers in the PAPI Study

Conditions:   Heart Diseases;   Coronary Disease;   Coronary Artery Disease;   Cardiovascular Diseases;   Myocardial Ischemia;   Artery Occlusion;   Aspirin Sensitivity;   Clopidogrel, Poor Metabolism of;   Platelet Dysfunction;   Platelet Thrombus
Interventions:   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   University of Maryland, Baltimore
Enrolling by invitation

Thu, 15 Jun 2017 12:00:00 EDT

Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla

Condition:   Thrombophilia With Recurrent Pregnancy Loss
Interventions:   Drug: Aspirin;   Drug: Heparin
Sponsor:   Shanghai First Maternity and Infant Hospital
Unknown status

Thu, 08 Dec 2016 12:00:00 EST

Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease

Conditions:   Peripheral Arterial Disease;   Clopidogrel, Poor Metabolism of
Intervention:  
Sponsor:   University of California, Davis
Completed

Mon, 05 Jun 2017 12:00:00 EDT

Use of PRF in Treatment of Dry Socket.

Condition:   Alveolar Osteitis
Interventions:   Procedure: PRF application;   Drug: Nipas application
Sponsor:   Medical University of Lodz
Enrolling by invitation

Fri, 17 Jul 2020 12:00:00 EDT

A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets

Condition:   Moderate Pain
Interventions:   Drug: 500 mg acetylsalicylic acid (Aspirin, BAYE4465);   Drug: 1000 mg acetylsalicylic acid (Aspirin, BAYE4465);   Drug: 400 mg ibuprofen(Nurofen);   Drug: 400 mg ibuprofen (Dolormin Extra)
Sponsor:   Bayer
Completed

Fri, 21 Jul 2017 12:00:00 EDT

Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

Conditions:   Prostate Adenocarcinoma;   Stage I Prostate Cancer AJCC v8;   Stage II Prostate Cancer AJCC v8;   Stage IIA Prostate Cancer AJCC v8;   Stage IIB Prostate Cancer AJCC v8;   Stage IIC Prostate Cancer AJCC v8;   Stage III Prostate Cancer AJCC v8;   Stage IIIA Prostate Cancer AJCC v8;   Stage IIIB Prostate Cancer AJCC v8;   Stage IIIC Prostate Cancer AJCC v8
Interventions:   Drug: Aspirin;   Procedure: Radical Prostatectomy;   Biological: Recombinant Interferon Alfa-2b;   Drug: Rintatolimod
Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI);   AIM ImmunoTech Inc.
Recruiting

Tue, 02 Apr 2019 12:00:00 EDT

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

Condition:   Tuberculous Meningitis
Interventions:   Drug: Aspirin;   Drug: Placebo of aspirin;   Drug: WHO TBM treatment;   Drug: Intensified TBM treatment
Sponsors:   ANRS, Emerging Infectious Diseases;   European Union;   European and Developing Countries Clinical Trials Partnership (EDCTP)
Recruiting

Wed, 30 Oct 2019 12:00:00 EDT

1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon

Conditions:   Antiplatelet Drug;   Acute Coronary Syndrome;   Angioplasty, Balloon
Interventions:   Drug: Aspirin 100mg for 1-month (immediately after PCI);   Drug: Ticagrelor 90mg for 6-month (immediately after PCI);   Drug: Aspirin 100mg for 6-month (6-month post PCI);   Drug: Aspirin 100mg for 12-month (immediately after PCI);   Drug: Ticagrelor 90mg for 12-month (immediately after PCI)
Sponsor:   Xijing Hospital
Not yet recruiting

Wed, 21 Jul 2021 12:00:00 EDT

Aspirin Effectiveness Study

Condition:   Coronary Artery Disease
Intervention:  
Sponsor:   Royal College of Surgeons, Ireland
Unknown status

Thu, 29 Apr 2010 12:00:00 EDT

NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH

Conditions:   Atrial Fibrillation;   Intracerebral Hemorrhage
Interventions:   Drug: NOAC;   Drug: Acetylsalicylic Acid
Sponsor:   Population Health Research Institute
Completed

Wed, 21 Dec 2016 12:00:00 EST

Safety Study of APD-791 With Aspirin and/or Clopidogrel

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Clopidogrel;   Drug: Aspirin;   Drug: APD791;   Drug: Placebo
Sponsors:   IlDong Pharmaceutical Co Ltd;   Asan Medical Center
Terminated

Mon, 13 Jan 2014 12:00:00 EST

The ARIES HeartMate 3 Pump IDE Study

Condition:   Heart Failure
Interventions:   Device: LVAD Implant;   Drug: Aspirin 100mg;   Drug: Placebo oral tablet
Sponsor:   Abbott Medical Devices
Recruiting

Wed, 28 Aug 2019 12:00:00 EDT

Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.

Condition:   Aortic Valve Disorder
Interventions:   Drug: SAVR Warfarin;   Drug: SAVR Aspirin;   Drug: TAVR Warfarin and clopidogrel;   Drug: TAVR Aspirin and clopidogrel
Sponsor:   The Cleveland Clinic
Terminated

Wed, 02 Mar 2016 12:00:00 EST

Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin

Condition:   Acute Chest Syndrome
Interventions:   Drug: Aspirin;   Drug: Atorvastatin;   Drug: Placebo Aspirin;   Drug: Placebo Atorvastatin
Sponsor:   Dr. med. Mahir Karakas
Recruiting

Tue, 29 Jan 2019 12:00:00 EST

Chronic Kidney Disease (CKD) Platelet Study

Conditions:   Chronic Kidney Diseases;   Heart Attack;   Stroke, Ischemic
Interventions:   Drug: Ticagrelor 90mg;   Drug: Clopidogrel 75mg;   Drug: Aspirin 81 mg
Sponsors:   University of Arkansas;   American Society of Nephrology
Active, not recruiting

Tue, 28 Aug 2018 12:00:00 EDT

The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy

Condition:   Infertility
Interventions:   Drug: Asprin;   Drug: placebo
Sponsor:   Royan Institute
Completed

Wed, 04 Jul 2012 12:00:00 EDT

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

Conditions:   Pulmonary Embolism;   Venous Thrombosis
Interventions:   Drug: Enteric Coated Aspirin;   Drug: Warfarin;   Drug: Rivaroxaban
Sponsors:   Dartmouth-Hitchcock Medical Center;   Patient-Centered Outcomes Research Institute;   University of Maryland, Baltimore;   Brigham and Women's Hospital;   Northwestern University;   Medical University of South Carolina
Recruiting

Thu, 23 Jun 2016 12:00:00 EDT

Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers

Condition:   Gastroduodenal Ulcer
Interventions:   Drug: Naproxen;   Drug: Aspirin;   Drug: Celecoxib;   Drug: Clopidogrel;   Drug: Placebo
Sponsor:   Research Associates of New York, LLP
Completed

Thu, 23 Oct 2008 12:00:00 EDT

Subclinical Cardiovascular Disease in Psoriatic Disease

Conditions:   Cardiovascular Diseases;   Myocardial Infarction;   Atherosclerotic Cardiovascular Disease;   Thrombotic Vascular Disease
Intervention:   Drug: Aspirin and/or Atorvastatin
Sponsor:   NYU Langone Health
Completed

Mon, 24 Jul 2017 12:00:00 EDT

Aspirin Mouthwash in Treating Patients With Oral Leukoplakia

Condition:   Precancerous Condition
Interventions:   Drug: acetylsalicylic acid;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: biopsy
Sponsor:   Institute of Head and Neck Studies and Education, United Kingdom
Completed

Wed, 10 Nov 2010 12:00:00 EST

The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent

Condition:   Coronary Artery Disease
Intervention:   Drug: Aspirin, Clopidogrel
Sponsors:   Samsung Medical Center;   Medtronic
Completed

Fri, 05 Jan 2007 12:00:00 EST

Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)

Condition:   Reproductive Techniques, Assisted
Intervention:   Drug: Acetyl Salicylic Acid and Terbutalin
Sponsor:   Sykehuset Telemark
Completed

Mon, 20 Aug 2007 12:00:00 EDT

Dose-escalation, Repeated and Single Oral Dosing Study

Condition:   Acute Coronary Syndrome
Interventions:   Drug: APD791;   Drug: Clopidogrel;   Drug: Aspirin;   Drug: Placebo for APD791
Sponsors:   IlDong Pharmaceutical Co Ltd;   Asan Medical Center
Terminated

Fri, 17 Apr 2015 12:00:00 EDT

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

Condition:   Ovarian Cancer Prevention
Interventions:   Drug: Acetylsalicylic acid;   Other: Placebo
Sponsors:   Canadian Cancer Trials Group;   Apotex Inc.
Recruiting

Thu, 29 Mar 2018 12:00:00 EDT

Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Conditions:   Atrial Fibrillation;   Stroke
Interventions:   Drug: Rivaroxaban;   Drug: Acetylsalicylic acid
Sponsors:   Ottawa Heart Institute Research Corporation;   Canadian Institutes of Health Research (CIHR);   Bayer;   Biotronik Canada Inc
Recruiting

Fri, 20 Jun 2014 12:00:00 EDT

A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Acetylsalicylic acid;   Drug: Rivaroxaban;   Drug: Clopidogrel;   Drug: Ticagrelor
Sponsors:   Janssen Research & Development, LLC;   Bayer;   Duke Clinical Research Institute;   Harvard Medical School
Completed

Tue, 18 Nov 2014 12:00:00 EST

A Comparison of microRNA Samples in Patients With Nasal Polyps and Aspirin Exacerbated Respiratory Disease and Those With Nasal Polyps Only

Conditions:   Aspirin-exacerbated Respiratory Disease;   Nasal Polyp
Intervention:   Genetic: microRNA
Sponsor:   University of South Florida
Completed

Fri, 29 Jun 2012 12:00:00 EDT

Physiological Effects of Altering Cancer-related Inflammation

Condition:   Colon Cancer
Interventions:   Drug: Aspirin;   Drug: Ibuprofen
Sponsors:   NHS Greater Glasgow and Clyde;   Academy of Medical Sciences;   Wellcome Trust
Unknown status

Thu, 07 Feb 2013 12:00:00 EST

Warfarin After Anterior ST-Elevation Myocardial Infarction

Condition:   Myocardial Infarction
Interventions:   Drug: aspirin + clopidogrel;   Drug: aspirin + clopidogrel + warfarin
Sponsor:   Hamilton Health Sciences Corporation
Completed

Mon, 21 Apr 2008 12:00:00 EDT

A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion

Condition:   Central Retinal Artery Occlusion
Interventions:   Drug: Alteplase;   Drug: acetylsalicylic acid;   Drug: Placebo Oral Tablet;   Drug: placebo IV
Sponsor:   Nantes University Hospital
Recruiting

Fri, 23 Jun 2017 12:00:00 EDT

Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol

Condition:   Elevated LDL Cholesterol
Interventions:   Drug: Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril);   Drug: Simvastatin, ramipril, acetylsalicylic acid
Sponsor:   Ferrer Internacional S.A.
Terminated

Mon, 30 May 2011 12:00:00 EDT

Rivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCI

Condition:   Rivaroxaban
Intervention:   Drug: clopidogrel combined with rivaroxaban arm
Sponsor:   Shenyang Northern Hospital
Not yet recruiting

Thu, 18 Mar 2021 12:00:00 EDT

Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT

Conditions:   Coronary Artery Disease;   Acute Coronary Syndrome
Interventions:   Drug: Aspirin;   Drug: P2Y12 inhibitor
Sponsor:   Humanitas Hospital, Italy
Unknown status

Thu, 13 Apr 2017 12:00:00 EDT

Symptomatic Treatment of Common Cold Symptoms

Condition:   Common Cold
Interventions:   Drug: Aspirin (Acetylsalicylic acid, BAYE4465);   Drug: Placebo
Sponsor:   Bayer
Completed

Wed, 16 Dec 2009 12:00:00 EST

To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their Effects

Conditions:   Pharmacodynamic Interaction;   Healthy Subjects
Interventions:   Drug: darexaban;   Drug: darexaban (double dose);   Drug: Acetyl Salicylic Acid;   Drug: clopidogrel
Sponsor:   Astellas Pharma Inc
Completed

Thu, 04 Aug 2011 12:00:00 EDT

Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome

Condition:   Recurrent Abortion
Interventions:   Drug: enoxaparin 40mg plus low dose aspirin;   Drug: Heparin calcium5,000 U twice daily plus low dose aspirin
Sponsors:   Cairo University;   Ahmed Elgazzar Hospital
Completed

Wed, 20 Jan 2010 12:00:00 EST

Placebo and Active Controlled, Double Dummy Study to Compare Efficacy of Aspirin and Ibuprofen in Treatment of Episodic Tension-type Headache

Conditions:   Headache;   Tension-Type Headache;   Tension-Type Headache (Episodic)
Interventions:   Drug: Acetylsalicylic acid (Aspirin, BAYE4465);   Drug: Ibuprofen;   Drug: Placebo
Sponsor:   Bayer
Completed

Fri, 04 Nov 2011 12:00:00 EDT

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Conditions:   Deep Vein Thrombosis;   Iliac Vein Thrombosis;   Iliac Vein Obstruction;   Iliac Vein Stenosis;   Iliac Vein Compression Syndrome
Interventions:   Drug: Rivaroxaban;   Drug: Aspirin
Sponsors:   First Affiliated Hospital of Zhejiang University;   Zhejiang University;   Ningbo No.2 Hospital;   Taizhou Hospital of Zhejiang Province;   The Central Hospital of Lishui City;   Taizhou Enze Hospital;   Taizhou First People's Hospital;   Boston Scientific Corporation
Not yet recruiting

Tue, 05 Jan 2021 12:00:00 EST

The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry

Conditions:   Platelet Activation Testing Before/After Anti-platelet Therapy;   Healthy
Interventions:   Drug: Aspirin;   Drug: Clopidogrel
Sponsors:   Beth Israel Deaconess Medical Center;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH)
Recruiting

Tue, 30 Mar 2021 12:00:00 EDT

Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI

Condition:   ST Elevation Myocardial Infarction
Interventions:   Drug: Atorvastatin;   Drug: Aspirin
Sponsor:   Assiut University
Not yet recruiting

Mon, 15 Feb 2021 12:00:00 EST

Reversing Ticagrelor's Effects With Fresh Platelets

Condition:   Coronary Artery Disease
Interventions:   Drug: Ticagrelor loading dose;   Drug: Aspirin loading dose;   Drug: Ticagrelor maintenance dose;   Drug: Aspirin maintenance dose
Sponsors:   Icahn School of Medicine at Mount Sinai;   AstraZeneca
Completed

Mon, 28 Jul 2014 12:00:00 EDT

Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke

Conditions:   Ischemic Stroke;   Antiplatelet Effect
Interventions:   Drug: Sanchitongshu;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: placebo of Sanchitongshu
Sponsor:   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Unknown status

Tue, 29 Oct 2019 12:00:00 EDT

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Conditions:   Solid Tumor;   Cancer
Interventions:   Drug: Aspirin;   Drug: Simvastatin;   Other: Observation
Sponsor:   Case Comprehensive Cancer Center
Completed

Fri, 07 Nov 2014 12:00:00 EST

Study to Learn More About the Effectiveness and Safety of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Patients Suffering From a Condition That Affects the Blood Vessels Supplying the Heart (CAD) and/or a Condition That Affects the Blood Vessel of the Lower Limbs (PAD).

Conditions:   Coronary Artery Disease(CAD);   Peripheral Artery Disease(PAD)
Interventions:   Drug: Rivaroxaban (Xarelto,Bay 59-7939);   Drug: Acetylsalicylic acid(ASA)
Sponsor:   Bayer
Not yet recruiting

Fri, 06 Mar 2020 12:00:00 EST

Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study

Conditions:   Coronary Artery Disease;   Diabetes Mellitus;   Renal Insufficiency, Chronic
Interventions:   Drug: Sarpogrelate;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Placebo (for Sarpogrelate)
Sponsors:   Seoul National University Bundang Hospital;   Yuhan Corporation
Completed

Wed, 19 Nov 2014 12:00:00 EST

Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis

Conditions:   Tuberculosis, Pulmonary;   Tuberculosis, MDR;   Tuberculosis Infection
Interventions:   Drug: Control group;   Drug: ASA group;   Drug: IBU group;   Drug: SoC TB
Sponsors:   Fundació Institut Germans Trias i Pujol;   National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia;   Perinatal HIV Research Unit of the University of the Witswatersrand
Recruiting

Mon, 05 Oct 2020 12:00:00 EDT

Ex Vivo Human Thrombosis Chamber Study

Condition:   Cardiovascular Disease
Interventions:   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   Bristol-Myers Squibb
Completed

Thu, 09 Jul 2009 12:00:00 EDT

Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

Conditions:   Ischemic Stroke;   Intracranial Atherosclerotic Disease
Interventions:   Drug: Rivaroxaban 2.5 Mg Oral Tablet bid;   Drug: Acetylsalicyclic acid 81 mg tablet qd
Sponsor:   Population Health Research Institute
Recruiting

Tue, 29 Oct 2019 12:00:00 EDT

Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)

Conditions:   Chronic Total Occlusion;   Atherosclerosis;   Coronary Artery Disease;   Peripheral Artery Disease
Interventions:   Device: Roxwood Anchoring Catheters;   Drug: Acetylsalicylic Acid;   Drug: Heparin
Sponsors:   Boston Scientific Corporation;   EKOS Corporation
Withdrawn

Fri, 16 Aug 2019 12:00:00 EDT

Effect of Apple Flavanols on Risk of Cardiovascular Disease

Condition:   Cardiovascular Disease
Interventions:   Dietary Supplement: Low PA apple puree;   Dietary Supplement: High PA apple puree;   Drug: Aspirin
Sponsor:   Quadram Institute Bioscience
Completed

Wed, 05 Dec 2007 12:00:00 EST

Naproxen Sodium/ASA Platelet Study

Condition:   Hematology
Interventions:   Drug: Naproxen Sodium (Aleve, BAY117031);   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465)
Sponsor:   Bayer
Completed

Mon, 01 Sep 2014 12:00:00 EDT

Aspirin Twice Daily in Diabetic Patients With Coronary Artery Disease

Condition:   Diabetes Mellitus
Intervention:  
Sponsor:   Hopital Lariboisière
Completed

Tue, 12 Jun 2012 12:00:00 EDT

Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm

Condition:   Cerebral Aneurysm
Interventions:   Drug: Clopidogrel;   Drug: Ticagrelor;   Drug: aspirin
Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
Completed

Fri, 05 Feb 2016 12:00:00 EST

Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Alogliptin;   Drug: Acarbose;   Drug: Metformin;   Drug: Aspirin
Sponsor:   Sanofi
Completed

Mon, 07 Jan 2019 12:00:00 EST

Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder

Conditions:   Schizophrenia;   Schizoaffective Disorder
Interventions:   Drug: minocycline;   Drug: pramipexole;   Drug: acetylsalicylic acid;   Drug: placebo
Sponsor:   Sheba Medical Center
Unknown status

Wed, 23 Mar 2011 12:00:00 EDT

The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects

Condition:   Hypertriglyceridemia
Interventions:   Drug: Simvastatin;   Drug: acetylsalicylic acid (ASA);   Drug: omefas
Sponsor:   AstraZeneca
Completed

Tue, 06 Dec 2011 12:00:00 EST

Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease

Condition:   Kawasaki Disease
Interventions:   Drug: Immunoglobulin G;   Drug: Acetylsalicylic acid
Sponsor:   Green Cross Corporation
Completed

Mon, 01 Jul 2019 12:00:00 EDT

A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

Condition:   Healthy Volunteers
Interventions:   Drug: BMS-986177;   Other: Placebo (for BMS-986177);   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   Bristol-Myers Squibb
Completed

Tue, 09 Oct 2018 12:00:00 EDT

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects

Condition:   Cardiovascular Disease
Interventions:   Drug: AZD3366;   Drug: Placebo;   Drug: Ticagrelor;   Drug: acetylsalicylic acid (ASA)
Sponsor:   AstraZeneca
Recruiting

Mon, 19 Oct 2020 12:00:00 EDT

Aspirin and Neutrophils in Preeclampsia

Conditions:   Preeclampsia;   Neutrophil;   Immunology;   Pregnancy
Intervention:   Diagnostic Test: Blood test
Sponsor:   Queen Mary University of London
Not yet recruiting

Fri, 23 Jul 2021 12:00:00 EDT

Apixaban for Treatment of Embolic Stroke of Undetermined Source

Condition:   Embolic Stroke of Undetermined Source
Interventions:   Drug: Apixaban;   Drug: Aspirin
Sponsors:   University Hospital Tuebingen;   Bristol-Myers Squibb;   Medtronic;   ZKS and IKEaB Tübingen
Completed

Mon, 27 Apr 2015 12:00:00 EDT

Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers

Condition:   Aspirin-Associated Gastric Ulcers
Intervention:   Drug: PA32540
Sponsor:   POZEN
Completed

Thu, 15 Oct 2009 12:00:00 EDT

Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin

Condition:   Coronary Artery Disease
Interventions:   Drug: Cloas;   Drug: Plavix/Astrix
Sponsor:   Ajou University School of Medicine
Unknown status

Thu, 07 Jul 2011 12:00:00 EDT

The Effect of Triflusal on Peripheral Microcirculation Dysfunction

Condition:   Vasospastic Syndrome
Interventions:   Drug: Triflusal;   Drug: Aspirin
Sponsor:   Yonsei University
Completed

Tue, 05 Jun 2012 12:00:00 EDT

Residual Platelet Activity In Advanced Peripheral Artery Disease

Condition:   Peripheral Arterial Disease
Interventions:   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsors:   University of Roma La Sapienza;   University of Florence
Unknown status

Mon, 25 Jun 2012 12:00:00 EDT

Role of Prostaglandins on Niacin-Induced Flushing

Condition:   Flushing
Intervention:   Drug: Niacin and aspirin
Sponsors:   Eastern Virginia Medical School;   Abbott
Completed

Thu, 02 Jul 2009 12:00:00 EDT

Aspirin and Clopidogrel Resistance Study

Condition:   Drug Resistance
Intervention:  
Sponsor:   University Hospital, Basel, Switzerland
Completed

Fri, 25 Dec 2009 12:00:00 EST

Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler

Condition:   Cerebral Infarction
Interventions:   Drug: Aspirin;   Drug: cilostazol
Sponsors:   Inje University;   Korea Otsuka Pharmaceutical Co., Ltd.
Completed

Tue, 26 Aug 2008 12:00:00 EDT

Alternative Options to Minimize Niacin-Induced Flushing

Conditions:   Hypercholesterolemia;   Flushing
Interventions:   Other: Apple pectin;   Drug: Aspirin 325 mg;   Other: Placebo
Sponsor:   Patrick Moriarty, MD, FACP, FACC
Completed

Fri, 08 May 2009 12:00:00 EDT

Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance

Condition:   Angioplasty, Transluminal, Percutaneous Coronary
Interventions:   Drug: Tirofiban;   Drug: Placebo
Sponsor:   Università degli Studi di Ferrara
Completed

Fri, 10 Nov 2006 12:00:00 EST

Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"

Condition:   Thrombosis
Interventions:   Drug: BMS-986141;   Drug: Aspirin;   Other: Placebo
Sponsor:   Bristol-Myers Squibb
Completed

Tue, 02 Feb 2016 12:00:00 EST

GLP-1 and Microvascular Function in Type 2 Diabetes

Condition:   Type 2 Diabetes
Interventions:   Drug: Liraglutide;   Other: diet;   Drug: Aspirin
Sponsors:   Royal Devon and Exeter NHS Foundation Trust;   University of Exeter
Completed

Tue, 04 Dec 2012 12:00:00 EST

Ticagrelor Versus Clopidogrel in Carotid Artery Stenting

Condition:   Carotid Artery Stenosis
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   University Hospital, Basel, Switzerland
Recruiting

Tue, 09 Feb 2016 12:00:00 EST

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: acetylsalicylic acid;   Drug: dexamethasone;   Drug: diethylstilbestrol
Sponsor:   St. Bartholomew's Hospital
Completed

Fri, 21 Apr 2006 12:00:00 EDT

COBRA SHIELD OCT Study

Condition:   Stable Angina
Interventions:   Drug: Aspirin;   Device: Resolute Integrity DES;   Device: COBRA PzF;   Drug: DAPT
Sponsors:   CeloNova BioSciences, Inc.;   ClinLogix. LLC
Terminated

Mon, 25 Aug 2014 12:00:00 EDT

Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: ASA evening;   Drug: Acetylsalicylic morning;   Drug: Placebos morning;   Drug: Placebo evening
Sponsors:   Basque Health Service;   Preventive Services and Health Promotion Research Network;   Spanish Clinical Research Network - SCReN;   Public Health Service of Cataluña
Completed

Wed, 05 Dec 2012 12:00:00 EST

Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND

Conditions:   Coronary Artery Disease;   Myocardial Infarction
Interventions:   Drug: Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81 mg + Ticagrelor 60mg twice daily;   Drug: Ticagrelor Monotherapy: Ticagrelor 60 mg twice daily;   Drug: Personalized Therapy Arm: Aspirin 81 mg or Ticagrelor 60mg twice daily or Clopidogrel 75 mg once daily
Sponsor:   Ottawa Heart Institute Research Corporation
Suspended

Fri, 02 Nov 2018 12:00:00 EDT

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

Condition:   Ovarian Neoplasms
Interventions:   Drug: Bevacizumab;   Drug: atezolizumab;   Drug: acetylsalicylic acid;   Drug: placebo
Sponsor:   European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting

Wed, 20 Jan 2016 12:00:00 EST

Clinical Significance of Platelet Reactivity on Clopidogrel During Off-pump Coronary Artery Bypass

Condition:   Coronary Artery Disease
Intervention:   Drug: Dual antiplatelet therapy including aspirin and clopidogrel after off-pump coronary bypass surgery
Sponsor:   Yonsei University
Completed

Wed, 09 Oct 2013 12:00:00 EDT

Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis

Condition:   Carotid Artery Stenosis
Interventions:   Device: Smart nitinol stent implantation;   Drug: antiplatelet drug
Sponsor:   Beijing Jishuitan Hospital
Completed

Wed, 15 Jun 2016 12:00:00 EDT

Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery Disease

Conditions:   Atrial Fibrillation;   Coronary Artery Disease
Interventions:   Drug: Dabigatrain plus aspirin;   Drug: Dabigatrain plus clopidogrel;   Device: Amplazter Cardiac Plug (ACP)
Sponsor:   Yonsei University
Terminated

Tue, 17 Nov 2015 12:00:00 EST

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack

Conditions:   Transient Ischemic Attacks;   Minor Stroke
Intervention:   Drug: anti-thrombotic treatment using Aspirin (ASA 75-325mg) and Clopidogrel (75mg)
Sponsor:   University of Alberta
Unknown status

Thu, 22 May 2014 12:00:00 EDT

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Conditions:   Intracranial Arteriosclerosis;   Stroke
Interventions:   Drug: Ticagrelor + Aspirin;   Drug: Rivaroxaban + Aspirin;   Drug: Clopidogrel + Aspirin;   Other: Risk Factor Management
Sponsors:   University of Florida;   National Institute of Neurological Disorders and Stroke (NINDS);   University of Cincinnati;   Medical University of South Carolina;   Janssen Scientific Affairs, LLC;   AstraZeneca
Not yet recruiting

Fri, 17 Sep 2021 12:00:00 EDT

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Condition:   Heart Failure
Interventions:   Device: HeartMate II (HMII);   Drug: Warfarin;   Drug: acetylsalicylic acid (ASA) therapy
Sponsor:   Abbott Medical Devices
Completed

Tue, 19 Jul 2016 12:00:00 EDT

Pulsed Radiofrequency for Frozen Shoulder Chronic Pain (PRFFSCP)

Condition:   Frozen Shoulder
Interventions:   Device: pulsed radiofrequency;   Drug: NSAIDs "ibubrofen,Aspirin"
Sponsor:   Assiut University
Unknown status

Wed, 07 Mar 2018 12:00:00 EST

Aggrenox Prevention of Access Stenosis

Condition:   Kidney Failure
Interventions:   Drug: Aggrenox;   Drug: Placebo
Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   The Cleveland Clinic;   Boston University;   Duke University;   University of Iowa;   MaineHealth;   University of Texas Southwestern Medical Center;   University of Alabama at Birmingham;   Washington University School of Medicine;   Baystate Medical Center;   Vanderbilt University;   CAMC Health System;   Emory University;   St. Louis University;   Tyler Nephrology Associates;   Vascular Surgery Associates LLC
Completed

Wed, 13 Aug 2003 12:00:00 EDT

Treatment of Coronary Heart Disease With Amiloride

Condition:   Coronary Heart Disease
Interventions:   Drug: Amiloride;   Drug: Nitrates, clopidogrel, aspirin, statins
Sponsors:   University of Carabobo;   Clinical Research Unit at the Docent Institute of Urology;   Northern Metropolitan Hospital;   Venezuelan Foundation of Heart Failure
Completed

Mon, 01 Nov 2010 12:00:00 EDT

Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence

Conditions:   Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions:   Drug: aspirin;   Drug: Antivitamins K or rivaroxaban or dabigatran or apixaban;   Device: Devices for PFO closure
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed

Thu, 22 Nov 2007 12:00:00 EST

Comparative Pharmacokinetics of YH14659

Condition:   Acute Coronary Syndrome
Interventions:   Drug: YH14659;   Drug: clopidogrel & aspirin
Sponsor:   Yuhan Corporation
Completed

Tue, 23 Aug 2011 12:00:00 EDT

REstart or STop Antithrombotic Randomised Trial in France

Condition:   Cerebral Hemorrhage
Intervention:   Drug: Clopidogrel or Aspirin and/or Dypyridamole
Sponsors:   University Hospital, Lille;   Région Hauts de France, France;   Ministry of Health, France
Recruiting

Thu, 17 Nov 2016 12:00:00 EST

Risk Stratification Procedure for Thromboembolism Prophylaxis

Condition:   Total Knee Replacement Surgeries
Intervention:   Drug: acetylsalicylic acid
Sponsors:   Ministry of Health, Saudi Arabia;   Prince Sultan Military College of Health Sciences;   Universiti Sains Malaysia
Completed

Wed, 24 Jul 2019 12:00:00 EDT

Targeting Platelets in Chronic HIV Infection

Condition:   HIV-1 Infection
Interventions:   Drug: Clopidogrel;   Drug: Aspirin;   Drug: Placebo
Sponsors:   Icahn School of Medicine at Mount Sinai;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Mon, 19 Oct 2015 12:00:00 EDT

Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study

Conditions:   Magnetic Resonance Imaging;   Asymptomatic Intracranial Stenosis;   Medical Treatment
Intervention:   Drug: Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin
Sponsor:   Anhui Medical University
Recruiting

Tue, 20 Apr 2021 12:00:00 EDT

On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction

Condition:   Acute ST-elevation Myocardial Infarction
Intervention:   Drug: Antiplatelet Regimen Modification (aspirin or ticagrelor)
Sponsor:   Clinical Centre of Serbia
Terminated

Mon, 03 Dec 2012 12:00:00 EST

The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Drug: Prasugrel;   Drug: Clopidogrel
Sponsor:   Daiichi Sankyo, Inc.
Completed

Wed, 15 Dec 2010 12:00:00 EST

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen

Conditions:   High Bleeding Risk;   Coronary Artery Disease;   PCI
Interventions:   Drug: Aspirin;   Drug: P2Y12 inhibitor
Sponsors:   ECRI bv;   Cardialysis B.V.;   European Cardiovascular Research Center;   University of Bern;   Terumo Medical Corporation
Completed

Wed, 18 Jan 2017 12:00:00 EST

Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately

Condition:   Peptic Ulcer Disease
Interventions:   Drug: Esomeprazole/ASA Fixed Combination;   Drug: Esomeprazole;   Drug: ASA
Sponsor:   AstraZeneca
Terminated

Wed, 18 Nov 2009 12:00:00 EST

Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects

Condition:   Migraine
Intervention:   Drug: Clopidogrel
Sponsors:   Laval University;   Sanofi;   Bristol-Myers Squibb
Completed

Thu, 27 Nov 2008 12:00:00 EST

Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease

Condition:   Kawasaki Disease
Interventions:   Drug: IVIG;   Drug: Aspirin;   Drug: Infliximab
Sponsors:   Children's Hospital of Fudan University;   Shanghai Children's Hospital;   Shanghai Children's Medical Center;   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine;   Shanghai 10th People's Hospital
Withdrawn

Wed, 02 Sep 2020 12:00:00 EDT

Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients

Condition:   Aspirin Resistance
Intervention:  
Sponsors:   Northwell Health;   Staten Island University Hospital
Completed

Mon, 17 Nov 2008 12:00:00 EST

To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection

Conditions:   Cervical Artery Dissection;   Carotid Artery Dissection;   Vertebral Artery Dissection;   Stroke
Interventions:   Drug: Antiplatelet (Aspirin, Dipyridamole, clopidogrel);   Drug: Anticoagulant (Unfractionated Heparin, LMW Heparin, Warfarin)
Sponsors:   St George's, University of London;   The Stroke Association, United Kingdom
Completed

Thu, 13 Oct 2005 12:00:00 EDT

Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients

Conditions:   Stroke;   Immunoregulation;   Inflammation;   Vinpocetine
Interventions:   Drug: vinpocetine;   Drug: Aspirin
Sponsor:   Tianjin Medical University General Hospital
Completed

Thu, 25 Aug 2016 12:00:00 EDT

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor 90mg;   Drug: Clopidogrel 75mg;   Drug: acetylsalicylic acid (ASA) 81mg
Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR)
Active, not recruiting

Thu, 15 Aug 2019 12:00:00 EDT

Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance

Conditions:   Impaired Glucose Tolerance;   Prediabetic State
Interventions:   Drug: Aspirin;   Drug: Alpha lipoic acid;   Drug: Olmesartan;   Drug: Placebo
Sponsors:   Emory University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Daiichi Sankyo, Inc.;   National Center for Research Resources (NCRR)
Completed

Fri, 22 Jul 2005 12:00:00 EDT

Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention

Conditions:   Ischemic Heart Disease;   Acute Coronary Syndromes
Intervention:   Drug: cilostazol in addition to aspirin and clopidogrel
Sponsor:   Shenyang Northern Hospital
Completed

Wed, 29 Nov 2006 12:00:00 EST

Reversal of the Anti-platelet Effects of Ticagrelor

Condition:   Coronary Artery Disease
Interventions:   Drug: Ticagrelor;   Drug: Aspirin + Ticagrelor;   Drug: Control
Sponsors:   The First Affiliated Hospital with Nanjing Medical University;   National Natural Science Foundation of China
Completed

Mon, 09 Mar 2015 12:00:00 EDT

Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease

Condition:   Kawasaki Disease
Interventions:   Drug: IVIG;   Drug: Aspirin;   Drug: Prednisolone
Sponsors:   Children's Hospital of Fudan University;   Jiangxi Province Children's Hospital;   First People's Hospital of Hangzhou;   Shengjing Hospital;   The First Hospital of Jilin University;   Chengdu Women's and Children's Central Hospital;   Children's Hospital of Chongqing Medical University;   Inner Mongolia People's Hospital;   Sichuan Provincial People's Hospital;   Wuhan Union Hospital, China;   Third Affiliated Hospital of Zhengzhou University;   Children's Hospital Of Soochow University;   Yuying Children's Hospital of Wenzhou Medical University;   Beijing Children's Hospital;   Qilu Hospital of Shandong University
Recruiting

Fri, 06 Sep 2019 12:00:00 EDT

Human Umbilical Cord Mesenchymal Stem Cell Therapy for Cerebral Infarction Patients in Convalescent Period.

Condition:   Cerebral Infarction
Interventions:   Biological: Allogeneic umbilical cord mesenchymal stem cell;   Drug: Aspirin Enteric-coated Tablets & Atorvastatin Calcium
Sponsor:   Sclnow Biotechnology Co., Ltd.
Suspended

Mon, 05 Jun 2017 12:00:00 EDT

Post-operative Treatment of Diabetic Peripheral Arterial Disease Guided by Platelet Reactivity Unit

Condition:   Peripheral Artery Disease
Interventions:   Other: platelet (P2Y12) reaction units;   Drug: ticagrelor;   Drug: Comparator
Sponsor:   Chang Gung Memorial Hospital
Unknown status

Thu, 05 May 2016 12:00:00 EDT

Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients

Condition:   Diabetes Mellitus, Type II
Intervention:  
Sponsor:   Hadassah Medical Organization
Completed

Tue, 01 Apr 2008 12:00:00 EDT

Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)

Condition:   Chronic Obstructive Pulmonary Disease (COPD)
Interventions:   Drug: Ticagrelor;   Drug: Aspirin;   Drug: Placebo Aspirin;   Drug: Placebo Ticagrelor
Sponsors:   Newcastle-upon-Tyne Hospitals NHS Trust;   AstraZeneca;   Newcastle University
Completed

Wed, 04 Apr 2018 12:00:00 EDT

Physiopathology of Rapid Aspirin Desensitization

Conditions:   Hypersensitivity;   Coronary Artery Disease
Intervention:  
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed

Thu, 06 May 2010 12:00:00 EDT

Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis

Condition:   Percutaneous Coronary Intervention
Interventions:   Drug: 12 months of P2Y12 receptor antagonist;   Drug: 24 months of P2Y12 receptor antagonist;   Drug: Aspirin
Sponsor:   Beijing Anzhen Hospital
Unknown status

Mon, 30 Mar 2015 12:00:00 EDT

The Dual Antiplatelet Therapy Study (DAPT Study)

Condition:   Coronary Artery Disease
Interventions:   Drug: Placebo & Aspirin;   Drug: Clopidogrel & Aspirin, Prasugrel & Aspirin
Sponsors:   Baim Institute for Clinical Research;   Abbott;   Boston Scientific Corporation;   Bristol-Myers Squibb;   Sanofi-Synthelabo;   Cordis Corporation;   Eli Lilly and Company;   Daiichi Sankyo, Inc.;   Medtronic
Completed

Wed, 16 Sep 2009 12:00:00 EDT

CYPRESS - CYPHER for Evaluating Sustained Safety

Condition:   Coronary Artery Disease
Interventions:   Drug: Clopidogrel & Aspirin, Prasugrel & Aspirin;   Drug: Placebo & Aspirin
Sponsor:   Cordis Corporation
Unknown status

Fri, 07 Aug 2009 12:00:00 EDT

Electrophilic Fatty Acid Derivatives in Asthma

Conditions:   Asthma;   Electrophilic Fatty Acids
Interventions:   Drug: Aspirin;   Drug: Indomethacin
Sponsor:   Sally E. Wenzel MD
Completed

Tue, 27 Nov 2012 12:00:00 EST

CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease

Condition:   Dietary Modification
Interventions:   Dietary Supplement: Carnitine;   Dietary Supplement: Choline;   Drug: Antibiotics;   Drug: Choline and Aspirin;   Drug: Carnitine and Aspirin
Sponsor:   The Cleveland Clinic
Enrolling by invitation

Wed, 21 Nov 2012 12:00:00 EST

Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation

Condition:   Coronary Artery Disease
Interventions:   Drug: Cilostazol;   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   Yonsei University
Completed

Wed, 01 Sep 2010 12:00:00 EDT

Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia

Condition:   Aspirin Resistance
Intervention:  
Sponsor:   University Hospital, Limoges
Completed

Thu, 15 Apr 2010 12:00:00 EDT

The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp

Condition:   Erythropoietin Adverse Reaction
Intervention:   Drug: Acetylsalicylic acid
Sponsor:   Zealand University Hospital
Not yet recruiting

Wed, 01 Apr 2020 12:00:00 EDT

Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin

Condition:   Recurrent Pregnancy Loss
Intervention:   Drug: Heparin
Sponsor:   Benha University
Recruiting

Wed, 21 May 2014 12:00:00 EDT

Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients

Condition:   Chronic Kidney Disease
Intervention:  
Sponsors:   Northwell Health;   Staten Island University Hospital
Completed

Thu, 02 Jun 2011 12:00:00 EDT

Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke

Condition:   Stroke
Interventions:   Drug: Aspirin;   Drug: Clopidogrel 75mg;   Drug: Alteplase
Sponsor:   General Hospital of Shenyang Military Region
Recruiting

Fri, 07 Sep 2018 12:00:00 EDT

Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination

Conditions:   Ulcers;   Upper GI Symptoms
Interventions:   Drug: Esomeprazole 40mg/ASA 325mg;   Drug: Esomeprazole;   Drug: ASA
Sponsor:   AstraZeneca
Completed

Tue, 03 Jun 2008 12:00:00 EDT

Analgesic Efficacy of Orally Administered VTS-K for Pain Management

Condition:   Pain, Acute
Intervention:   Drug: VTS-K
Sponsor:   Antonios Likourezos
Recruiting

Mon, 11 Jan 2021 12:00:00 EST

Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients

Condition:   Coronary Artery Disease (CAD)
Interventions:   Drug: Clopidogrel;   Drug: aspirin 100mg
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Fri, 12 Apr 2013 12:00:00 EDT

Effect of Aspirin Vs Omega 3 Fatty Acid After Scaling and Root Planing in Type II Diabetic Patients With Chronic Periodontitis

Conditions:   Periodontitis;   Type2 Diabetes
Intervention:   Other: Scaling and root planing
Sponsor:   Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
Completed

Thu, 26 Jul 2018 12:00:00 EDT

PGD2 Formation in Vascular Injury

Conditions:   Coronary Artery Disease;   Acute Coronary Syndrome;   Stable Angina
Interventions:   Drug: No ASA;   Drug: Low dose ASA;   Drug: 325 mg ASA
Sponsor:   University of Pennsylvania
Terminated

Mon, 26 Oct 2009 12:00:00 EDT

Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma

Conditions:   Stage III Cutaneous Melanoma;   Stage IIIA Cutaneous Melanoma;   Stage IIIB Cutaneous Melanoma;   Stage IIIC Cutaneous Melanoma;   Stage IV Cutaneous Melanoma
Interventions:   Drug: Aspirin;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
Sponsors:   University of California, San Francisco;   Merck Sharp & Dohme Corp.
Active, not recruiting

Thu, 11 Jan 2018 12:00:00 EST

Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor;   Drug: clopidogrel;   Drug: Aspirin;   Procedure: PCI
Sponsor:   RenJi Hospital
Unknown status

Mon, 28 Jul 2014 12:00:00 EDT

Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy

Conditions:   Myocardial Infarction, Acute;   Coronary Artery Disease
Interventions:   Drug: Shortened DAPT followed by P2Y12 inhibitor monotherapy (cessation of aspirin);   Drug: Standard DAPT
Sponsor:   MicroPort CRM
Not yet recruiting

Mon, 15 Feb 2021 12:00:00 EST

Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)

Conditions:   Platelet Aggregation Inhibitors;   Coronary Heart Disease
Interventions:   Drug: Clopidogrel;   Drug: Aspirin
Sponsors:   University of Maryland, Baltimore;   National Institute of General Medical Sciences (NIGMS);   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 27 Nov 2008 12:00:00 EST

P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold

Conditions:   Coronary Artery Disease;   Stents;   Atherosclerosis
Interventions:   Drug: Clopidogrel;   Drug: Ticagrelor;   Drug: Aspirin
Sponsor:   Samsung Medical Center
Recruiting

Tue, 18 Apr 2017 12:00:00 EDT

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Conditions:   Brain Ischemia;   Intracranial Hemorrhages
Interventions:   Drug: Cilostazol;   Drug: Probucol;   Drug: Aspirin;   Drug: placebo of cilostazol;   Drug: placebo of aspirin;   Device: ankle-brachial index (ABI);   Device: intima-medial thickness (IMT);   Device: new asymptomatic brain hemorrhage;   Device: new ischemic lesions on follow-up FLAIR images
Sponsors:   Asan Medical Center;   Korea Otsuka Pharmaceutical Co., Ltd.
Unknown status

Fri, 13 Nov 2009 12:00:00 EST

Cilostazol Stroke Prevention Study for Antiplatelet Combination

Condition:   Noncardioembolic Cerebral Infarction
Interventions:   Drug: aspirin;   Drug: clopidogrel;   Drug: cilostazol
Sponsors:   Japan Cardiovascular Research Foundation;   Otsuka Pharmaceutical Co., Ltd.
Completed

Tue, 26 Nov 2013 12:00:00 EST

Prevalence and Level of Thienopyridine Resistance Seen in a Contemporary Percutaneous Coronary Intervention or Coronary Artery Bypass Graft Population

Condition:   Increased Drug Resistance
Interventions:   Other: Thienopyridine resistance testing;   Other: Aspirin resistance testing;   Other: Genetic polymorphism assessment
Sponsor:   Medstar Health Research Institute
Unknown status

Wed, 03 Aug 2011 12:00:00 EDT

Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)

Condition:   Critical Limb Ischemia
Interventions:   Drug: Triple antiplatelet therapy (aspirin (100 mg), clopidogrel (75 mg), and cilostazol (200 mg) );   Drug: Dual antiplatelet therapy (aspirin (100 mg) and clopidogrel (75 mg)) using aspirin and clopidogrel;   Drug: Dual antiplatelet therapy (aspirin (100 mg) and cilostazol (200 mg)) using aspirin and cilostazol
Sponsor:   Yonsei University
Unknown status

Tue, 12 Jul 2016 12:00:00 EDT

What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.

Conditions:   Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention:   Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
Sponsors:   R&D Cardiologie;   St. Antonius Hospital
Recruiting

Fri, 18 Dec 2015 12:00:00 EST

Cilostazol in Acute Ischemic Stroke Treatment (CAIST)

Condition:   Cerebral Infarction
Interventions:   Drug: Cilostazol;   Drug: Aspirin
Sponsors:   Korea Otsuka Pharmaceutical Co., Ltd.;   Seoul National University Boramae Hospital;   Korea Otsuka International Asia Arab Co., Ltd.
Completed

Fri, 06 Jan 2006 12:00:00 EST

Endoscopic Mucosal Colonic Resection and Polypectomy Under Aspirin

Condition:   Polyps
Intervention:   Procedure: Colonic polypectomy or endoscopic mucosal resection (EMR)
Sponsor:   Société Française d'Endoscopie Digestive
Completed

Tue, 29 Nov 2011 12:00:00 EST

Aggravated Airway Inflammation: Research on Genomics and Optimal Medical Care (AirGOs-medical)

Condition:   Chronic Rhinosinusitis (Diagnosis)
Interventions:   Drug: Placebo Oral Tablet;   Drug: Acetyl Salicylic Acid
Sponsors:   Sanna Salmi;   University of Helsinki
Recruiting

Thu, 31 Jan 2019 12:00:00 EST

Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease

Conditions:   Coronary Heart Disease;   Non ST-elevation Acute Coronary Syndromes
Intervention:  
Sponsors:   University of Sao Paulo General Hospital;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Completed

Thu, 28 Mar 2013 12:00:00 EDT

Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation

Conditions:   Unstable Angina Pectoris;   Coronary Stent Implantation
Interventions:   Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 45 mg;   Drug: Aspirin
Sponsor:   Xiaofan Wu
Unknown status

Wed, 08 Aug 2018 12:00:00 EDT

Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial

Condition:   Acute Ischaemic Stroke
Interventions:   Drug: Recombinant human urokinase;   Drug: Aspirin;   Drug: rhPro-UK simulation agent;   Drug: Aspirin simulation agent
Sponsor:   Tasly Biopharmaceuticals Co., Ltd.
Completed

Fri, 06 Jul 2018 12:00:00 EDT

Duration of Platelet Inhibition by Aspirin

Condition:   Coronary Artery Disease
Intervention:   Other: Platelet aggregation
Sponsor:   Hopital du Sacre-Coeur de Montreal
Completed

Fri, 02 May 2008 12:00:00 EDT

Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts

Condition:   Congenital Heart Disease
Intervention:  
Sponsor:   University of Utah
Completed

Fri, 03 Aug 2012 12:00:00 EDT

Antiplatelet Therapy in Heart Transplantation

Conditions:   Cardiac Allograft Vasculopathy;   Heart Transplant
Interventions:   Drug: Placebo;   Drug: aspirin;   Drug: Clopidogrel
Sponsors:   Ottawa Heart Institute Research Corporation;   Canadian Institutes of Health Research (CIHR)
Not yet recruiting

Thu, 25 Feb 2021 12:00:00 EST

Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms

Conditions:   Unruptured Intracranial Aneurysm;   Stents;   Antiplatelet Drugs
Interventions:   Drug: Aspirin and clopidogrel/Ticagrelor;   Device: Light transmittance aggregometry
Sponsor:   Beijing Neurosurgical Institute
Completed

Tue, 18 Jun 2019 12:00:00 EDT

CV004-007 Thrombosis Chamber Study

Condition:   Thrombosis
Interventions:   Drug: BMS-986120;   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   Bristol-Myers Squibb
Completed

Fri, 08 May 2015 12:00:00 EDT

Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions

Conditions:   Vascular Dementia;   Stroke
Interventions:   Drug: Cilostazol;   Drug: Aspirin
Sponsors:   Peking University First Hospital;   Zhejiang Otsuka Pharmaceutical Co., Ltd.
Completed

Thu, 19 Feb 2009 12:00:00 EST

Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting

Condition:   CVD
Interventions:   Drug: Argatroban;   Drug: non-argatroban treated group
Sponsor:   Jinling Hospital, China
Completed

Fri, 16 Jul 2010 12:00:00 EDT

Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease

Conditions:   Atrial Fibrillation;   Valve Heart Disease
Interventions:   Drug: Dabigatran;   Drug: Acetylsalicylic acid;   Drug: Warfarin
Sponsors:   Asan Medical Center;   Boehringer Ingelheim
Completed

Tue, 06 Dec 2016 12:00:00 EST

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Conditions:   Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions:   Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
Sponsor:   Cogentus Pharmaceuticals
Terminated

Wed, 14 Nov 2007 12:00:00 EST

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

Condition:   Peripheral Arterial Disease
Interventions:   Drug: Rivaroxaban 2.5 Mg Oral Tablet;   Drug: Placebo;   Drug: Aspirin 81Mg Ec Tab
Sponsors:   Vanderbilt University Medical Center;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting

Wed, 18 Aug 2021 12:00:00 EDT

Barrett's Esophagus - 315 - 3 Way Cross Over

Condition:   Barrett's Esophagus
Interventions:   Drug: Esomeprazole;   Drug: Aspirin;   Drug: Rofecoxib
Sponsor:   AstraZeneca
Completed

Tue, 18 Mar 2008 12:00:00 EDT

Aspirin Resistance Reversibility in Diabetic Patients

Condition:   Aspirin Resistance
Intervention:   Drug: lysine acetylsalicylate
Sponsor:   Azienda Ospedaliera San Giovanni Battista
Unknown status

Thu, 05 Sep 2013 12:00:00 EDT

The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)

Conditions:   Coronary Disease;   Cerebral Infarction;   Ischemic Attack, Transient
Intervention:  
Sponsors:   Ministry of Health, Labour and Welfare, Japan;   The National Institute of Biomedical Innovation
Completed

Tue, 08 Nov 2005 12:00:00 EST

Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization

Conditions:   Ischemia;   Anticoagulants
Intervention:   Drug: Combination drug
Sponsor:   Mansoura University
Recruiting

Tue, 19 Nov 2019 12:00:00 EST

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort

Conditions:   Chronic Total Occlusion of Coronary Artery;   Vascular Disease;   Myocardial Ischemia;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Artery Disease;   Coronary Restenosis
Interventions:   Drug: placebo + aspirin;   Drug: clopidogrel + aspirin OR prasugrel + aspirin;   Device: XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS)
Sponsors:   Abbott Medical Devices;   Baim Institute for Clinical Research;   Bristol-Myers Squibb;   Eli Lilly and Company;   Daiichi Sankyo, Inc.
Completed

Tue, 20 Apr 2010 12:00:00 EDT

Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects

Conditions:   Hypertension,Essential;   Obesity
Interventions:   Drug: acetylsalicylic acid;   Drug: Tomato Fruit Extract
Sponsor:   Beata Krasinska
Completed

Sun, 02 Jul 2017 12:00:00 EDT

PeriOperative ISchemic Evaluation-2 Trial

Condition:   Cardiovascular Disease
Interventions:   Drug: Active Clonidine;   Drug: Placebo Clonidine;   Drug: Active ASA;   Drug: Placebo ASA
Sponsors:   Hamilton Health Sciences Corporation;   McMaster University
Completed

Tue, 09 Mar 2010 12:00:00 EST

XIENCE 28 USA Study

Conditions:   Bleeding Disorder;   Ischemic Stroke;   Hemorrhagic Stroke;   Hematological Diseases;   Thrombocytopenia;   Coagulation Disorder;   Anemia;   Renal Insufficiency;   Coronary Artery Disease
Interventions:   Device: XIENCE;   Drug: DAPT (aspirin and/or P2Y12 receptor inhibitor)
Sponsor:   Abbott Medical Devices
Completed

Thu, 24 Jan 2019 12:00:00 EST

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation

Conditions:   Aortic Valve Disease;   Myocardial Infarction;   Stroke;   Bleeding
Interventions:   Drug: Aspirin + clopidogrel;   Drug: Aspirin monotherapy;   Drug: OAC + clopicogrel;   Drug: OAC monotherapy
Sponsor:   St. Antonius Hospital
Completed

Tue, 23 Sep 2014 12:00:00 EDT

1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials

Condition:   Coronary Artery Disease
Interventions:   Drug: AntiPlatelet therapy;   Procedure: Percutaneous coronary intervention
Sponsor:   Nanjing First Hospital, Nanjing Medical University
Recruiting

Mon, 03 Jun 2019 12:00:00 EDT

Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events

Conditions:   Percutaneous Transluminal Coronary Angioplasty;   Coronary Disease
Interventions:   Drug: aspirin and clopidogrel;   Drug: Clopidogrel only
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea
Active, not recruiting

Thu, 20 Oct 2016 12:00:00 EDT

Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women

Conditions:   Placental Insufficiency;   Enoxaparin
Interventions:   Drug: Enoxaparin 40 mg / 0.4 mL Prefilled Syringe;   Drug: Aspirin 100 mg Oral Tablet, Enteric Coated
Sponsor:   Les Laboratoires des Médicaments Stériles
Completed

Fri, 18 May 2018 12:00:00 EDT

Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine

Conditions:   Common Cold;   Pharyngitis
Interventions:   Drug: Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine;   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465);   Drug: Pseudoephedrine;   Drug: Placebo
Sponsor:   Bayer
Completed

Thu, 04 Feb 2010 12:00:00 EST

Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure

Condition:   Thrombosis
Interventions:   Drug: Rivaroxaban;   Drug: Acetylsalicylic Acid
Sponsors:   Janssen Research & Development, LLC;   Bayer
Completed

Wed, 27 Jul 2016 12:00:00 EDT

Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate

Condition:   HIV-1 Infection
Interventions:   Drug: Niacin;   Drug: Aspirin;   Drug: Fenofibrate
Sponsors:   AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Wed, 31 Aug 2011 12:00:00 EDT

NeuroCognition After Carotid Recanalization

Conditions:   Cognition Disorder;   Stroke;   Occlusion Carotid
Interventions:   Procedure: Endovascular intervention;   Drug: Aspirin and Clopidogrel (maximal medical Therapy)
Sponsor:   David Hasan
Recruiting

Tue, 07 Jan 2020 12:00:00 EST

Association of PeriOPerative Aspirin-ResisTance and CardioVascular Outcome

Condition:   Vascular Surgery
Intervention:  
Sponsor:   University Hospital Heidelberg
Unknown status

Tue, 13 Aug 2019 12:00:00 EDT

GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

Condition:   Coronary Artery Disease (CAD)
Interventions:   Drug: Ticagrelor;   Drug: Acetylsalicylic Acid;   Drug: Clopidogrel
Sponsors:   ECRI bv;   Biosensors International;   AstraZeneca;   The Medicines Company
Completed

Tue, 19 Mar 2013 12:00:00 EDT

Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia

Condition:   Preeclampsia
Interventions:   Drug: Lovenox® (enoxaparin);   Drug: Aspegic ® (Aspirin)
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed

Wed, 30 Sep 2009 12:00:00 EDT

The Effects of COX-inhibiting Drugs on Skeletal Muscle Adaptations to Resistance Exercise in Healthy Adults

Condition:   Skeletal Muscle Mass Regulation
Interventions:   Drug: Ibuprofen;   Drug: Acetylsalicylic acid
Sponsor:   Karolinska Institutet
Completed

Mon, 24 Aug 2015 12:00:00 EDT

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Condition:   Elevated LDL Cholesterol
Interventions:   Drug: Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril),;   Drug: Simvastatin
Sponsor:   Ferrer Internacional S.A.
Terminated

Fri, 30 Oct 2009 12:00:00 EDT

Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients

Condition:   Covid19
Intervention:   Drug: 3-dayIVM 200 mcg/kg/day/14-day 75mgASA/day + standard of care (intervention 1)
Sponsors:   Makerere University;   Ministry of Health, Uganda;   Mbarara University of Science and Technology;   Joint Clinical Research Center
Not yet recruiting

Wed, 24 Feb 2021 12:00:00 EST

NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event

Conditions:   Ischemic Stroke;   Transient Ischemic Attack (TIA)
Interventions:   Other: Vitamin E tocotrienol (TCT) capsules ; Low dose Aspirin;   Other: Placebo vehicle control
Sponsors:   Andrew Slivka;   Government of Malaysia
Completed

Tue, 17 Apr 2012 12:00:00 EDT

L-arginine in Treatment of Intrauterine Growth Restriction

Condition:   Intrauterine Growth Restriction Asymmetrical
Interventions:   Drug: L-arginine 1000 mg and Acetylesalicylic acid75mg;   Drug: acetylsalicylic acid 75 mg
Sponsor:   Ain Shams University
Unknown status

Wed, 25 Oct 2017 12:00:00 EDT

Evaluation Of HUK in Acute Stroke Patients: MRS and CTP

Condition:   Acute Ischemic Stroke
Interventions:   Drug: Human urinary kallidinogenase (HUK);   Drug: aspirin® , clopidogrel® , atorvastatin®
Sponsor:   Xuanwu Hospital, Beijing
Completed

Tue, 13 Feb 2018 12:00:00 EST

Platelet Reactivity After TAVI: A Multicenter Pilot Study

Conditions:   Severe Aortic Valve Stenosis;   Transcatheter Aortic Valve Implantation;   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Ticagrelor 90 mg twice per day during three months following TAVI;   Drug: Aspirin 100 mg plus Clopidogrel 75 mg daily during three months following TAVI
Sponsor:   Hospital de Meixoeiro
Completed

Mon, 25 Aug 2014 12:00:00 EDT

Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm

Conditions:   Aneurysm, Cerebral;   Endovascular Procedures
Interventions:   Drug: Aspirin;   Drug: Prasugrel;   Drug: Clopidogrel;   Drug: Cilostazol
Sponsors:   Seoul National University Hospital;   Seoul National University Bundang Hospital
Completed

Tue, 10 Jul 2018 12:00:00 EDT

Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation

Condition:   Coronary Artery Disease
Interventions:   Drug: Clopidogrel;   Drug: Aspirin plus clopidogrel
Sponsors:   CHEOL WHAN LEE, M.D., Ph.D;   CardioVascular Research Foundation, Korea;   Medtronic;   Chong Kun Dang Pharmaceutical Corp.
Terminated

Fri, 10 Jul 2015 12:00:00 EDT

Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus

Conditions:   Myocardial Infarction;   Diabetes Mellitus;   Peripheral Arterial Disease
Interventions:   Drug: Vorapaxar;   Drug: Clopidogrel;   Drug: Aspirin
Sponsors:   University of Florida;   Merck Sharp & Dohme Corp.
Completed

Mon, 14 Sep 2015 12:00:00 EDT

A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects

Condition:   Thrombosis
Interventions:   Drug: BMS-962212;   Drug: Aspirin;   Other: Placebo
Sponsor:   Bristol-Myers Squibb
Completed

Fri, 23 Jun 2017 12:00:00 EDT

Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study

Conditions:   Stroke, Acute;   Ischemic Attack, Transient
Interventions:   Drug: Sanchitongshu;   Drug: placebo of Sanchitongshu;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: placebo of clopidogrel
Sponsor:   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Unknown status

Tue, 29 Nov 2016 12:00:00 EST

The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)

Condition:   Peripheral Arterial Disease
Interventions:   Drug: Dipyridamole 200mg and Aspirin 25mg bid:;   Drug: Dipyridamole 200 mg bid;   Drug: Aspirin 25 mg bid
Sponsors:   University of Pennsylvania;   Boehringer Ingelheim
Terminated

Thu, 21 May 2009 12:00:00 EDT

Pathways of Eicosanoid Metabolism

Condition:   Metabolism of Prostaglandin D2
Interventions:   Dietary Supplement: niacin;   Drug: aspirin;   Other: PGD2
Sponsors:   Vanderbilt University;   Vanderbilt University Medical Center
Enrolling by invitation

Thu, 09 Jul 2020 12:00:00 EDT

Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis

Conditions:   Carotid Artery Stenosis;   Atherosclerosis;   Stroke
Interventions:   Procedure: Carotid Endarterectomy;   Drug: atorvastatin, aspirin, losartan, amlodipine
Sponsor:   Russian Cardiology Research and Production Center
Terminated

Tue, 09 Dec 2008 12:00:00 EST

S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: indobufen;   Drug: aspirin
Sponsor:   Pfizer
Completed

Wed, 26 Oct 2005 12:00:00 EDT

Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation

Condition:   Cardio-cerebrovascular Disease
Interventions:   Drug: Low-dose PPI (Rabeprazole sodium);   Drug: High-dose PPI (Rabeprazole sodium);   Drug: Non-PPI (Gefarnate)
Sponsors:   Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan;   Gastro-Intestinal Medical Care Research Center
Completed

Mon, 18 Jan 2010 12:00:00 EST

The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma

Condition:   Venous Thromboembolism
Interventions:   Drug: Dalteparin sodium;   Drug: Dalteparin sodium/aspirin
Sponsors:   Denver Health and Hospital Authority;   Eisai Inc.
Completed

Fri, 15 Jan 2010 12:00:00 EST

The Bochum Optimizing Clopidogrel-Aspirin Therapy and MORTality Study (BOCLA-Mort)

Condition:   Coronary Artery Disease
Intervention:  
Sponsor:   Ruhr University of Bochum
Completed

Fri, 22 Feb 2013 12:00:00 EST

Optimization of Postpartum Thromboprophylaxis

Condition:   Venous Thromboembolism
Interventions:   Drug: Prophylactic low molecular weight heparin;   Drug: Low molecular weight heparin and low-dose aspirin
Sponsor:   Mount Sinai Hospital, Canada
Active, not recruiting

Tue, 28 Sep 2021 12:00:00 EDT

Sildenafil Citrate Added to Low Molecular Weight Heparin and Low Dose Aspirin in High-risk Pregnancy

Condition:   High Risk Pregnancy
Intervention:   Drug: Sildenafil
Sponsor:   Fayoum University Hospital
Recruiting

Tue, 01 Oct 2019 12:00:00 EDT

The Safety and Efficacy of RIC on Adult Moyamoya Disease

Condition:   Moyamoya Disease
Interventions:   Device: RIC;   Drug: Aspirin
Sponsor:   Capital Medical University
Completed

Tue, 09 Jul 2019 12:00:00 EDT

Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese Patients

Condition:   Coronary Disease
Intervention:   Other: Blood samples will be taken to assess platelet function. There is no change in treatment.
Sponsor:   Chinese University of Hong Kong
Completed

Wed, 28 Apr 2021 12:00:00 EDT

The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users

Condition:   Uncomplicated Peptic Ulcer
Intervention:  
Sponsor:   AstraZeneca
Completed

Wed, 20 Mar 2013 12:00:00 EDT

Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects

Condition:   Acute Coronary Syndrome
Interventions:   Drug: YH14659;   Drug: clopidogrel & aspirin
Sponsor:   Yuhan Corporation
Completed

Fri, 03 Aug 2012 12:00:00 EDT

Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes

Conditions:   Type 2 Diabetes Mellitus;   Hypercholesterolemia
Interventions:   Drug: Atorvastatin;   Drug: Placebo
Sponsor:   University of Roma La Sapienza
Unknown status

Fri, 25 Mar 2011 12:00:00 EDT

Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)

Conditions:   Aspirin Exacerbated Respiratory Disease;   Aspirin-Sensitive Asthma;   Nasal Polyps
Intervention:  
Sponsors:   National Jewish Health;   The Scripps Research Institute
Suspended

Mon, 10 Feb 2020 12:00:00 EST

Inducing Immune Quiescence to Prevent HIV Infection in Women

Condition:   HIV
Interventions:   Drug: Acetylsalicylic Acid (ASA);   Drug: Hydroxychloroquine (HCQ)
Sponsors:   University of Manitoba;   University of Nairobi
Completed

Wed, 05 Mar 2014 12:00:00 EST

Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

Conditions:   Gastric Ulcer;   Duodenal Ulcer
Intervention:   Other: No Intervention
Sponsor:   Eisai Co., Ltd.
Completed

Wed, 22 Apr 2015 12:00:00 EDT

The Clinical Benefit and Risk of Oral Aspirin for Unruptured Intracranial Aneurysm Combined With Cerebral Ischemia

Conditions:   Intracranial Aneurysm;   Cerebral Ischemia
Intervention:  
Sponsors:   Beijing Tiantan Hospital;   Xuanwu Hospital, Beijing;   Beijing Chao Yang Hospital;   Beijing Friendship Hospital;   The Second Hospital of Hebei Medical University;   Tianjin Medical University General Hospital;   Tianjin Huanhu Hospital
Unknown status

Wed, 27 Jul 2016 12:00:00 EDT

Influence of Vorapaxar on Thrombin Generation and Coagulability

Conditions:   Coronary Artery Disease;   Peripheral Vascular Disease;   Myocardial Infarction
Interventions:   Drug: Vorapaxar;   Drug: Vorapaxar and Aspirin;   Drug: Vorapaxar and Clopidogrel;   Drug: Vorapaxar, Aspirin, and Clopidogrel
Sponsors:   Inova Health Care Services;   Merck Sharp & Dohme Corp.
Completed

Sun, 02 Jul 2017 12:00:00 EDT

Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents

Condition:   Ischemic Heart Disease
Interventions:   Drug: 6-month dual anti-platelet therapy;   Drug: 12-month dual anti-platelet therapy;   Device: Zotarolimus eluting stent;   Device: Biolimus eluting stent
Sponsor:   Gangnam Severance Hospital
Completed

Fri, 17 Feb 2017 12:00:00 EST

Natural Language Processing and Quality Assessment in Primary Care

Condition:   Diabetes
Interventions:   Other: Brochure: Care of the Feet for Those at Risk;   Other: Quality Survey: foot exam, tobacco and aspirin use
Sponsor:   Mayo Clinic
Completed

Wed, 02 Dec 2009 12:00:00 EST

Challenge Test for Acetylsalicylic Acid Hypersensitivity

Conditions:   Asthma Aspirin-sensitive;   ASA Intolerant Asthma;   Asthma, Aspirin-Induced;   Asthma, Nasal Polyps, and Aspirin Intolerance
Interventions:   Drug: Acetylsalicylate;   Drug: Isotonic NaCl
Sponsors:   Helse Stavanger HF;   University Hospital, Akershus
Unknown status

Mon, 10 Sep 2012 12:00:00 EDT

Retinal Blood Flow and Microthrombi in Type 1 Diabetes

Conditions:   Diabetes;   Diabetic Retinopathy
Interventions:   Drug: aspirin;   Drug: clopidogrel
Sponsor:   Schepens Eye Research Institute
Completed

Mon, 04 Dec 2006 12:00:00 EST

Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin

Conditions:   Respiratory Tract Infections;   Fever
Interventions:   Drug: Acetylsalicylic acid (Aspirin, BAYE4465);   Drug: Paracetamol;   Drug: Placebo
Sponsor:   Bayer
Completed

Fri, 04 Nov 2011 12:00:00 EDT

Prevention of Recurrent Ulcer Bleeding in High-risk Users of Low-dose Aspirin

Condition:   Ulcer Hemorrhage
Intervention:  
Sponsor:   Chinese University of Hong Kong
Completed

Wed, 19 Jan 2011 12:00:00 EST

Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease

Conditions:   Stable Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions:   Drug: Berberine;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Statin
Sponsor:   Peking Union Medical College Hospital
Active, not recruiting

Tue, 16 Jun 2020 12:00:00 EDT

Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)

Conditions:   Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction
Interventions:   Drug: Vorapaxar;   Drug: Placebo;   Drug: Aspirin;   Drug: Clopidogrel
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Mon, 26 May 2008 12:00:00 EDT

Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism

Conditions:   Coronary Artery Stenosis;   Maximal Platelet Aggregation;   Late Platelet Aggregation;   High Post-Treatment Platelet Reactivity
Interventions:   Drug: cilostazol;   Drug: clopidogrel;   Drug: aspirin
Sponsor:   Gyeongsang National University Hospital
Unknown status

Fri, 01 May 2009 12:00:00 EDT

Overcome Biochemical Aspirin Resistance Through Cilostazol Combination

Condition:   Cerebral Infarction
Interventions:   Drug: Cilostazol;   Drug: placebo
Sponsors:   Asan Medical Center;   Korea Otsuka Pharmaceutical Co., Ltd.
Completed

Tue, 13 Mar 2007 12:00:00 EDT

Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)

Condition:   Cerebral Infarction
Interventions:   Drug: Vorapaxar 2.5 mg;   Drug: Vorapaxar 1 mg;   Drug: Placebo;   Drug: Aspirin 75-150 mg
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Mon, 26 May 2008 12:00:00 EDT

Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization

Condition:   Aspirin Sensitivity
Interventions:   Drug: Omalizumab;   Drug: placebo
Sponsors:   David Lang;   Genentech, Inc.
Completed

Fri, 09 Nov 2007 12:00:00 EST

Assessment of the Efficacy of the First Aspirin Dose in Children Undergoing Surgery for Congenital Heart Disease (CHD) Who Require Post-operative Antiplatelet Therapy

Condition:   Congenital Heart Disease
Intervention:  
Sponsor:   University of Colorado, Denver
Completed

Mon, 17 Feb 2014 12:00:00 EST

Distal Venous Arterialisation of Ischemic Limb

Condition:   Critical Limb Ischemia
Interventions:   Procedure: distal venous arterialisation;   Drug: Aspirin
Sponsors:   Clinical Centre of Serbia;   University of California, Los Angeles
Unknown status

Thu, 30 Sep 2010 12:00:00 EDT

Endovascular Stenting of Medically Refractory ICASD (Clinical and Sonographic Study)

Condition:   Stroke, Ischemic
Interventions:   Device: Intracranial Stenting by Intracranial Stent Device;   Drug: Optimum medical treatment
Sponsor:   Ain Shams University
Completed

Tue, 19 May 2020 12:00:00 EDT

Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation

Condition:   Percutaneous Transluminal Coronary Angioplasty
Interventions:   Procedure: QCA and Aspirin;   Procedure: QCA and Clopidogrel;   Procedure: Imaging guided and Aspirin;   Procedure: Imaging guided and Clopidogrel
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea
Terminated

Wed, 13 Jul 2016 12:00:00 EDT

Prevention of Recurrent Ulcer Bleeding in High-risk Aspirin Users Who Are Not Infected With Helicobacter Pylori

Condition:   Ulcer Bleeding
Intervention:  
Sponsor:   Chinese University of Hong Kong
Completed

Wed, 12 Jan 2011 12:00:00 EST

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

Condition:   Prevention & Control
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
Sponsors:   Bayer;   Population Health Research Institute;   Janssen Research & Development, LLC
Completed

Mon, 28 Jan 2013 12:00:00 EST

A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders

Condition:   Stable Coronary Artery Disease
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   AstraZeneca
Completed

Tue, 25 Mar 2008 12:00:00 EDT

Study of the AFB and Stenting of the Iliac Arteries

Condition:   Aorta-iliac Segment Lesion (C,D Type by TASC II)
Interventions:   Procedure: Aorta-femoral bypass;   Procedure: Recanalization and stenting of aorta-iliac segment;   Drug: Therapy: aspirin and clopidogrel
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Active, not recruiting

Tue, 05 Aug 2014 12:00:00 EDT

Anticoagulant Therapy During Pacemaker Implantation

Conditions:   Hemorrhage;   Thrombosis;   Embolism
Interventions:   Drug: Warfarin;   Drug: Aspirin;   Device: Permanent pacemaker;   Device: Implantable Cardioverter-defibrillator
Sponsors:   University of Turku;   Satakunta Central Hospital;   Oulu University Hospital;   Tampere University Hospital
Completed

Mon, 28 May 2007 12:00:00 EDT

One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease

Condition:   Ischemic Heart Disease
Intervention:   Drug: Aspirin, Atorvastatin, Perindopril
Sponsor:   University of Roma La Sapienza
Not yet recruiting

Mon, 04 Nov 2019 12:00:00 EST

Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

Condition:   Persistent or Permanent Non-valvular Atrial Fibrillation
Interventions:   Drug: AZD0837;   Drug: Aspirin
Sponsor:   AstraZeneca
Completed

Tue, 26 Feb 2008 12:00:00 EST

Gefitinib Combined With Thalidomide to Treat NSCLC

Condition:   NSCLC
Interventions:   Drug: Thalidomide;   Drug: placebo;   Drug: Gefitinib;   Drug: Aspirin
Sponsor:   Bai Jun
Unknown status

Thu, 12 Mar 2015 12:00:00 EDT

Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors

Condition:   Soft Tissue Neoplasms
Interventions:   Device: MRgHIFU;   Drug: Aspirin;   Drug: Enoxaparin
Sponsor:   Pejman Ghanouni
Terminated

Thu, 17 Oct 2013 12:00:00 EDT

Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention

Conditions:   Coronary Artery Disease;   Diabetes Mellitus, Type 2
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Aspirin
Sponsor:   Peking Union Medical College Hospital
Completed

Fri, 22 Apr 2016 12:00:00 EDT

The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency

Condition:   Coronary Artery Disease
Interventions:   Drug: Aspirin;   Drug: Tirofiban;   Drug: Clopidogrel;   Drug: Prasugrel
Sponsor:   Prince Sultan Cardiac Center, Adult Cardiology Department.
Unknown status

Tue, 15 May 2012 12:00:00 EDT

Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study

Conditions:   Disease Free Survival;   Overall Survival;   Pancreatic Cancer
Intervention:   Behavioral: use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins
Sponsor:   Massimo Falconi
Recruiting

Wed, 29 Jan 2020 12:00:00 EST

Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin

Condition:   Prevention
Interventions:   Drug: Esomeprazole;   Drug: Placebo
Sponsor:   AstraZeneca
Completed

Wed, 17 Feb 2010 12:00:00 EST

Alcohol Inhibits Drug Metabolism by Carboxylesterases

Condition:   Drug Interactions
Interventions:   Drug: Placebo;   Drug: Ethanol;   Drug: Oseltamivir;   Drug: Aspirin
Sponsor:   University of Tennessee
Completed

Tue, 16 Oct 2012 12:00:00 EDT

Low Dose Aspirin Studied With the AggreGuide

Condition:   Platelet Aggregation
Intervention:  
Sponsor:   Edward R. Teitel, M.D.
Completed

Wed, 23 May 2012 12:00:00 EDT

Safety of Cold Snare Polypectomy in Patients With Uninterrupted Antiplatelet Agent

Condition:   Post Polypectomy Bleeding
Intervention:   Procedure: cold snare polypectomy
Sponsors:   Incheon St.Mary's Hospital;   Seoul Hospital, Soonchunhyang University;   St. Vincent's Hospital-Manhattan;   Uijeongbu St. Mary's Hospital, The Catholic University of Korea;   Soonchunhyang University Cheonan Hospital;   Bucheon St. Mary's Hospital;   Eunpyeong St. Mary's Hospital, The Catholic University of Korea;   Soonchunhyang University Hospital;   Gangneung Asan Hospital;   Kyemyoung University Dongsan Medical Center
Recruiting

Wed, 01 Apr 2020 12:00:00 EDT

A Phase III Study of Apixaban in Patients With Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: Apixaban;   Drug: Acetylsalicylic acid
Sponsors:   Bristol-Myers Squibb;   Pfizer
Completed

Wed, 04 Jul 2007 12:00:00 EDT

Chlorthalidone and HCTZ Impacts on Platelet Activation

Condition:   Hypertension
Interventions:   Drug: Chlorthalidone 12.5 mg;   Drug: Hydrochlorothiazide 25 mg;   Drug: Aspirin 81 mg
Sponsors:   Creighton University;   Dialysis Clinic, Inc.
Unknown status

Tue, 01 Apr 2014 12:00:00 EDT

Helicobacter Eradication Aspirin Trial

Conditions:   Gastrointestinal Ulcer Haemorrhage;   Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions:   Drug: Lansoprazole 30mg, Clarithromycin 500mg, Metronidazole 400mg;   Drug: Placebo lansoprazole 30mg, clarithromycin 500mg, metronidazole 400mg
Sponsors:   University of Nottingham;   Nottingham University Hospitals NHS Trust;   University of Southampton;   University of Durham;   University of Birmingham;   University of Oxford;   Queen's University, Belfast
Active, not recruiting

Tue, 10 Jan 2012 12:00:00 EST

Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease

Conditions:   Chronic Rhinosinusitis;   Aspirin Exacerbated Respiratory Disease;   Asthma;   Aspirin Sensitivity
Interventions:   Behavioral: Low salicylate diet;   Behavioral: Normal Diet
Sponsor:   Lawson Health Research Institute
Completed

Tue, 29 Jan 2013 12:00:00 EST

A Healthy Female and Male Volunteers Aspirin Study

Condition:   Healthy
Interventions:   Drug: Capsule ASA 81mg/esomeprazole 20mg;   Drug: Acetylsalicylzuur Apotex Cardio
Sponsor:   AstraZeneca
Completed

Fri, 07 Oct 2011 12:00:00 EDT

Alternate Dosing Regimens of BG00012 in Healthy Volunteers

Condition:   Healthy
Interventions:   Drug: Dimethyl Fumarate (BG00012);   Drug: Aspirin;   Drug: BG00012 matching placebo;   Drug: ASA matching placebo
Sponsor:   Biogen
Completed

Fri, 21 Jan 2011 12:00:00 EST

Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia

Conditions:   Aspirin;   Dyspepsia
Interventions:   Drug: esomeprazole;   Drug: Famotidine
Sponsors:   Ruttonjee Hospital;   Queen Mary Hospital, Hong Kong
Unknown status

Wed, 16 Sep 2009 12:00:00 EDT

Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty

Condition:   Primary Total Hip and Knee Arthroplasty
Interventions:   Drug: Arixtra;   Device: Pneumatic compression stockings;   Drug: Aspirin
Sponsors:   LifeBridge Health;   Haemonetics Corporation
Completed

Tue, 12 Mar 2013 12:00:00 EDT

The Benefit of Add On DLBS1033 for Ischemic Stroke Patient

Condition:   Ischemic Stroke
Interventions:   Drug: DLBS1033;   Drug: Aspirin;   Drug: Statin;   Drug: Vit B12
Sponsors:   Duta Wacana Christian University;   Dexa Laboratories Of Biomolecular Science
Recruiting

Thu, 11 Jun 2020 12:00:00 EDT

Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.

Condition:   Myocardial Infarction
Interventions:   Drug: FDC;   Drug: Separately drugs, simvastatin, aspirin and ramipril
Sponsors:   Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III;   Mario Negri Institute for Pharmacological Research;   Rusculleda Foundation Instituto DAMIC;   Fundacion Clinic per a la Recerca Biomédica;   ARTTIC International Management Services;   Federación Argentina de Cardiología FAC;   World Health Organization;   Instituto de Salud Carlos III;   Ferrer Internacional S.A.
Completed

Wed, 23 Mar 2011 12:00:00 EDT

A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Clopidogrel;   Drug: Prasugrel;   Drug: Commercially-available Aspirin
Sponsors:   Eli Lilly and Company;   Daiichi Sankyo Co., Ltd.;   Duke Clinical Research Institute
Completed

Wed, 18 Jun 2008 12:00:00 EDT

Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study

Condition:   Human Immunodeficiency Virus
Interventions:   Drug: Aspirin;   Drug: Atorvastatin
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Fri, 07 Mar 2014 12:00:00 EST

Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease

Condition:   COPD
Intervention:   Drug: Acetylsalicylic acid
Sponsor:   Medical University of Vienna
Unknown status

Mon, 04 Apr 2011 12:00:00 EDT

COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer

Conditions:   Breast Cancer;   Estrogen Receptor-positive Breast Cancer
Interventions:   Drug: Aspirin;   Drug: Tamoxifen Pill;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Paclitaxel
Sponsor:   University of Virginia
Recruiting

Tue, 30 Jul 2019 12:00:00 EDT

Characterisation of Nasal Polyps in Patients With and Without Aspirin-exacerbated Respiratory Disease

Condition:   Polyp Sinus
Intervention:   Other: biopsy
Sponsors:   Medical University of Vienna;   AstraZeneca
Completed

Wed, 20 Feb 2019 12:00:00 EST

Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism

Condition:   Myocardial Infarction
Interventions:   Drug: cilostazol;   Drug: clopidogrel (Plavix);   Genetic: CYP2C19;   Drug: aspirin (Acetylsalicylic acid)
Sponsor:   Gyeongsang National University Hospital
Completed

Mon, 08 Jun 2009 12:00:00 EDT

Secondary Prevention of Small Subcortical Strokes Trial

Conditions:   Cerebrovascular Accident;   Hypertension
Interventions:   Drug: aspirin;   Drug: clopidogrel;   Other: Target of Blood Pressure;   Other: placebo
Sponsors:   University of British Columbia;   National Institute of Neurological Disorders and Stroke (NINDS)
Completed

Thu, 24 Apr 2003 12:00:00 EDT

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Condition:   COVID-19
Interventions:   Drug: Apixaban 2.5 MG;   Drug: Apixaban 5MG;   Drug: Aspirin;   Drug: Placebo
Sponsors:   Frank C Sciurba;   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting

Tue, 04 Aug 2020 12:00:00 EDT

Mechanisms of Action of Acetaminophen

Conditions:   Myocardial Infarction;   Arthritis
Interventions:   Drug: Aspirin First;   Drug: Aspirin Last;   Drug: Acetaminophen 1000 mg/d;   Drug: Acetaminophen 4000 mg/d;   Drug: Ibuprofen 800 mg/d
Sponsor:   University of Pennsylvania
Completed

Mon, 31 Mar 2008 12:00:00 EDT

Intensive Medical Therapy for High-risk Intracranial or Extracranial Arterial Stenosis

Conditions:   Acute Stroke;   Transient Ischemic Attack
Interventions:   Drug: Intensive antiplatelet;   Drug: Standard antiplatelet;   Drug: Immediate high-intensity statin;   Drug: Delayed high-intensity statin
Sponsors:   Beijing Tiantan Hospital;   Ministry of Science and Technology of the People's Republic of China
Recruiting

Fri, 17 Aug 2018 12:00:00 EDT

Mildronate for Acute Ischemic Stroke

Condition:   Acute Ischemic Stroke
Interventions:   Drug: mildronate injection;   Drug: cinepazide maleate injection;   Drug: aspirin
Sponsor:   Xijing Hospital
Completed

Fri, 12 Apr 2013 12:00:00 EDT

Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients

Condition:   Coronary Heart Disease
Interventions:   Drug: Clopidogrel 75mg;   Drug: Clopidogrel 150mg;   Drug: Aspirin 100mg;   Drug: Cilostazol 100mg
Sponsors:   Chinese Academy of Medical Sciences, Fuwai Hospital;   Beijing Municipal Health Bureau;   Haemonetics Corporation;   Zhejiang Otsuka Pharmaceutical Co., Ltd.
Completed

Wed, 30 Jan 2013 12:00:00 EST

A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke

Conditions:   Stroke, Acute;   Neurological Impairment
Interventions:   Drug: EGb761;   Drug: Placebo;   Drug: Acetylsalicylic acid
Sponsor:   Ipsen
Completed

Fri, 13 Jan 2006 12:00:00 EST

PROMUS Element Plus US Post-Approval Study

Condition:   Coronary Artery Disease
Interventions:   Device: PROMUS Element Plus Coronary Stent System;   Drug: Aspirin;   Drug: P2Y12 antagonist
Sponsor:   Boston Scientific Corporation
Completed

Wed, 02 May 2012 12:00:00 EDT

A Project to Improve the Diagnosis and Prognosis of Myocardial Injury Associated to Non Cardiac Surgery

Condition:   Myocardium; Injury
Interventions:   Diagnostic Test: Troponin;   Drug: Acetylsalicylic acid;   Drug: Statin
Sponsor:   Parc de Salut Mar
Active, not recruiting

Fri, 28 Apr 2017 12:00:00 EDT

Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan

Conditions:   Platelet Aggregation;   Coronary Artery Disease
Intervention:  
Sponsor:   Accriva Diagnostics
Active, not recruiting

Mon, 06 Aug 2018 12:00:00 EDT

A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers

Conditions:   Stomach Ulcer;   Duodenal Ulcer
Interventions:   Drug: Lansoprazole;   Drug: Gefarnate
Sponsor:   Takeda
Terminated

Tue, 30 Sep 2008 12:00:00 EDT

Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).

Conditions:   Atrial Fibrillation;   Device Related Thrombus;   Left Atrial Appendage Thrombosis;   Watchman LAA Closure Device
Intervention:   Drug: Dabigatran Etexilate Oral Capsule
Sponsors:   Vanderbilt University Medical Center;   Boehringer Ingelheim
Active, not recruiting

Tue, 29 May 2018 12:00:00 EDT

A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure

Conditions:   Non-Valvular Atrial Fibrillation;   Left Atrial Appendage Closure
Interventions:   Drug: Edoxaban;   Device: WATCHMAN LAA Closure;   Drug: Aspirin and Clopidogrel;   Drug: Aspirin and Warfarin
Sponsors:   Scripps Health;   Daiichi Sankyo, Inc.
Unknown status

Thu, 23 Mar 2017 12:00:00 EDT

Thrombectomy In TANdem Occlusion

Conditions:   Carotid Artery Diseases;   Thrombectomy;   Tandem Occlusion;   Stroke
Interventions:   Device: Carotid Stenting;   Drug: Procedural Aspirin;   Drug: Dual dual antiplatelet therapy after 24-hours imaging follow-up;   Procedure: Intracranial thrombectomy
Sponsor:   Central Hospital, Nancy, France
Recruiting

Fri, 07 Jun 2019 12:00:00 EDT

Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection

Conditions:   Cirrhosis;   Hypertension;   Status;Splenectomy;   Venous Thrombosis
Interventions:   Drug: Warfarin;   Drug: Dipyridamole;   Drug: Aspirin;   Drug: Low Molecular Weight Heparin
Sponsor:   Yangzhou University
Completed

Thu, 25 Sep 2014 12:00:00 EDT

Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy

Conditions:   Cirrhosis;   Hypertension;   Venous Thrombosis;   Status; Splenectomy
Interventions:   Drug: Warfarin;   Drug: Dipyridamole;   Drug: Aspirin;   Drug: Low Molecular Weight Heparin
Sponsor:   Yangzhou University
Unknown status

Fri, 12 Sep 2014 12:00:00 EDT

Low-dose Acetylsalicylic Acid Before Non-cardiac Surgery

Conditions:   Surgery;   Platelet Dysfunction
Intervention:   Other: preoperative questionnaires
Sponsor:   Universitätsklinikum Hamburg-Eppendorf
Completed

Fri, 10 Feb 2017 12:00:00 EST

SAPT Versus DAPT in Incomplete Revascularization After CABG

Condition:   Coronary Artery Disease
Interventions:   Drug: Ticagrelor;   Drug: acetylsalicylic acid
Sponsor:   Campus Bio-Medico University
Recruiting

Mon, 31 Dec 2018 12:00:00 EST

Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease

Condition:   Aspirin Exacerbated Respiratory Disease (AERD)
Interventions:   Drug: Ifetroban, Oral Capsule;   Drug: Placebo, Oral Capsule
Sponsor:   Cumberland Pharmaceuticals
Completed

Wed, 13 Aug 2014 12:00:00 EDT

Cross-over Study of Coronary Risk Factors With a Polypill

Condition:   Coronary Artery Disease
Interventions:   Drug: Polypill of acetylsalicylic acid, ramipril and atorvastatin;   Drug: Drugs taken separately: acetylsalicylic acid, ramipril and atorvastatin
Sponsor:   Fundación para la Investigación Biosanitaria del Principado de Asturias
Not yet recruiting

Wed, 01 Sep 2021 12:00:00 EDT

Aspirin Response in High Risk Patients With Coronary Artery Disease

Conditions:   Coronary Artery Disease;   Myocardial Infarction;   Diabetes Mellitus;   Renal Insufficiency, Chronic
Intervention:  
Sponsors:   University of Aarhus;   Aarhus University Hospital Skejby;   Danish Heart Foundation
Unknown status

Tue, 28 Jun 2011 12:00:00 EDT

Paediatric Arteriopathy Steroid Aspirin Project

Condition:   Arterial Ischemic Stroke
Intervention:   Drug: Methylprednisolone + prednisolone
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Ministry of Health, France
Not yet recruiting

Tue, 15 Aug 2017 12:00:00 EDT

Efficacy of Ticagrelor Plus Aspirin in Minor Non-cardioembolic Ischemic Stroke

Conditions:   Ischemic Stroke;   Transient Ischemic Attack
Interventions:   Drug: Ticagrelor 90mg;   Drug: Clopidogrel 75 mg
Sponsor:   Mazandaran University of Medical Sciences
Recruiting

Thu, 04 Feb 2021 12:00:00 EST

Thrombolysis of Urokinase for Minor Stroke

Condition:   Minor Stroke
Interventions:   Drug: Urokinase thrombolysis;   Drug: Aspirin;Clopidogrel
Sponsors:   The First Affiliated Hospital of Zhengzhou University;   Beijing Tiantan Hospital;   Shanghai 10th People's Hospital;   General Hospital of Shenyang Military Region
Not yet recruiting

Tue, 09 Jun 2020 12:00:00 EDT

Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions

Condition:   Ulcers, Duodenal and Gastric
Interventions:   Drug: Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one;   Drug: Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two;   Drug: ASA 100 mg tablet;   Drug: Pantoprazole 20 mg gastro-resistant tablet
Sponsors:   GlaxoSmithKline;   Piramal Clinical Research (Hyderabad, India)
Completed

Mon, 06 May 2013 12:00:00 EDT

Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor

Condition:   Myocardial Infarction
Interventions:   Drug: Prasugrel;   Drug: Vorapaxar;   Drug: Aspirin;   Drug: Ticagrelor
Sponsors:   University of Florida;   Merck Sharp & Dohme Corp.
Completed

Thu, 10 Sep 2015 12:00:00 EDT

Effect of Herbal Products on Platelet Function and Clotting

Condition:   Platelet Function Test
Interventions:   Drug: Curcuma longa;   Drug: Angelica sinensis;   Drug: Siwu Tang;   Drug: Aspirin
Sponsors:   Singapore General Hospital;   Singhealth Foundation
Completed

Wed, 11 Dec 2013 12:00:00 EST

Ticagrelor in Human Endotoxemia Response to Human Endotoxemia

Condition:   Endotoxemia
Interventions:   Drug: ticagrelor;   Drug: Clopidogrel;   Drug: Acetylsalicylic acid lysinate;   Drug: Placebo
Sponsor:   Radboud University
Completed

Mon, 23 Nov 2015 12:00:00 EST

Recurrent Carotid Stenosis

Conditions:   Cardiovascular Diseases;   Carotid Stenosis;   Cerebrovascular Disorders;   Heart Diseases;   Vascular Diseases
Interventions:   Drug: aspirin;   Drug: dipyridamole
Sponsors:   Emory University;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 28 Oct 1999 12:00:00 EDT

Physicians' Health Study

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia
Interventions:   Drug: aspirin;   Drug: carotene
Sponsors:   Brigham and Women's Hospital;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 28 Oct 1999 12:00:00 EDT

Platelet Drug Trial in Coronary Disease Progression

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia
Interventions:   Drug: aspirin;   Drug: dipyridamole
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 28 Oct 1999 12:00:00 EDT

ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA

Condition:   Upper Gastrointestinal Bleeding
Interventions:   Drug: Rabeprazole;   Drug: Famotidine
Sponsor:   Chinese University of Hong Kong
Completed

Wed, 03 Aug 2011 12:00:00 EDT

High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)

Conditions:   ASA Triad;   Asthma, Nasal Polyps, And Aspirin Intolerance
Intervention:   Behavioral: Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams
Sponsor:   Brigham and Women's Hospital
Completed

Mon, 17 Feb 2014 12:00:00 EST

Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

Condition:   Stroke
Interventions:   Drug: Aspirin / Clopidogrel, Atorvastatin / Simvastatin;   Drug: Asprin / Clopidogrel, Atorvastatin / Simvastatin
Sponsor:   Peking Union Medical College Hospital
Completed

Wed, 23 Apr 2008 12:00:00 EDT

Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor

Conditions:   Peptic Ulcer;   Ulcer Complications
Interventions:   Drug: lansoprazole;   Drug: aluminum hydroxide 334 mg and Mg hydroxide 166 mg
Sponsor:   Taipei Veterans General Hospital, Taiwan
Unknown status

Tue, 03 Mar 2009 12:00:00 EST

Acute Coronary Syndrome Sri Lanka Audit Project

Conditions:   Acute Coronary Syndrome;   Unstable Angina;   Non ST Elevation Myocardial Infarction;   ST Elevation Myocardial Infarction
Intervention:   Drug: aspirin, clopidogrel, statin, enoxaparin, streptokinase
Sponsors:   University of Colombo;   Ministry of Health, Sri Lanka
Withdrawn

Thu, 08 Sep 2016 12:00:00 EDT

Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

Condition:   Gastric or Duodenal Ulcers Caused by Low-dose Aspirin
Interventions:   Drug: E3810;   Drug: Teprenone
Sponsor:   Eisai Co., Ltd.
Completed

Tue, 19 Jul 2011 12:00:00 EDT

Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

Condition:   Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin
Intervention:   Drug: Rabeprazole
Sponsor:   Eisai Co., Ltd.
Completed

Wed, 20 Jul 2011 12:00:00 EDT

Perioperative Aspirin Usage Survey

Conditions:   Surgery;   Cardiovascular Disease
Intervention:   Behavioral: Survey
Sponsor:   University of New Mexico
Completed

Mon, 28 Sep 2015 12:00:00 EDT

Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP)

Condition:   Chronic Myeloid Leukemia, Chronic Phase
Interventions:   Drug: Ponatinib 15 MG;   Drug: Acetylsalicylic acid 100 MG
Sponsors:   Fundacion CRIS de Investigación para Vencer el Cáncer;   Incyte Biosciences UK;   Apices Soluciones S.L.
Recruiting

Wed, 13 Nov 2019 12:00:00 EST

Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs

Conditions:   Chronic Arthritis;   Ischemic Heart Disease;   Atrial Fibrillation;   Anemia;   Bleeding
Interventions:   Drug: Misoprostol;   Drug: Placebo
Sponsor:   NHS Greater Glasgow and Clyde
Completed

Tue, 29 Jul 2014 12:00:00 EDT

Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion

Condition:   Peptic Ulcer/Erosions
Intervention:   Drug: pantoprazole vs famotidine
Sponsor:   Ruttonjee Hospital
Completed

Fri, 13 Feb 2009 12:00:00 EST

High-Shear Microfluidic Thrombosis Assay

Condition:   Coagulation Defects, Other and Unspecified
Intervention:  
Sponsor:   Emory University
Completed

Tue, 21 Apr 2015 12:00:00 EDT

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Condition:   Diabetic Nephropathies
Interventions:   Drug: SGLT2 inhibitor;   Drug: ACE inhibitor
Sponsor:   Nahla H Tohami
Recruiting

Fri, 29 Jun 2018 12:00:00 EDT

Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

Conditions:   Acute Coronary Syndrome;   Percutaneous Coronary Intervention
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Acetylsalicylic acid ASA
Sponsor:   AstraZeneca
Completed

Fri, 11 Feb 2011 12:00:00 EST

Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin

Conditions:   Acute Coronary Syndrome;   Acute Myocardial Infarction
Interventions:   Drug: esomeprazole 20 mg daily;   Drug: famotidine 40 mg daily
Sponsor:   Ruttonjee Hospital
Completed

Thu, 04 Feb 2010 12:00:00 EST

Anticoagulation in Stent Intervention

Conditions:   Atrial Fibrillation;   Stroke
Interventions:   Drug: Acetylsalicylic Acid + clopidogrel + acenocoumarol;   Drug: Acetylsalicylic Acid + clopidogrel
Sponsor:   Hospital Universitari Vall d'Hebron Research Institute
Unknown status

Thu, 10 Jun 2010 12:00:00 EDT

"Normal Coronary Artery" With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up

Condition:   Coronary Angiography
Interventions:   Drug: Statin, aspirin;   Drug: Dipyridamole
Sponsor:   Hillel Yaffe Medical Center
Unknown status

Tue, 18 Aug 2009 12:00:00 EDT

Prophylactic Anticoagulation for Catheter-related Thrombosis

Conditions:   Venous Thrombosis Due to Central Venous Access Device (Disorder);   Prophylactic Anticoagulation;   Patients With Tumor
Interventions:   Drug: Rivaroxaban 10mg;   Drug: Aspirin 100mg;   Drug: low molecule heparin
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting

Wed, 05 Feb 2020 12:00:00 EST

Efficacy and Safety of Mildronate for Acute Ischemic Stroke

Condition:   Acute Ischemic Stroke
Interventions:   Drug: infusion of mildronate;   Drug: placebo;   Drug: aspirin
Sponsor:   Xijing Hospital
Unknown status

Wed, 27 Feb 2013 12:00:00 EST

The Standardized Management of Hypertension in Rural Shaanxi

Condition:   Hypertension
Intervention:   Drug: Hydrochlorothiazide, Captopril, Nitrendipine, Aspirin
Sponsor:   First Affiliated Hospital Xi'an Jiaotong University
Completed

Fri, 01 May 2020 12:00:00 EDT

Polypectomy in Patients Taking Dual Antiplatelet Agents

Condition:   Colonic Polyps
Interventions:   Drug: Continue thienopyridine;   Drug: Discontinue thienopyridine
Sponsor:   Incheon St.Mary's Hospital
Unknown status

Mon, 15 Aug 2016 12:00:00 EDT

Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers

Condition:   Healthy
Interventions:   Drug: Aggrenox;   Drug: Persantin Retard;   Drug: Acetylsalicylic acid
Sponsor:   Boehringer Ingelheim
Completed

Wed, 27 Aug 2014 12:00:00 EDT

Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine

Conditions:   PFO - Patent Foramen Ovale;   Migraine
Interventions:   Device: PFO closure device;   Drug: Aspirin and clopidogrel;   Drug: Triptans
Sponsor:   Guangdong Provincial People's Hospital
Not yet recruiting

Thu, 01 Jul 2021 12:00:00 EDT

Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)

Condition:   Ischemic Stroke
Interventions:   Drug: Aspirin;   Drug: tinzaparin sodium;   Drug: eptifibatide
Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
Completed

Mon, 26 May 2003 12:00:00 EDT

Appropriateness of Aspirin Use in Medical Outpatients

Condition:   Primary Prevention of Cardiovascular Diseases
Intervention:   Other: Non-interventional study
Sponsor:   Muğla Sıtkı Koçman University
Unknown status

Tue, 02 Jan 2018 12:00:00 EST

Pharmacodynamic Study of Cilostazol in Healthy Volunteers

Condition:   Healthy
Interventions:   Drug: Cilostazol;   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsor:   Otsuka Pharmaceutical Co., Ltd.
Completed

Fri, 18 Sep 2015 12:00:00 EDT

Dupilumab for Aspirin-exacerbated Respiratory Disease

Condition:   Aspirin-exacerbated Respiratory Disease
Intervention:   Drug: Dupilumab
Sponsor:   Rochester General Hospital
Completed

Mon, 23 Jul 2018 12:00:00 EDT

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Conditions:   Stable Coronary Syndrome;   Percutaneous Coronary Intervention;   Antiplatelet Therapy;   Ticagrelor
Interventions:   Drug: Ticagrelor 60mg;   Drug: Clopidogrel 75mg;   Drug: Aspirin 81 mg
Sponsor:   Ottawa Heart Institute Research Corporation
Terminated

Fri, 21 Jul 2017 12:00:00 EDT

PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study

Conditions:   Brain Ischemia;   Intracranial Hemorrhages
Interventions:   Drug: cilostazol;   Drug: Probucol;   Drug: Aspirin;   Drug: placebo of cilostazol;   Drug: Placebo of aspirin;   Device: Intima-medial thickness
Sponsors:   Asan Medical Center;   Korea Otsuka Pharmaceutical Co., Ltd.
Unknown status

Fri, 26 Jun 2015 12:00:00 EDT

Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy

Conditions:   Coronary Artery Disease;   Acute Coronary Syndrome
Interventions:   Drug: Aspirin and clopidogrel / Prasugrel;   Device: VerifyNow;   Drug: Aspirin
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Allies in Cardiovascular Trials Initiatives and Organized;   Institut National de la Santé Et de la Recherche Médicale, France;   Sanofi;   Bristol-Myers Squibb;   Medtronic;   Cordis Corporation;   Fondation de France;   Diagnostica Stago;   Boston Scientific Corporation
Completed

Thu, 22 Jan 2009 12:00:00 EST

Effect of Dupilumab on Aspirin Intolerance

Condition:   AERD - Aspirin Exacerbated Respiratory Disease
Intervention:   Drug: Dupilumab
Sponsor:   Medical University of Vienna
Recruiting

Mon, 22 Jun 2020 12:00:00 EDT

Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban

Conditions:   Nasal Polyps;   Asthma, Aspirin-Induced;   Aspirin-exacerbated Respiratory Disease;   Aspirin-Sensitive Asthma With Nasal Polyps
Interventions:   Drug: Ifetroban;   Drug: Placebo
Sponsor:   Brigham and Women's Hospital
Recruiting

Mon, 30 Oct 2017 12:00:00 EDT

Aspirin Resistance and Sleep Apnea in Type-2 Diabetic Patients

Conditions:   Atherothrombosis;   Type 2 Diabetes;   Obstructive Sleep Apnea Syndrome
Intervention:   Device: CPAP
Sponsor:   University Hospital, Grenoble
Terminated

Mon, 11 Feb 2013 12:00:00 EST

Warfarin and Antiplatelet Therapy in Chronic Heart Failure

Condition:   Heart Failure
Interventions:   Drug: Warfarin titrated to an INR of 2.5-3.0;   Drug: Aspirin;   Drug: Clopidogrel 75
Sponsors:   US Department of Veterans Affairs;   Sanofi-Synthelabo;   Bristol-Myers Squibb
Completed

Mon, 01 Jan 2001 12:00:00 EST

ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)

Condition:   Stable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease
Interventions:   Device: Coroflex ISAR;   Drug: 3 months DAPT;   Drug: 6 months DAPT
Sponsors:   Ajou University School of Medicine;   B. Braun Korea Co., Ltd.
Unknown status

Fri, 20 Nov 2015 12:00:00 EST

Novel Treatment for Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Drug: Placebo;   Drug: amiloride
Sponsors:   University of Carabobo;   Clinical Research Unit at the Instituto Docente de Urologia;   Northern Metropolitan Hospital;   Venezuelan Foundation of Heart Failure
Unknown status

Tue, 26 Oct 2010 12:00:00 EDT

Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD

Condition:   Cervical Artery Dissection
Interventions:   Drug: Acetylsalicylic acid;   Drug: Vitamin K antagonist
Sponsor:   Stefan Engelter
Completed

Mon, 27 Jan 2014 12:00:00 EST

Mechanisms of Alcohol Sensitivity in AERD

Conditions:   Aspirin-Sensitive Asthma With Nasal Polyps;   Samter's Syndrome
Interventions:   Dietary Supplement: Water;   Dietary Supplement: Red wine;   Dietary Supplement: Polyphenolic Compounds
Sponsor:   University of Virginia
Unknown status

Thu, 22 Feb 2018 12:00:00 EST

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

Conditions:   Atrial Fibrillation;   Antithrombotic Therapy;   Acute Coronary Syndrome;   Percutaneous Coronary Interventions
Interventions:   Drug: Ticagrelor;   Drug: Dabigatran Etexilate;   Drug: Aspirin;   Drug: Clopidogrel
Sponsors:   Medical University of Gdansk;   Medical University of Warsaw;   Nicolaus Copernicus University;   Institute of Cardiology, Warsaw, Poland;   Military Institute of Medicine, Poland;   Bielanski Hospital;   Medical University of Silesia;   Poznan University of Medical Sciences;   University of Opole, Poland;   Medical University of Łódź;   Voivodeship Hospital, Kielce, Poland;   Voivode Specialist Hospital in Olsztyn, Poland;   Medical University of Lublin;   Pomeranian Medical University Szczecin;   Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
Not yet recruiting

Tue, 05 Jan 2021 12:00:00 EST

Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI)

Condition:   Critical Limb Ischemia
Intervention:   Other: Blood draw only
Sponsor:   University of Southern California
Completed

Mon, 24 Mar 2014 12:00:00 EDT

Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer

Condition:   Colorectal Cancer
Interventions:   Drug: nitric oxide-releasing acetylsalicylic acid derivative;   Other: laboratory biomarker analysis;   Procedure: biopsy
Sponsors:   Stony Brook University;   National Cancer Institute (NCI)
Completed

Wed, 31 May 2006 12:00:00 EDT

Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban/Placebo;   Drug: Placebo;   Drug: Rivaroxaban
Sponsors:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.;   Bayer
Completed

Wed, 22 Nov 2006 12:00:00 EST

Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus

Condition:   Diabetes Mellitus
Interventions:   Drug: Abciximab;   Drug: control
Sponsor:   Seoul National University Bundang Hospital
Completed

Mon, 21 Nov 2011 12:00:00 EST

New Topical Treatment for Continued Pain After Shingles

Condition:   Postherpetic Neuralgia
Interventions:   Drug: Epikeia coatings with aspirin;   Drug: Epikeia coatings with lidocaine;   Other: Epikeia coatings alone
Sponsors:   Biomedical Development Corporation;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);   The University of Texas Health Science Center, Houston
Completed

Tue, 04 Dec 2007 12:00:00 EST

Testing a Community Intervention to Increase Aspirin Use

Conditions:   Myocardial Infarction;   Stroke
Interventions:   Other: Mass Media plus clinic intervention.;   Other: Media
Sponsor:   University of Minnesota
Completed

Wed, 18 Nov 2015 12:00:00 EST

Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation

Condition:   Drug-eluting Stent (DES)
Interventions:   Drug: Atorvastatin (High dose statin treatment);   Drug: Pravastatin (High dose statin treatment)
Sponsor:   Yonsei University
Unknown status

Mon, 19 Mar 2012 12:00:00 EDT

Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )

Conditions:   Acute Ischemic Stroke AIS;   Intracranial Atherosclerosis ICAS
Intervention:   Drug: aggressive medical management
Sponsors:   Wei-Hai Xu;   Peking Union Medical College Hospital;   General Hospital of Chinese Armed Police Forces;   General Hospital of Shenyang Military Region;   Subei People's Hospital of Jiangsu Province;   Fujian Medical University Union Hospital;   Tangshan Gongren Hospital;   Third Affiliated Hospital, Sun Yat-Sen University;   Qingdao Municipal Hospital;   West China Hospital;   Shanghai Tong Ren Hospital;   Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine;   The First Affiliated Hospital of University of South China;   JiNing NO.1 People Hospital;   Tongji Hospital;   The University of HongKong-Shenzhen Hospital;   Beijing Anzhen Hospital;   Beijing Hospital;   Peking University International Hospital;   Beijing Tongren Hospital;   China-Japan Friendship Hospital;   Peking University First Hospital;   Beijing Friendship Hospital;   Beijing Chao Yang Hospital;   Qilu Hospital of Shandong University (Qingdao);   Shandong Provincial Hospital;   The Second Hospital of Hebei Medical University;   Hebei General Hospital;   First Affiliated Hospital of Zhejiang University;   China-Japan Union Hospital, Jilin University;   Zhejiang Provincial Tongde Hospital;   People's Hospital of Ningxia Hui Autonomous Region;   Taiyuan Central Hospital of Shanxi Medical University;   Hong Xinglong Central Hospital;   Changzhi People's Hospital;   Weihai Municipal Hospital;   The first hospital affiliated to AMU (Southwest Hospital);   Affiliated Taihe Hospital of Hubei University of Medicine;   Nanshi Hospital of Nanyang
Recruiting

Thu, 25 Oct 2018 12:00:00 EDT

Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis

Condition:   Cerebrovascular Disease
Intervention:   Drug: Asprin, Cilostazol
Sponsors:   Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan;   Foundation for Biomedical Research and Innovation;   Neurology, Tokyo Women's Medical University, School of Medicine;   Kobe City General Hospital;   Tohoku University;   Kyushu University;   Department of Neurology, Saiseikai Central Hospital;   China National Center for Cardiovascular Diseases
Completed

Fri, 02 Jun 2006 12:00:00 EDT

Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery

Condition:   Coronary Artery Disease
Interventions:   Drug: ticagrelor;   Drug: Placebo
Sponsors:   Cardiology Research UBC;   University of British Columbia
Completed

Wed, 15 Jun 2011 12:00:00 EDT

Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)

Condition:   Asthma, Aspirin-Induced
Interventions:   Drug: Ifetroban Oral Capsule;   Drug: Placebo Oral Capsule
Sponsor:   Cumberland Pharmaceuticals
Recruiting

Mon, 23 Jan 2017 12:00:00 EST

Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users

Conditions:   Small Bowel Disease;   Rifaximin
Interventions:   Drug: Rifaximin;   Drug: Placebo oral tablet
Sponsors:   Chinese University of Hong Kong;   Beijing Friendship Hospital
Recruiting

Fri, 24 May 2019 12:00:00 EDT

Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement

Condition:   Aortic Valve Disease
Intervention:   Procedure: Prophylaxis of Thrombosis after aortic valve replacement
Sponsors:   Ottawa Heart Institute Research Corporation;   Edwards Lifesciences
Completed

Tue, 24 Apr 2007 12:00:00 EDT

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor + ASA + Bivalirudin;   Drug: Clopidogrel + ASA + Bivalirudin
Sponsors:   Juan J Badimon;   AstraZeneca
Completed

Tue, 17 Jul 2012 12:00:00 EDT

The Effect of a Probiotic Strain on Aspirin-induced GI Damage.

Condition:   Side Effects of Acetylsalicylic Acid Use
Interventions:   Dietary Supplement: probiotic strain;   Dietary Supplement: Placebo
Sponsors:   Chr Hansen;   Atlantia Food Clinical Trials
Completed

Tue, 25 Jul 2017 12:00:00 EDT

Aspirin Resistance and Percutaneous Coronary Intervention (PCI)

Condition:   Stable Angina
Interventions:   Drug: Intravenous Glycoprotein inhibitor + ASA, Clopidogrel;   Drug: Antiplatelet Therapy (ASA, Clopidogrel)
Sponsor:   Icahn School of Medicine at Mount Sinai
Completed

Wed, 14 Apr 2010 12:00:00 EDT

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority

Condition:   Rheumatic Heart Disease
Interventions:   Drug: Rivaroxaban (20 mg);   Drug: Vitamin K antagonists (VKA)
Sponsors:   Population Health Research Institute;   University of Cape Town;   Bayer
Active, not recruiting

Thu, 14 Jul 2016 12:00:00 EDT

Safety And Efficacy of Low Dose Oral Anticoagulants And Aspirin Therapy

Condition:   Anticoagulation in Pregnancy
Interventions:   Drug: Warfarin;   Drug: phenindione
Sponsor:   Yasser Elnahas
Completed

Tue, 01 Jan 2013 12:00:00 EST

Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.

Condition:   Cardiovascular Disease
Interventions:   Drug: slow release acetyl salicylic acid;   Drug: ASA;   Drug: SR-ASA
Sponsor:   Rottapharm Spain
Completed

Mon, 22 Jan 2007 12:00:00 EST

Simplified Anti-Thrombotic Therapy for FFR

Condition:   Coronary Artery Disease
Interventions:   Procedure: FFR;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Bivalirudin
Sponsor:   Odessa Heart Institute
Completed

Tue, 10 Mar 2015 12:00:00 EDT

Effect of Allopurinol on Mono and Co-administration With Statins on Platelets Reactivity on Diabetic Patiets Treated With Aspirin and Insulin

Condition:   Diabetes Mellitus Type 2 Platelets Reactivity Statin
Interventions:   Drug: Atorvastatin 80mg;   Drug: ALLOPURINOL 300 MG;   Drug: Atorvastatin 80mg AND allopurinol 300 mg
Sponsor:   University of Roma La Sapienza
Unknown status

Thu, 22 Jun 2017 12:00:00 EDT

ASA vs. Rivaroxaban in Newly Diagnosed or Relapsed and Refractory Multiple Myeloma Patients Treated With Len-Dex Combination Therapy.

Conditions:   Multiple Myeloma in Relapse;   Multiple Myeloma Progression;   Multiple Myeloma Stage II;   Multiple Myeloma Stage I;   Multiple Myeloma With Failed Remission;   Multiple Myeloma Stage III
Interventions:   Drug: Rivaroxaban;   Drug: ASA
Sponsors:   Lawson Health Research Institute;   The Ottawa Hospital;   Dalhousie University;   St. Boniface Hospital;   Hamilton Health Sciences Corporation
Unknown status

Fri, 09 Feb 2018 12:00:00 EST

Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease

Condition:   Kawasaki Disease
Intervention:   Drug: immunoglobulin G
Sponsor:   Green Cross Corporation
Completed

Thu, 02 Feb 2012 12:00:00 EST

Platelet Administration To Patients With Traumatic Brain Injury Who Were Treated With Aspirin

Conditions:   Aspirin Treatment;   Traumatic Intracranial Bleed;   Hemorrhage Growth;   Neurological Outcome
Intervention:   Drug: platelets
Sponsor:   Tel-Aviv Sourasky Medical Center
Unknown status

Thu, 03 Jun 2010 12:00:00 EDT

Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"

Condition:   Gastric or Duodenal Ulcers
Intervention:   Drug: Vonoprazan
Sponsor:   Takeda
Completed

Tue, 11 Jul 2017 12:00:00 EDT

Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin

Condition:   Coronary Artery Disease
Interventions:   Drug: Closone;   Drug: Plavix with Astrix
Sponsor:   Seoul St. Mary's Hospital
Completed

Wed, 09 Jan 2013 12:00:00 EST

Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty

Condition:   Venous Thromboembolism
Intervention:   Drug: rivaroxaban and ASA
Sponsors:   David Anderson;   Canadian Institutes of Health Research (CIHR)
Completed

Fri, 02 Nov 2012 12:00:00 EDT

Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study

Condition:   Atrial Fibrillation
Interventions:   Drug: Rivaroxaban and single antiplatelet drug (aspirin, clopidogrel or prasugrel);   Drug: Rivaroxaban
Sponsor:   Japan Cardiovascular Research Foundation
Unknown status

Wed, 30 Dec 2015 12:00:00 EST

Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France

Condition:   Self-administered Questionnaire to Patients
Intervention:  
Sponsor:   AstraZeneca
Withdrawn

Thu, 11 Nov 2010 12:00:00 EST

Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users

Condition:   Peptic Ulcer
Interventions:   Drug: Placebo;   Drug: PMK-S005 1;   Drug: PMK-S005 2;   Drug: PMK-S005 3
Sponsor:   PharmaKing
Completed

Wed, 21 Jan 2015 12:00:00 EST

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Condition:   Cardiovascular Disease
Intervention:  
Sponsor:   AstraZeneca
Completed

Wed, 21 May 2008 12:00:00 EDT

Evaluate Misoprostol for the Healing of Small Bowel Ulcers in Low-dose Aspirin Users Complicated by Small Bowel Bleeding

Condition:   Ulcer Hemorrhage
Interventions:   Drug: Misoprostol;   Drug: Placebo
Sponsor:   Chinese University of Hong Kong
Completed

Mon, 02 Dec 2013 12:00:00 EST

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

Condition:   Coronary Artery Disease
Interventions:   Device: PROMUS Element Coronary Stent System;   Drug: Aspirin;   Drug: Thienopyridine
Sponsor:   Boston Scientific Corporation
Completed

Wed, 28 Dec 2011 12:00:00 EST

Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches

Condition:   Delayed Alcohol Induced Headache
Interventions:   Drug: VVD-101;   Drug: Placebo
Sponsors:   Cady, Roger, M.D.;   Vivid Pharma Inc.
Completed

Fri, 27 Jun 2014 12:00:00 EDT

The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients

Condition:   Patients Taking Low-dose Aspirin
Interventions:   Drug: Albis Tab;   Drug: Placebo
Sponsor:   Daewoong Pharmaceutical Co. LTD.
Unknown status

Tue, 19 Jul 2011 12:00:00 EDT

App Reminder on ASA Adherence

Condition:   Thromboembolic Event
Interventions:   Behavioral: Standard Education;   Behavioral: Medication Reminder App
Sponsors:   Emory University;   National Association of Orthopaedic Nurses
Completed

Wed, 09 Aug 2017 12:00:00 EDT

A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin

Condition:   Platelet Inhibition
Interventions:   Drug: PN400;   Drug: ASA;   Drug: Placebo
Sponsors:   AstraZeneca;   POZEN
Completed

Mon, 29 Mar 2010 12:00:00 EDT

Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers

Condition:   Healthy
Interventions:   Drug: Aggrenox®;   Drug: Placebo;   Other: Ethanol
Sponsor:   Boehringer Ingelheim
Completed

Thu, 30 Oct 2014 12:00:00 EDT

Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

Condition:   Gastric or Duodenal Ulcers
Intervention:   Drug: Lansoprazole
Sponsor:   Takeda
Completed

Mon, 31 Mar 2014 12:00:00 EDT

Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Condition:   Head and Neck Cancer
Interventions:   Drug: Pembrolizumab;   Drug: Clopidogrel;   Drug: acetylsalicylic acid
Sponsor:   Medical University of South Carolina
Recruiting

Thu, 10 Aug 2017 12:00:00 EDT

The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel Disease

Conditions:   Chronic Total Occlusion of Coronary Artery;   Percutaneous Coronary Intervention;   Coronary Artery Disease;   Viable Myocardium
Interventions:   Drug: aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor;   Device: coronary wires. stents or coronary balloons
Sponsors:   Beijing Anzhen Hospital;   The First Affiliated Hospital of Dalian Medical University;   Beijing Friendship Hospital
Enrolling by invitation

Thu, 14 Dec 2017 12:00:00 EST

Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease

Conditions:   Acute Stroke;   Dual Antiplatelet Therapy;   Statin
Interventions:   Drug: Clopidogrel;   Drug: Aspirin;   Drug: Atorvastatin;   Drug: Rosuvastatin
Sponsor:   Chang Gung Memorial Hospital
Recruiting

Thu, 01 Apr 2021 12:00:00 EDT

Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy

Condition:   Coronary Artery Disease
Intervention:   Procedure: Hybrid coronary revascularization
Sponsors:   Aarhus University Hospital Skejby;   Danish Heart Foundation;   Aase and Ejnar Danielsens Foundation
Completed

Wed, 19 Nov 2014 12:00:00 EST

International PFO Consortium

Conditions:   Stroke;   Transient Ischemic Attack
Interventions:   Drug: Antithrombotic treatment;   Device: percutaneous device closure of PFO
Sponsors:   University Hospital Inselspital, Berne;   University Hospital, Basel, Switzerland;   University of Lausanne Hospitals;   University Hospital, Geneva;   University Hospital, Zürich;   Triemli Hospital;   Cantonal Hospital of Aarau, Switzerland;   Alfried-Krupp Krankenhaus of Essen, Germany;   University Hospital, Essen;   Klinikum Worms;   Tufts Medical Center;   Baystate Medical Center;   East Medical Center Tyler, Texas;   Universitaire Ziekenhuizen Leuven;   Ammerland Klinik GmbH, Westerstede, Germany;   University Hospital, Ghent;   Arcispedale Santa Maria Nuova-IRCCS
Recruiting

Wed, 11 Mar 2009 12:00:00 EDT

Anticoagulation in Blunt Cerebrovascular Injuries

Conditions:   Carotid Artery Injury;   Vertebral Artery Injury
Interventions:   Drug: heparin;   Drug: aspirin and clopidogrel
Sponsor:   C. Clay Cothren, MD
Withdrawn

Fri, 29 Jun 2007 12:00:00 EDT

Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

Conditions:   Gastric Ulcers;   Duodenal Ulcers
Interventions:   Drug: TAK-438;   Drug: Placebo;   Drug: Lansoprazole
Sponsor:   Takeda
Completed

Mon, 17 Oct 2011 12:00:00 EDT

Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

Conditions:   Gastric Ulcers;   Duodenal Ulcers
Interventions:   Drug: TAK-438;   Drug: Placebo;   Drug: Lansoprazole
Sponsor:   Takeda
Completed

Thu, 20 Oct 2011 12:00:00 EDT

Heredity and Phenotype Intervention (HAPI) Heart Study

Condition:   Cardiovascular Diseases
Interventions:   Other: Aspirin;   Other: Cold Pressor Test;   Other: High Fat Meal;   Other: Dietary Salt
Sponsors:   University of Maryland, Baltimore;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Tue, 22 Apr 2008 12:00:00 EDT

The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)

Conditions:   Hibernation, Myocardial;   Complete Occlusion of Coronary Artery
Interventions:   Device: stenting or balloon expansion;   Drug: aspirin, clopidogrel, ticagrelor, atorvastatin, rosuvastatin, betaloc
Sponsors:   The First Affiliated Hospital of Dalian Medical University;   Beijing Anzhen Hospital;   First Hospital of China Medical University;   Nanfang Hospital of Southern Medical University
Completed

Tue, 10 May 2016 12:00:00 EDT

TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI

Condition:   ST Elevation Myocardial Infarction
Interventions:   Drug: Ticagrelor;   Other: Placebo
Sponsors:   Papworth Hospital NHS Foundation Trust;   AstraZeneca
Unknown status

Tue, 09 May 2017 12:00:00 EDT

Asymptomatic Carotid Artery Plaque Study (ACAPS)

Conditions:   Cardiovascular Diseases;   Carotid Stenosis;   Cerebral Arteriosclerosis;   Cerebrovascular Disorders;   Heart Diseases;   Vascular Diseases
Interventions:   Drug: aspirin;   Drug: lovastatin
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 28 Oct 1999 12:00:00 EDT

First Approach for Aspirin Misuse Objective Screening

Condition:   Peripheral Arterial Disease
Intervention:   Device: Laser speckle flowmetry
Sponsor:   University Hospital, Angers
Completed

Tue, 20 Dec 2016 12:00:00 EST

Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)

Conditions:   Gastric Ulcer;   Duodenal Ulcer
Interventions:   Drug: Esomeprazole 40 mg;   Drug: Esomeprazole 20 mg;   Drug: Placebo
Sponsor:   AstraZeneca
Completed

Thu, 01 Mar 2007 12:00:00 EST

AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

Condition:   Platelet Dysfunction Due to Aspirin Ingestion
Intervention:  
Sponsor:   Aggredyne, Inc.
Completed

Fri, 02 Aug 2013 12:00:00 EDT

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

Conditions:   Aortic Valve Stenosis;   Cardiovascular Diseases;   Heart Valve Diseases;   Ventricular Outflow Obstruction;   Thrombosis
Interventions:   Drug: Acetylsalicylic acid;   Drug: Clopidogrel;   Drug: Rivaroxaban
Sponsors:   ECRI bv;   Rigshospitalet, Denmark;   Bayer;   Cardialysis BV
Completed

Thu, 14 Jul 2016 12:00:00 EDT

Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke

Condition:   Ischemic Stroke
Interventions:   Drug: acetylsalicylic acid, clopidogrel bisulfate and/or warfarin, Apixaban, Rivaroxaban, Dabigatran;   Drug: alteplase;   Procedure: endovascular
Sponsor:   Rabin Medical Center
Unknown status

Fri, 05 Dec 2014 12:00:00 EST

Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting

Condition:   Carotid Stenosis
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel;   Procedure: Carotid stenting
Sponsor:   Assiut University
Not yet recruiting

Mon, 16 Sep 2019 12:00:00 EDT

Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior Circulation

Conditions:   Stroke of Basilar Artery;   Optical Coherence Tomography;   Antithrombotics;   Endovascular Thrombectomy
Interventions:   Drug: Unfractionated heparin;   Drug: Acetylsalicylic Acid (ASA)
Sponsor:   Sunnybrook Health Sciences Centre
Recruiting

Thu, 10 Oct 2019 12:00:00 EDT

Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

Conditions:   High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions:   Drug: PEGASYS;   Drug: Hydroxyurea;   Drug: Aspirin
Sponsors:   Ronald Hoffman;   Myeloproliferative Disorders-Research Consortium;   National Cancer Institute (NCI);   Roche Pharma AG
Completed

Tue, 14 Dec 2010 12:00:00 EST

Cilostazol and Endothelial Progenitor Cell

Condition:   Myocardial Infarction, Acute
Interventions:   Drug: Cilostazol Tablets;   Drug: placebo;   Drug: Aspirin;   Drug: Clopidogrel
Sponsors:   Gyeongsang National University Hospital;   Korea Otsuka Pharmaceutical Co., Ltd.
Active, not recruiting

Fri, 29 May 2020 12:00:00 EDT

The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction

Conditions:   STEMI - ST Elevation Myocardial Infarction;   Left Ventricular Systolic Dysfunction
Interventions:   Drug: Dapagliflozin 10Mg Tab;   Drug: Placebo
Sponsor:   Assiut University
Not yet recruiting

Thu, 16 Sep 2021 12:00:00 EDT

Hydroxychloroquine in Prevention of Preeclampsia

Condition:   Hydroxychloroquine
Interventions:   Drug: Hydroxychloroquine;   Drug: Folic acid;   Drug: Low-dose aspirin;   Drug: Placebo
Sponsor:   Assiut University
Recruiting

Tue, 16 Feb 2021 12:00:00 EST

PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)

Condition:   Coronary Artery Disease
Interventions:   Device: PROMUS Element Everolimus-Eluting Coronary Stent System;   Drug: Aspirin;   Drug: Thienopyridine
Sponsor:   Boston Scientific Corporation
Completed

Mon, 16 Jan 2012 12:00:00 EST

Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke

Condition:   Ischemic Stroke
Interventions:   Drug: Qizhitongluo Capsule;   Drug: Naoxintong Capsule;   Drug: Aspirin Enteric-coated Tablets;   Behavioral: the routine recovery training;   Drug: placebo
Sponsor:   China Academy of Chinese Medical Sciences
Completed

Mon, 07 Jan 2013 12:00:00 EST

Aspirin Resistance Following Coronary Bypass Surgery

Condition:   Ischemic Heart Disease
Intervention:   Procedure: Coronary artery bypass surgery
Sponsor:   Sheba Medical Center
Terminated

Thu, 01 Dec 2005 12:00:00 EST